Seed	Sign	Gene_target	Ensembl	Repeated	N_repeated	Repeated2	N_repeated2	P-value	Ortholist2	Orthologs	TRRUST(+)	Phenotype	GO	GOterm	Keyword	Reactome	Reactome_terms
COQ2	positive	RAD51AP1	ENSG00000111247	COQ2	1	COQ2	1	0.00219605374795884					GO:0005634;GO:0003723;GO:0003677;GO:0006281;GO:0005515;GO:0006310;GO:0006974;GO:0003697;GO:0003690;GO:0005654;GO:0032991;GO:0010569;GO:0000790;GO:0000724;GO:0071479;GO:0036297	nucleus;RNA binding;DNA repair;single-stranded DNA binding;double-stranded DNA binding;DNA binding;protein binding;DNA recombination;cellular response to DNA damage stimulus;nucleoplasm;protein-containing complex;regulation of double-strand break repair via homologous recombination;nuclear chromatin;double-strand break repair via homologous recombination;cellular response to ionizing radiation;interstrand cross-link repair	Alternative splicing;DNA damage;DNA recombination;DNA repair;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome	R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-5693579;R-HSA-5693554	HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;Homologous DNA Pairing and Strand Exchange;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
COQ2	positive	SLC25A15	ENSG00000102743	COQ2	1	COQ2	1	0.00244090410188869	WBGene00020422			Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome;Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome;Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	GO:0016020;GO:0016021;GO:0005743;GO:0005739;GO:0000050;GO:0000064;GO:1990575	membrane;integral component of membrane;mitochondrial inner membrane;mitochondrion;urea cycle;L-ornithine transmembrane transporter activity;mitochondrial L-ornithine transmembrane transport	Disease mutation;Membrane;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-71291;R-HSA-70635	Metabolism;Metabolism of amino acids and derivatives;Urea cycle
COQ2	positive	RFC3	ENSG00000133119	COQ2	1	COQ2	1	0.00244090410188869	WBGene00004339	WBGene00004339(0)			GO:0005634;GO:0003677;GO:0005515;GO:0032508;GO:0006260;GO:0006261;GO:0005654;GO:0016887;GO:1901796;GO:0019985;GO:0006283;GO:0042276;GO:0017116;GO:0003689;GO:0042769;GO:0046683;GO:0006296;GO:0033683;GO:0000731;GO:0032201;GO:1900264;GO:0031390;GO:0006297;GO:0070987;GO:0006271;GO:0005663	DNA binding;DNA replication;nucleus;protein binding;DNA duplex unwinding;ATPase activity;DNA-dependent DNA replication;DNA repair;nucleoplasm;regulation of signal transduction by p53 class mediator;translesion synthesis;transcription-coupled nucleotide-excision repair;error-prone translesion synthesis;single-stranded DNA helicase activity;DNA damage response, detection of DNA damage;response to organophosphorus;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;DNA synthesis involved in DNA repair;telomere maintenance via semi-conservative replication;DNA clamp loader activity;positive regulation of DNA-directed DNA polymerase activity;Ctf18 RFC-like complex;nucleotide-excision repair, DNA gap filling;error-free translesion synthesis;DNA strand elongation involved in DNA replication;DNA replication factor C complex	Acetylation;Alternative splicing;DNA replication;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-73886;R-HSA-5633007;R-HSA-6804756;R-HSA-176187;R-HSA-157579;R-HSA-180786;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-5685938;R-HSA-110312;R-HSA-5655862;R-HSA-5656121;R-HSA-69190;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174411;R-HSA-174417;R-HSA-69091;R-HSA-69109;R-HSA-69186;R-HSA-110320;R-HSA-5696397	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Chromosome Maintenance;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Activation of ATR in response to replication stress;Telomere Maintenance;Extension of Telomeres;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);HDR through Single Strand Annealing (SSA);Translesion synthesis by REV1;Translesion synthesis by POLK;Translesion synthesis by POLI;DNA strand elongation;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Polymerase switching;Leading Strand Synthesis;Lagging Strand Synthesis;Translesion Synthesis by POLH;Gap-filling DNA repair synthesis and ligation in GG-NER
COQ2	positive	NCAPG2	ENSG00000146918	COQ2	1	COQ2	1	0.00244090410188869	WBGene00010093	WBGene00010093(0)		Severe Neurodevelopmental Syndrome;KAHN-KAHN-KATSANIS SYNDROME	GO:0005634;GO:0016607;GO:0016020;GO:0051301;GO:0005515;GO:0007049;GO:0005654;GO:0030261;GO:0035064;GO:0043425;GO:0098772;GO:0001833;GO:0006366;GO:0030218;GO:0045647;GO:0061098;GO:2000273;GO:0000796	nucleus;nuclear speck;membrane;nucleoplasm;cell division;protein binding;cell cycle;chromosome condensation;methylated histone binding;bHLH transcription factor binding;inner cell mass cell proliferation;transcription by RNA polymerase II;erythrocyte differentiation;negative regulation of erythrocyte differentiation;positive regulation of protein tyrosine kinase activity;positive regulation of signaling receptor activity;condensin complex	Alternative splicing;Cell cycle;Cell division;DNA condensation;Disease mutation;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-68886;R-HSA-69278;R-HSA-68875;R-HSA-2299718	Cell Cycle;M Phase;Cell Cycle, Mitotic;Mitotic Prophase;Condensation of Prophase Chromosomes
COQ2	positive	PFAS	ENSG00000178921	COQ2	1	COQ2	1	0.00244090410188869	WBGene00008654	WBGene00008654(0)			GO:0005737;GO:0046872;GO:0000166;GO:0005524;GO:0016874;GO:0006164;GO:0006541;GO:0006189;GO:0005829;GO:0070062;GO:0004642;GO:0009156;GO:0009168;GO:0042493;GO:0097065	'de novo' IMP biosynthetic process;phosphoribosylformylglycinamidine synthase activity;cytoplasm;metal ion binding;nucleotide binding;ATP binding;ligase activity;purine nucleotide biosynthetic process;glutamine metabolic process;cytosol;extracellular exosome;purine nucleobase biosynthetic process;ribonucleoside monophosphate biosynthetic process;purine ribonucleoside monophosphate biosynthetic process;response to drug;anterior head development	ATP-binding;Cytoplasm;Glutamine amidotransferase;Ligase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Purine biosynthesis;Reference proteome	R-HSA-1430728;R-HSA-15869;R-HSA-73817;R-HSA-8956320	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
COQ2	positive	SMC4	ENSG00000113810	COQ2	1	COQ2	1	0.00271019341646339	WBGene00004874;WBGene00001086	WBGene00004874(1);WBGene00001086(0)			GO:0005634;GO:0005737;GO:0016607;GO:0000166;GO:0005524;GO:0005829;GO:0051301;GO:0005694;GO:0005515;GO:0051276;GO:0007049;GO:0005654;GO:0030261;GO:0046982;GO:0000070;GO:0007076;GO:0000796;GO:0003697;GO:0010032;GO:0045132;GO:0051383	ATP binding;protein binding;chromosome;chromosome organization;nucleus;cytoplasm;nuclear speck;nucleotide binding;cytosol;cell division;cell cycle;nucleoplasm;chromosome condensation;mitotic sister chromatid segregation;mitotic chromosome condensation;condensin complex;condensin core heterodimer;single-stranded DNA binding;meiotic chromosome condensation;meiotic chromosome segregation;kinetochore organization	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell cycle;Cell division;Chromosome;Coiled coil;Cytoplasm;DNA condensation;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-68886;R-HSA-69278;R-HSA-68877;R-HSA-68875;R-HSA-2299718;R-HSA-2514853	Cell Cycle;M Phase;Cell Cycle, Mitotic;Mitotic Prometaphase;Mitotic Prophase;Condensation of Prophase Chromosomes;Condensation of Prometaphase Chromosomes
COQ2	positive	CCNB1	ENSG00000134057	COQ2	1	COQ2	1	0.00271019341646339	WBGene00000865;WBGene00000866;WBGene00000867;WBGene00000863	WBGene00000867(0);WBGene00000866(0);WBGene00000865(0);WBGene00000871(0);WBGene00000870(0);WBGene00014069(0);WBGene00021040(0);WBGene00000863(0);WBGene00000864(0);WBGene00017259(0)			GO:0005737;GO:0005634;GO:0005829;GO:0051301;GO:0005856;GO:0005515;GO:0007049;GO:0005813;GO:0005815;GO:0005759;GO:0006977;GO:0005654;GO:0019901;GO:0031145;GO:1901990;GO:0000086;GO:0045737;GO:0006367;GO:0044389;GO:0045931;GO:0000942;GO:0007052;GO:0004672;GO:0016538;GO:0000079;GO:0007077;GO:0044772;GO:0051726;GO:0000307;GO:0010971;GO:1905448;GO:0097125;GO:0005113;GO:0016301;GO:0035173;GO:0061575;GO:0000278;GO:0001556;GO:0001701;GO:0001933;GO:0006468;GO:0007080;GO:0007283;GO:0009612;GO:0009636;GO:0010629;GO:0031442;GO:0033129;GO:0042246;GO:0042493;GO:0045787;GO:0046680;GO:0048146;GO:0048565;GO:0051987;GO:0055015;GO:0060045;GO:0060623;GO:0065003;GO:0071283;GO:0071398;GO:0071407;GO:0071456;GO:0090266;GO:2000775;GO:0000922;GO:0016020	nucleus;cytoplasm;cell;cytosol;cytoskeleton;cell division;protein binding;cell cycle;centrosome;microtubule organizing center;mitochondrial matrix;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;nucleoplasm;protein kinase binding;anaphase-promoting complex-dependent catabolic process;regulation of mitotic cell cycle phase transition;G2/M transition of mitotic cell cycle;positive regulation of cyclin-dependent protein serine/threonine kinase activity;transcription initiation from RNA polymerase II promoter;ubiquitin-like protein ligase binding;positive regulation of mitotic cell cycle;condensed nuclear chromosome outer kinetochore;mitotic spindle organization;protein kinase activity;cyclin-dependent protein serine/threonine kinase regulator activity;regulation of cyclin-dependent protein serine/threonine kinase activity;mitotic nuclear envelope disassembly;mitotic cell cycle phase transition;regulation of cell cycle;cyclin-dependent protein kinase holoenzyme complex;positive regulation of G2/M transition of mitotic cell cycle;positive regulation of mitochondrial ATP synthesis coupled electron transport;cyclin B1-CDK1 complex;patched binding;histone kinase activity;cyclin-dependent protein serine/threonine kinase activator activity;mitotic cell cycle;oocyte maturation;in utero embryonic development;negative regulation of protein phosphorylation;protein phosphorylation;mitotic metaphase plate congression;spermatogenesis;response to mechanical stimulus;response to toxic substance;negative regulation of gene expression;positive regulation of mRNA 3'-end processing;positive regulation of histone phosphorylation;tissue regeneration;response to drug;positive regulation of cell cycle;response to DDT;positive regulation of fibroblast proliferation;digestive tract development;positive regulation of attachment of spindle microtubules to kinetochore;ventricular cardiac muscle cell development;positive regulation of cardiac muscle cell proliferation;regulation of chromosome condensation;protein-containing complex assembly;cellular response to iron(III) ion;cellular response to fatty acid;cellular response to organic cyclic compound;cellular response to hypoxia;regulation of mitotic cell cycle spindle assembly checkpoint;histone H3-S10 phosphorylation involved in chromosome condensation;spindle pole;membrane	3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Cyclin;Cytoplasm;Cytoskeleton;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-174143;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-453274;R-HSA-453276;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-69481;R-HSA-69620;R-HSA-8852276;R-HSA-8878166;R-HSA-2500257;R-HSA-68877;R-HSA-2980766;R-HSA-3301854;R-HSA-68875;R-HSA-2565942;R-HSA-453279;R-HSA-69206;R-HSA-174048;R-HSA-176412;R-HSA-69473;R-HSA-75035;R-HSA-6804114;R-HSA-69273;R-HSA-2465910;R-HSA-113507;R-HSA-113510;R-HSA-162658;R-HSA-2299718;R-HSA-156711;R-HSA-2514853;R-HSA-2980767;R-HSA-69478;R-HSA-4419969;R-HSA-176417	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;APC/C-mediated degradation of cell cycle proteins;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;M Phase;G2/M Transition;Cell Cycle, Mitotic;G2/M Checkpoints;Cell Cycle Checkpoints;The role of GTSE1 in G2/M progression after G2 checkpoint;Transcriptional regulation by RUNX2;Resolution of Sister Chromatid Cohesion;Mitotic Prometaphase;Nuclear Envelope Breakdown;Nuclear Pore Complex (NPC) Disassembly;Mitotic Prophase;Regulation of PLK1 Activity at G2/M Transition;Mitotic G1 phase and G1/S transition;G1/S Transition;APC/C:Cdc20 mediated degradation of Cyclin B;Phosphorylation of the APC/C;G2/M DNA damage checkpoint;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Cyclin A/B1/B2 associated events during G2/M transition;MASTL Facilitates Mitotic Progression;E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;Golgi Cisternae Pericentriolar Stack Reorganization;Condensation of Prophase Chromosomes;Polo-like kinase mediated events;Condensation of Prometaphase Chromosomes;Activation of NIMA Kinases NEK9, NEK6, NEK7;G2/M DNA replication checkpoint;Depolymerisation of the Nuclear Lamina;Phosphorylation of Emi1
COQ2	positive	SMC2	ENSG00000136824	COQ2	1	COQ2	1	0.00271019341646339	WBGene00003367	WBGene00003367(0)			GO:0005634;GO:0005737;GO:0000166;GO:0005524;GO:0005730;GO:0051301;GO:0005694;GO:0005515;GO:0051276;GO:0007049;GO:0005654;GO:0005829;GO:0070062;GO:0030261;GO:0046982;GO:0000228;GO:0000793;GO:0007076;GO:0000796;GO:0003697;GO:0010032;GO:0045132;GO:0051383	ATP binding;protein binding;chromosome;chromosome organization;nucleus;cytoplasm;nucleotide binding;nucleoplasm;nucleolus;cell division;cell cycle;cytosol;extracellular exosome;chromosome condensation;nuclear chromosome;condensed chromosome;mitotic chromosome condensation;condensin complex;condensin core heterodimer;single-stranded DNA binding;meiotic chromosome condensation;meiotic chromosome segregation;kinetochore organization	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell cycle;Cell division;Chromosome;Coiled coil;Cytoplasm;DNA condensation;Mitosis;Nucleotide-binding;Nucleus;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-68886;R-HSA-69278;R-HSA-68877;R-HSA-68875;R-HSA-2299718;R-HSA-2514853	Cell Cycle;M Phase;Cell Cycle, Mitotic;Mitotic Prometaphase;Mitotic Prophase;Condensation of Prophase Chromosomes;Condensation of Prometaphase Chromosomes
COQ2	positive	PRKDC	ENSG00000253729	COQ2	1	COQ2	1	0.00271019341646339	WBGene00000226			Severe combined immunodeficiency due to DNA-PKcs deficiency;Immunodeficiency 26 with or without neurologic abnormalities	GO:0045944;GO:0032869;GO:0005634;GO:0003723;GO:0016020;GO:0000166;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005654;GO:0003677;GO:0006281;GO:0005515;GO:0006303;GO:0006310;GO:0006974;GO:0048511;GO:0002376;GO:0045087;GO:0005730;GO:0016567;GO:0005829;GO:0006302;GO:0000784;GO:2001034;GO:0008630;GO:0005667;GO:0001933;GO:0032991;GO:0019904;GO:0006464;GO:0006468;GO:0004672;GO:0042752;GO:0032481;GO:0002218;GO:0018105;GO:0008134;GO:0032993;GO:0000723;GO:0043066;GO:0003690;GO:0048660;GO:0070419;GO:0033152;GO:0005958;GO:0004677;GO:0019899;GO:0001756;GO:0002326;GO:0002328;GO:0002360;GO:0002377;GO:0002638;GO:0002684;GO:0007420;GO:0007507;GO:0010212;GO:0010332;GO:0014823;GO:0016233;GO:0030098;GO:0031648;GO:0033077;GO:0033151;GO:0033153;GO:0035234;GO:0043065;GO:0048146;GO:0048536;GO:0048538;GO:0048639;GO:0050678;GO:0072431;GO:0097681;GO:2000773;GO:2001229	DNA binding;nucleus;ATP binding;protein binding;DNA repair;kinase activity;double-strand break repair via nonhomologous end joining;DNA-dependent protein kinase activity;positive regulation of transcription by RNA polymerase II;cellular response to insulin stimulus;RNA binding;membrane;nucleotide binding;protein serine/threonine kinase activity;transferase activity;phosphorylation;nucleoplasm;DNA recombination;cellular response to DNA damage stimulus;rhythmic process;immune system process;innate immune response;nucleolus;protein ubiquitination;cytosol;double-strand break repair;nuclear chromosome, telomeric region;positive regulation of double-strand break repair via nonhomologous end joining;intrinsic apoptotic signaling pathway in response to DNA damage;transcription factor complex;negative regulation of protein phosphorylation;protein-containing complex;protein domain specific binding;cellular protein modification process;protein phosphorylation;protein kinase activity;regulation of circadian rhythm;positive regulation of type I interferon production;activation of innate immune response;peptidyl-serine phosphorylation;transcription factor binding;protein-DNA complex;telomere maintenance;negative regulation of apoptotic process;double-stranded DNA binding;regulation of smooth muscle cell proliferation;nonhomologous end joining complex;immunoglobulin V(D)J recombination;DNA-dependent protein kinase-DNA ligase 4 complex;enzyme binding;somitogenesis;B cell lineage commitment;pro-B cell differentiation;T cell lineage commitment;immunoglobulin production;negative regulation of immunoglobulin production;positive regulation of immune system process;brain development;heart development;response to ionizing radiation;response to gamma radiation;response to activity;telomere capping;lymphocyte differentiation;protein destabilization;T cell differentiation in thymus;V(D)J recombination;T cell receptor V(D)J recombination;ectopic germ cell programmed cell death;positive regulation of apoptotic process;positive regulation of fibroblast proliferation;spleen development;thymus development;positive regulation of developmental growth;regulation of epithelial cell proliferation;signal transduction involved in mitotic G1 DNA damage checkpoint;double-strand break repair via alternative nonhomologous end joining;negative regulation of cellular senescence;negative regulation of response to gamma radiation	3D-structure;ATP-binding;Acetylation;Alternative splicing;Biological rhythms;DNA damage;DNA recombination;DNA repair;DNA-binding;Disease mutation;Immunity;Innate immunity;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SCID;Serine/threonine-protein kinase;TPR repeat;Transferase;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-8866654;R-HSA-5693532;R-HSA-73894;R-HSA-1834949;R-HSA-5693571;R-HSA-1834941;R-HSA-3270619	Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;DNA Double-Strand Break Repair;DNA Repair;Cytosolic sensors of pathogen-associated DNA ;Nonhomologous End-Joining (NHEJ);STING mediated induction of host immune responses;IRF3-mediated induction of type I IFN
COQ2	positive	NUP37	ENSG00000075188	COQ2	1	COQ2	1	0.00300602278781814				Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;MICROCEPHALY 24 PRIMARY AUTOSOMAL RECESSIVE	GO:0051028;GO:0005634;GO:0015031;GO:0005654;GO:0051301;GO:0005694;GO:0007049;GO:0005643;GO:0007059;GO:0000775;GO:0000776;GO:0000777;GO:0005515;GO:0005829;GO:0075733;GO:0043657;GO:0006110;GO:0006406;GO:0006409;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0031080	protein binding;nuclear pore outer ring;mRNA transport;nucleus;protein transport;nucleoplasm;cell division;chromosome;cell cycle;nuclear pore;chromosome segregation;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cytosol;intracellular transport of virus;host cell;regulation of glycolytic process;mRNA export from nucleus;tRNA export from nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope	3D-structure;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Disease mutation;Kinetochore;Mitosis;Nuclear pore complex;Nucleus;Primary microcephaly;Protein transport;Reference proteome;Repeat;Translocation;Transport;WD repeat;mRNA transport	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-1430728;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-72306;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1280215;R-HSA-162909;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-5619115;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-8953897;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-165054;R-HSA-168253;R-HSA-168254;R-HSA-168255;R-HSA-168271;R-HSA-168273;R-HSA-168274;R-HSA-168276;R-HSA-168325;R-HSA-168333;R-HSA-170822;R-HSA-176033;R-HSA-177243;R-HSA-180746;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-211000;R-HSA-2980766;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-3232142;R-HSA-3301854;R-HSA-3371453;R-HSA-3371556;R-HSA-4085377;R-HSA-4551638;R-HSA-4570464;R-HSA-4615885;R-HSA-5578749;R-HSA-5619102;R-HSA-5619107;R-HSA-6784531;R-HSA-68875;R-HSA-72202;R-HSA-72203;R-HSA-913531;R-HSA-141424;R-HSA-141444;R-HSA-69618	Immune System;Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Metabolism;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;tRNA processing;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Disorders of transmembrane transporters;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;Cellular responses to external stimuli;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Rev-mediated nuclear export of HIV RNA;Host Interactions with Influenza Factors;Influenza Infection;Influenza Life Cycle;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);tRNA processing in the nucleus;Mitotic Prophase;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
COQ2	positive	POLA1	ENSG00000101868	COQ2	1	COQ2	1	0.00300602278781814	WBGene00012936	WBGene00012936(1)		X-linked reticulate pigmentary disorder;Pigmentary disorder reticulate with systemic manifestations X-linked	GO:0003676;GO:0005634;GO:0046872;GO:0016740;GO:0005829;GO:0005654;GO:0003677;GO:0000166;GO:0006260;GO:0016779;GO:0003887;GO:0051536;GO:0051539;GO:0071897;GO:0001882;GO:0046982;GO:0005658;GO:0005737;GO:0005515;GO:0006270;GO:0006281;GO:0005730;GO:0019901;GO:0003682;GO:0008283;GO:0016032;GO:0003697;GO:0006269;GO:0000785;GO:0016363;GO:0000082;GO:0006303;GO:0005635;GO:0003688;GO:0000083;GO:0017076;GO:0019103;GO:0000731;GO:0006271;GO:0006272;GO:0006273;GO:0032201;GO:1902975	DNA binding;nucleic acid binding;DNA replication;nucleotide binding;DNA-directed DNA polymerase activity;nucleoside binding;nucleus;metal ion binding;transferase activity;nucleoplasm;cytosol;nucleotidyltransferase activity;iron-sulfur cluster binding;4 iron, 4 sulfur cluster binding;DNA biosynthetic process;alpha DNA polymerase:primase complex;cytoplasm;protein binding;DNA replication initiation;DNA repair;nucleolus;protein kinase binding;chromatin binding;viral process;DNA replication, synthesis of RNA primer;chromatin;nuclear matrix;G1/S transition of mitotic cell cycle;double-strand break repair via nonhomologous end joining;nuclear envelope;single-stranded DNA binding;DNA replication origin binding;regulation of transcription involved in G1/S transition of mitotic cell cycle;purine nucleotide binding;pyrimidine nucleotide binding;DNA synthesis involved in DNA repair;DNA strand elongation involved in DNA replication;leading strand elongation;lagging strand elongation;telomere maintenance via semi-conservative replication;regulation of type I interferon production;mitotic DNA replication initiation	3D-structure;4Fe-4S;Acetylation;Cytoplasm;DNA replication;DNA-binding;DNA-directed DNA polymerase;Direct protein sequencing;Disease mutation;Dwarfism;Host-virus interaction;Iron;Iron-sulfur;Mental retardation;Metal-binding;Nucleotidyltransferase;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Zinc;Zinc-finger	R-HSA-1640170;R-HSA-69002;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-73886;R-HSA-453279;R-HSA-69206;R-HSA-68962;R-HSA-157579;R-HSA-180786;R-HSA-113510;R-HSA-69190;R-HSA-69205;R-HSA-113501;R-HSA-174411;R-HSA-174417;R-HSA-174430;R-HSA-68952;R-HSA-69091;R-HSA-69109;R-HSA-69166;R-HSA-69183;R-HSA-69186	Cell Cycle;DNA Replication Pre-Initiation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Chromosome Maintenance;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of the pre-replicative complex;Telomere Maintenance;Extension of Telomeres;E2F mediated regulation of DNA replication;DNA strand elongation;G1/S-Specific Transcription;Inhibition of replication initiation of damaged DNA by RB1/E2F1;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Telomere C-strand synthesis initiation;DNA replication initiation;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis
COQ2	positive	MRPL3	ENSG00000114686	COQ2	1	COQ2	1	0.00300602278781814	WBGene00016142	WBGene00016142(1)		Combined oxidative phosphorylation defect type 9;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9	GO:0003723;GO:0005739;GO:0003735;GO:0006412;GO:0005840;GO:0005762;GO:0005743;GO:0070125;GO:0070126;GO:0005622	structural constituent of ribosome;translation;ribosome;RNA binding;mitochondrion;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination	3D-structure;Disease mutation;Mitochondrion;Polymorphism;Primary mitochondrial disease;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ2	positive	ZWINT	ENSG00000122952	COQ2	1	COQ2	1	0.00300602278781814					GO:0005737;GO:0005634;GO:0005829;GO:0005654;GO:0051301;GO:0005694;GO:0005515;GO:0007049;GO:0016604;GO:0000776;GO:0000775;GO:0000777;GO:0007093;GO:0030425;GO:0000070;GO:0047485;GO:0051649;GO:0043005;GO:0043231	kinetochore;mitotic cell cycle checkpoint;cytoplasm;cell;nucleus;nucleoplasm;cytosol;cell division;chromosome;protein binding;cell cycle;nuclear body;chromosome, centromeric region;condensed chromosome kinetochore;dendrite;mitotic sister chromatid segregation;protein N-terminus binding;establishment of localization in cell;neuron projection;intracellular membrane-bounded organelle	Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Kinetochore;Mitosis;Nucleus;Polymorphism;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
COQ2	positive	NUP85	ENSG00000125450	COQ2	1	COQ2	1	0.00300602278781814	WBGene00003788	WBGene00003788(0)		Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;NEPHROTIC SYNDROME TYPE 17	GO:0051028;GO:0005634;GO:0016020;GO:0015031;GO:0005643;GO:0006913;GO:0031965;GO:0017056;GO:0031080;GO:0005737;GO:0005829;GO:0005694;GO:0005856;GO:0005515;GO:0005819;GO:0000775;GO:0000776;GO:0000777;GO:0045893;GO:0075733;GO:0043657;GO:0006110;GO:0006406;GO:0006409;GO:0006606;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0072006;GO:0006935;GO:0030032;GO:0048246	mRNA transport;nucleus;membrane;protein transport;nuclear pore;nucleocytoplasmic transport;nuclear membrane;structural constituent of nuclear pore;nuclear pore outer ring;cytoplasm;nucleoplasm;cytosol;cytoskeleton;chromosome;protein binding;spindle;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;positive regulation of transcription, DNA-templated;intracellular transport of virus;host cell;regulation of glycolytic process;mRNA export from nucleus;tRNA export from nucleus;protein import into nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope;nephron development;chemotaxis;lamellipodium assembly;macrophage chemotaxis	3D-structure;Acetylation;Alternative splicing;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Disease mutation;Kinetochore;Membrane;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Translocation;Transport;mRNA transport	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-1430728;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-72306;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1280215;R-HSA-162909;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-5619115;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-8953897;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-165054;R-HSA-168253;R-HSA-168254;R-HSA-168255;R-HSA-168271;R-HSA-168273;R-HSA-168274;R-HSA-168276;R-HSA-168325;R-HSA-168333;R-HSA-170822;R-HSA-176033;R-HSA-177243;R-HSA-180746;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-211000;R-HSA-2980766;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-3232142;R-HSA-3301854;R-HSA-3371453;R-HSA-3371556;R-HSA-4085377;R-HSA-4551638;R-HSA-4570464;R-HSA-4615885;R-HSA-5578749;R-HSA-5619102;R-HSA-5619107;R-HSA-6784531;R-HSA-68875;R-HSA-72202;R-HSA-72203;R-HSA-913531;R-HSA-141424;R-HSA-141444;R-HSA-69618	Immune System;Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Metabolism;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;tRNA processing;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Disorders of transmembrane transporters;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;Cellular responses to external stimuli;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Rev-mediated nuclear export of HIV RNA;Host Interactions with Influenza Factors;Influenza Infection;Influenza Life Cycle;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);tRNA processing in the nucleus;Mitotic Prophase;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
COQ2	positive	NUDT15	ENSG00000136159	COQ2	1	COQ2	1	0.00300602278781814				Azathioprine or 6-mercatopurine toxicity or dose selection;THIOPURINES POOR METABOLISM OF 2	GO:0046872;GO:0016787;GO:0042738;GO:0005829;GO:0005515;GO:0004551;GO:0035529;GO:0061136;GO:0000278;GO:0047429;GO:0034656;GO:0008413;GO:0035539;GO:0006195;GO:0006203;GO:0042262;GO:0017110;GO:0000302;GO:0009217;GO:1901292	hydrolase activity;metal ion binding;cytosol;protein binding;exogenous drug catabolic process;nucleotide diphosphatase activity;NADH pyrophosphatase activity;nucleoside-triphosphate diphosphatase activity;regulation of proteasomal protein catabolic process;mitotic cell cycle;nucleobase-containing small molecule catabolic process;8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity;8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity;purine nucleotide catabolic process;dGTP catabolic process;DNA protection;nucleoside-diphosphatase activity;response to reactive oxygen species;purine deoxyribonucleoside triphosphate catabolic process;nucleoside phosphate catabolic process	3D-structure;Hydrolase;Magnesium;Manganese;Metal-binding;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-15869;R-HSA-74259;R-HSA-8956319;R-HSA-2393930	Metabolism;Metabolism of nucleotides;Purine catabolism;Nucleobase catabolism;Phosphate bond hydrolysis by NUDT proteins
COQ2	positive	PRMT3	ENSG00000185238	COQ2	1	COQ2	1	0.00300602278781814					GO:0003676;GO:0005737;GO:0046872;GO:0016740;GO:0008168;GO:0032259;GO:0005515;GO:0006479;GO:0005634;GO:0005829;GO:0031397;GO:0016274;GO:0043022;GO:0035246;GO:0016020;GO:0016021	nucleic acid binding;methyltransferase activity;protein methylation;cytoplasm;metal ion binding;transferase activity;methylation;protein binding;nucleus;cytosol;negative regulation of protein ubiquitination;protein-arginine N-methyltransferase activity;ribosome binding;peptidyl-arginine N-methylation;membrane;integral component of membrane	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Metal-binding;Methyltransferase;Phosphoprotein;Polymorphism;Reference proteome;S-adenosyl-L-methionine;Transferase;Zinc;Zinc-finger	R-HSA-392499;R-HSA-597592;R-HSA-3247509;R-HSA-4839726;R-HSA-3214858;R-HSA-8876725	Metabolism of proteins;Post-translational protein modification;Chromatin modifying enzymes;Chromatin organization;RMTs methylate histone arginines;Protein methylation
COQ2	positive	RPA3	ENSG00000106399	COQ2	1	COQ2	1	0.0033306367871434					GO:0005634;GO:0003677;GO:0006281;GO:0005515;GO:0006310;GO:0006974;GO:0006260;GO:0006298;GO:0005654;GO:0007346;GO:0042127;GO:1900034;GO:0036297;GO:0003697;GO:0006284;GO:1901796;GO:0000082;GO:0000724;GO:0019985;GO:0006283;GO:0003684;GO:0005662;GO:0042276;GO:0006289;GO:0035861;GO:0000723;GO:0042769;GO:0006293;GO:0006295;GO:0006296;GO:0033683;GO:0006294;GO:0032201;GO:0006297;GO:0070987	DNA binding;nucleus;DNA repair;DNA replication;DNA recombination;protein binding;cellular response to DNA damage stimulus;mismatch repair;nucleoplasm;regulation of mitotic cell cycle;regulation of cell population proliferation;regulation of cellular response to heat;interstrand cross-link repair;base-excision repair;single-stranded DNA binding;regulation of signal transduction by p53 class mediator;G1/S transition of mitotic cell cycle;double-strand break repair via homologous recombination;translesion synthesis;transcription-coupled nucleotide-excision repair;damaged DNA binding;DNA replication factor A complex;error-prone translesion synthesis;nucleotide-excision repair;site of double-strand break;telomere maintenance;DNA damage response, detection of DNA damage;nucleotide-excision repair, preincision complex stabilization;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;nucleotide-excision repair, preincision complex assembly;telomere maintenance via semi-conservative replication;nucleotide-excision repair, DNA gap filling;error-free translesion synthesis	3D-structure;Acetylation;DNA damage;DNA recombination;DNA repair;DNA replication;Isopeptide bond;Nucleus;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-6783310;R-HSA-73894;R-HSA-2262752;R-HSA-69002;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-8953897;R-HSA-3371453;R-HSA-3371556;R-HSA-73886;R-HSA-5633007;R-HSA-453279;R-HSA-69206;R-HSA-6804756;R-HSA-176187;R-HSA-68962;R-HSA-157579;R-HSA-180786;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-912446;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-5685938;R-HSA-110312;R-HSA-5655862;R-HSA-5656121;R-HSA-69190;R-HSA-3371511;R-HSA-5696395;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174417;R-HSA-69166;R-HSA-69183;R-HSA-69186;R-HSA-110320;R-HSA-5696397;R-HSA-174414;R-HSA-174437;R-HSA-5358508;R-HSA-5358565;R-HSA-5358606	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Reproduction;Meiosis;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Fanconi Anemia Pathway;DNA Repair;Cellular responses to stress;DNA Replication Pre-Initiation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Cellular responses to external stimuli;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Chromosome Maintenance;Regulation of TP53 Activity;Mitotic G1 phase and G1/S transition;G1/S Transition;Regulation of TP53 Activity through Phosphorylation;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;Telomere Maintenance;Extension of Telomeres;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Meiotic recombination;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);HDR through Single Strand Annealing (SSA);Translesion synthesis by REV1;Translesion synthesis by POLK;Translesion synthesis by POLI;DNA strand elongation;HSF1 activation;Formation of Incision Complex in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;Translesion Synthesis by POLH;Gap-filling DNA repair synthesis and ligation in GG-NER;Processive synthesis on the C-strand of the telomere;Removal of the Flap Intermediate from the C-strand;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
COQ2	positive	MCM3	ENSG00000112118	COQ2	1	COQ2	1	0.0033306367871434	WBGene00003155	WBGene00003155(0)			GO:0048471;GO:0005634;GO:0016020;GO:0005813;GO:0000166;GO:0005524;GO:0005654;GO:0016787;GO:0003677;GO:0005515;GO:0032508;GO:0006270;GO:0007049;GO:0006260;GO:0003678;GO:0004386;GO:0042555;GO:0000784;GO:0003697;GO:0000082;GO:0000727;GO:0003688;GO:1902975;GO:0006267;GO:0006271;GO:0005658;GO:0005737	DNA binding;ATP binding;DNA replication;DNA replication initiation;MCM complex;perinuclear region of cytoplasm;nucleus;membrane;nucleotide binding;nucleoplasm;hydrolase activity;centrosome;protein binding;DNA duplex unwinding;cell cycle;DNA helicase activity;helicase activity;nuclear chromosome, telomeric region;G1/S transition of mitotic cell cycle;double-strand break repair via break-induced replication;single-stranded DNA binding;DNA replication origin binding;mitotic DNA replication initiation;pre-replicative complex assembly involved in nuclear cell cycle DNA replication;DNA strand elongation involved in DNA replication;alpha DNA polymerase:primase complex;cytoplasm	ATP-binding;Acetylation;Alternative splicing;Cell cycle;DNA replication;DNA-binding;Direct protein sequencing;Glycoprotein;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-68867;R-HSA-68949;R-HSA-69002;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-453279;R-HSA-69206;R-HSA-176187;R-HSA-68962;R-HSA-176974;R-HSA-69190	Cell Cycle;Assembly of the pre-replicative complex;Orc1 removal from chromatin;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;Unwinding of DNA;DNA strand elongation
COQ2	positive	UMPS	ENSG00000114491	COQ2	1	COQ2	1	0.0033306367871434	WBGene00011559;WBGene00020036	WBGene00011559(0)		Hereditary orotic aciduria;OROTIC ACIDURIA TYPE 1;OROTIC ACIDURIA	GO:0005634;GO:0005737;GO:0016740;GO:0009116;GO:0003824;GO:0016829;GO:0016757;GO:0008152;GO:0016831;GO:0006207;GO:0006221;GO:0005829;GO:0004588;GO:0004590;GO:0006222;GO:0007565;GO:0007595;GO:0035690;GO:0044205;GO:0019856;GO:0046134	catalytic activity;nucleoside metabolic process;'de novo' pyrimidine nucleobase biosynthetic process;orotidine-5'-phosphate decarboxylase activity;orotate phosphoribosyltransferase activity;pyrimidine nucleotide biosynthetic process;'de novo' UMP biosynthetic process;nucleus;cytoplasm;transferase activity;lyase activity;transferase activity, transferring glycosyl groups;metabolic process;carboxy-lyase activity;cytosol;UMP biosynthetic process;female pregnancy;lactation;cellular response to drug;pyrimidine nucleobase biosynthetic process;pyrimidine nucleoside biosynthetic process	3D-structure;Acetylation;Alternative splicing;Decarboxylase;Disease mutation;Glycosyltransferase;Lyase;Multifunctional enzyme;Phosphoprotein;Polymorphism;Pyrimidine biosynthesis;Reference proteome;Transferase	R-HSA-1430728;R-HSA-15869;R-HSA-8956320;R-HSA-500753	Metabolism;Metabolism of nucleotides;Nucleobase biosynthesis;Pyrimidine biosynthesis
COQ2	positive	SNRNP25	ENSG00000161981	COQ2	1	COQ2	1	0.0033306367871434					GO:0005829;GO:0005654;GO:0045171;GO:0000398;GO:0005689;GO:0005515;GO:0006397;GO:0008380;GO:0005634;GO:0005681	protein binding;mRNA splicing, via spliceosome;U12-type spliceosomal complex;nucleoplasm;cytosol;intercellular bridge;mRNA processing;RNA splicing;nucleus;spliceosomal complex	Nucleus;Reference proteome;Spliceosome;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-72203;R-HSA-72172;R-HSA-72165	Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing;mRNA Splicing - Minor Pathway
COQ2	positive	GGCT	ENSG00000006625	COQ2	1	COQ2	1	0.00368642944761599	WBGene00016629	WBGene00016629(1)			GO:0003839;GO:0016829;GO:0005829;GO:0042803;GO:0070062;GO:0001836;GO:0006750	gamma-glutamylcyclotransferase activity;lyase activity;cytosol;protein homodimerization activity;extracellular exosome;release of cytochrome c from mitochondria;glutathione biosynthetic process	3D-structure;Alternative splicing;Lyase;Phosphoprotein;Reference proteome	R-HSA-1430728;R-HSA-156580;R-HSA-156590;R-HSA-174403;R-HSA-211859	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Glutathione synthesis and recycling;Biological oxidations
COQ2	positive	NDC1	ENSG00000058804	COQ2	1	COQ2	1	0.00368642944761599	WBGene00007118	WBGene00007118(0)			GO:0051028;GO:0005634;GO:0016020;GO:0016021;GO:0015031;GO:0005886;GO:0031965;GO:0015629;GO:0005643;GO:0075733;GO:0043657;GO:0017056;GO:0006110;GO:0006406;GO:0006409;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0051292;GO:0006999;GO:0007129;GO:0007283;GO:0031081;GO:0005737;GO:0070762	mRNA transport;nucleus;membrane;integral component of membrane;protein transport;plasma membrane;nuclear membrane;actin cytoskeleton;nuclear pore;intracellular transport of virus;host cell;structural constituent of nuclear pore;regulation of glycolytic process;mRNA export from nucleus;tRNA export from nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope;nuclear pore complex assembly;nuclear pore organization;synapsis;spermatogenesis;nuclear pore distribution;cytoplasm;nuclear pore transmembrane ring	Alternative splicing;Membrane;Nuclear pore complex;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Translocation;Transmembrane;Transmembrane helix;Transport;mRNA transport	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-1430728;R-HSA-1640170;R-HSA-72306;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1280215;R-HSA-162909;R-HSA-2262752;R-HSA-5619115;R-HSA-68886;R-HSA-69278;R-HSA-8953897;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-165054;R-HSA-168253;R-HSA-168254;R-HSA-168255;R-HSA-168271;R-HSA-168273;R-HSA-168274;R-HSA-168276;R-HSA-168325;R-HSA-168333;R-HSA-170822;R-HSA-176033;R-HSA-177243;R-HSA-180746;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-211000;R-HSA-2980766;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-3232142;R-HSA-3301854;R-HSA-3371453;R-HSA-3371556;R-HSA-4085377;R-HSA-4551638;R-HSA-4570464;R-HSA-4615885;R-HSA-5578749;R-HSA-5619102;R-HSA-5619107;R-HSA-6784531;R-HSA-68875;R-HSA-72202;R-HSA-72203;R-HSA-913531	Immune System;Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Metabolism;Cell Cycle;tRNA processing;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Cellular responses to stress;Disorders of transmembrane transporters;M Phase;Cell Cycle, Mitotic;Cellular responses to external stimuli;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Rev-mediated nuclear export of HIV RNA;Host Interactions with Influenza Factors;Influenza Infection;Influenza Life Cycle;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);tRNA processing in the nucleus;Mitotic Prophase;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling
COQ2	positive	TTF2	ENSG00000116830	COQ2	1	COQ2	1	0.00368642944761599	WBGene00010061;WBGene00020742		TPO		GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0008270;GO:0000166;GO:0005524;GO:0005829;GO:0016787;GO:0003677;GO:0005515;GO:0005681;GO:0004386;GO:0008023;GO:0006353;GO:0008094;GO:0006369	zinc ion binding;ATP binding;mRNA processing;RNA splicing;nucleus;cytoplasm;nucleotide binding;cytosol;hydrolase activity;DNA binding;protein binding;spliceosomal complex;helicase activity;transcription elongation factor complex;DNA-templated transcription, termination;DNA-dependent ATPase activity;termination of RNA polymerase II transcription	ATP-binding;Alternative splicing;Cytoplasm;DNA-binding;Helicase;Hydrolase;Isopeptide bond;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Spliceosome;Transcription;Transcription regulation;Transcription termination;Ubl conjugation;Zinc;Zinc-finger;mRNA processing;mRNA splicing		
COQ2	positive	CCNA2	ENSG00000145386	COQ2	1	COQ2	1	0.00368642944761599	WBGene00000863;WBGene00000865;WBGene00000866;WBGene00000867	WBGene00000867(0);WBGene00000866(0);WBGene00000865(0);WBGene00000871(0);WBGene00000870(0)		Autosomal Recessive Mental Retardation	GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0051301;GO:0005515;GO:0007049;GO:0019901;GO:0016579;GO:0016032;GO:0019904;GO:0004672;GO:0000086;GO:0006275;GO:0016538;GO:0000079;GO:0044772;GO:0000307;GO:0007265;GO:0097472;GO:0016572;GO:0044843;GO:0097124;GO:0031100;GO:0032355;GO:0033762;GO:0036120;GO:0044320;GO:0045893;GO:0048146;GO:0071314;GO:0071373;GO:0071392;GO:0071407;GO:0071456;GO:0071732;GO:0090102;GO:1990314;GO:0001939;GO:0001940	nucleus;cytoplasm;nucleoplasm;cytosol;cell division;protein binding;cell cycle;protein kinase binding;protein deubiquitination;viral process;protein domain specific binding;protein kinase activity;G2/M transition of mitotic cell cycle;regulation of DNA replication;cyclin-dependent protein serine/threonine kinase regulator activity;regulation of cyclin-dependent protein serine/threonine kinase activity;mitotic cell cycle phase transition;cyclin-dependent protein kinase holoenzyme complex;Ras protein signal transduction;histone phosphorylation;cell cycle G1/S phase transition;cyclin A2-CDK2 complex;animal organ regeneration;response to estradiol;response to glucagon;cellular response to platelet-derived growth factor stimulus;cellular response to leptin stimulus;positive regulation of transcription, DNA-templated;positive regulation of fibroblast proliferation;cellular response to cocaine;cellular response to luteinizing hormone stimulus;cellular response to estradiol stimulus;cellular response to organic cyclic compound;cellular response to hypoxia;cellular response to nitric oxide;cochlea development;cellular response to insulin-like growth factor stimulus;female pronucleus;male pronucleus	3D-structure;Acetylation;Cell cycle;Cell division;Cyclin;Cytoplasm;Host-virus interaction;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-6804116;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-174143;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-2262752;R-HSA-453274;R-HSA-453276;R-HSA-5688426;R-HSA-5689880;R-HSA-68949;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69563;R-HSA-69580;R-HSA-69615;R-HSA-69620;R-HSA-8953897;R-HSA-5633007;R-HSA-6804757;R-HSA-6806003;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-2559583;R-HSA-6804756;R-HSA-68911;R-HSA-2559582;R-HSA-5693607;R-HSA-69273;R-HSA-2559586;R-HSA-1538133;R-HSA-1362300;R-HSA-170145	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;APC/C-mediated degradation of cell cycle proteins;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Cellular responses to stress;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Deubiquitination;Ub-specific processing proteases;Orc1 removal from chromatin;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cellular responses to external stimuli;Regulation of TP53 Activity;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Cellular Senescence;Regulation of TP53 Activity through Phosphorylation;G2 Phase;Senescence-Associated Secretory Phenotype (SASP);Processing of DNA double-strand break ends;Cyclin A/B1/B2 associated events during G2/M transition;DNA Damage/Telomere Stress Induced Senescence;G0 and Early G1;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes
COQ2	positive	AIFM1	ENSG00000156709	COQ2	1	COQ2	1	0.00368642944761599	WBGene00006937	WBGene00006937(1)		Severe X-linked mitochondrial encephalomyopathy;Spondyloepimetaphyseal dysplasia Bieganski type;X-linked Charcot-Marie-Tooth disease type 4;X-linked hereditary sensory and autonomic neuropathy with deafness;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6;COWCHOCK SYNDROME;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6;COWCHOCK SYNDROME;Deafness X-linked 5	GO:0050660;GO:0055114;GO:0046983;GO:0016491;GO:0005634;GO:0005737;GO:0016020;GO:0005743;GO:0003677;GO:0005739;GO:0005829;GO:0005515;GO:0006915;GO:0048471;GO:0005758;GO:0043065;GO:0030261;GO:0006919;GO:0070059;GO:0016174;GO:0016651;GO:0071949;GO:0002931;GO:0009636;GO:0010942;GO:0043525;GO:0051402;GO:0070301;GO:0071392;GO:0071732;GO:0090650;GO:1902065;GO:1902510;GO:1904045	flavin adenine dinucleotide binding;oxidation-reduction process;oxidoreductase activity;protein dimerization activity;nucleus;cytoplasm;membrane;mitochondrial inner membrane;DNA binding;mitochondrion;cytosol;protein binding;apoptotic process;perinuclear region of cytoplasm;mitochondrial intermembrane space;positive regulation of apoptotic process;chromosome condensation;FAD binding;activation of cysteine-type endopeptidase activity involved in apoptotic process;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;NAD(P)H oxidase activity;oxidoreductase activity, acting on NAD(P)H;mitochondrial respiratory chain complex assembly;protein import into mitochondrial intermembrane space;response to ischemia;response to toxic substance;positive regulation of cell death;positive regulation of neuron apoptotic process;neuron apoptotic process;cellular response to hydrogen peroxide;cellular response to estradiol stimulus;cellular response to nitric oxide;cellular response to oxygen-glucose deprivation;response to L-glutamate;regulation of apoptotic DNA fragmentation;cellular response to aldosterone	3D-structure;Acetylation;Alternative splicing;Apoptosis;Charcot-Marie-Tooth disease;Cytoplasm;DNA-binding;Deafness;Direct protein sequencing;Disease mutation;FAD;Flavoprotein;Isopeptide bond;Membrane;Mental retardation;Mitochondrion;Mitochondrion inner membrane;NAD;Neurodegeneration;Neuropathy;Nucleus;Oxidoreductase;Phosphoprotein;Primary mitochondrial disease;Reference proteome;Transit peptide;Ubl conjugation		
COQ2	positive	PARPBP	ENSG00000185480	COQ2	1	COQ2	1	0.00368642944761599					GO:0005654;GO:2000042;GO:0005634;GO:0005737;GO:0003677;GO:0006281;GO:0006974;GO:0005515;GO:0000785	negative regulation of double-strand break repair via homologous recombination;nucleoplasm;nucleus;cytoplasm;DNA binding;DNA repair;cellular response to DNA damage stimulus;protein binding;chromatin	Alternative splicing;Cytoplasm;DNA damage;DNA repair;DNA-binding;Nucleus;Polymorphism;Reference proteome		
COQ2	positive	SMC1A	ENSG00000072501	COQ2	1	COQ2	1	0.00407595011845663	WBGene00001860	WBGene00012198(0);WBGene00019087(0)		Cornelia de Lange syndrome;Wiedemann-Steiner syndrome;CORNELIA DE LANGE SYNDROME TYPE 2;Epileptic encephalopathy;CORNELIA DE LANGE SYNDROME 2	GO:0003723;GO:0005634;GO:0000166;GO:0005524;GO:0005829;GO:0005654;GO:0051301;GO:0005694;GO:0006281;GO:0005515;GO:0051276;GO:0006974;GO:0007049;GO:0051321;GO:0003682;GO:0008278;GO:0000775;GO:0000776;GO:0000777;GO:0036033;GO:0007064;GO:0019827;GO:0030893;GO:0016363;GO:0046982;GO:0097431;GO:0000794;GO:0009314;GO:1901673;GO:0000070;GO:0007062;GO:0072423	ATP binding;protein binding;DNA repair;chromatin binding;chromosome;chromosome organization;mitotic sister chromatid cohesion;cohesin complex;RNA binding;nucleus;nucleotide binding;nucleoplasm;cytosol;cell division;cellular response to DNA damage stimulus;cell cycle;meiotic cell cycle;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;mediator complex binding;stem cell population maintenance;meiotic cohesin complex;nuclear matrix;protein heterodimerization activity;mitotic spindle pole;condensed nuclear chromosome;response to radiation;regulation of mitotic spindle assembly;mitotic sister chromatid segregation;sister chromatid cohesion;response to DNA damage checkpoint signaling	ATP-binding;Acetylation;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;DNA damage;DNA repair;Direct protein sequencing;Disease mutation;Kinetochore;Meiosis;Mental retardation;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-1221632;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69242;R-HSA-69278;R-HSA-2500257;R-HSA-68877;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-8939211;R-HSA-9006931;R-HSA-9018519;R-HSA-2468052;R-HSA-2470946;R-HSA-68884	Metabolism of proteins;Post-translational protein modification;Signal Transduction;Meiotic synapsis;Reproduction;Meiosis;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;S Phase;Cell Cycle, Mitotic;Resolution of Sister Chromatid Cohesion;Mitotic Prometaphase;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Establishment of Sister Chromatid Cohesion;Cohesin Loading onto Chromatin;Mitotic Telophase/Cytokinesis
COQ2	positive	CAD	ENSG00000084774	COQ2	1	COQ2	1	0.00407595011845663	WBGene00004259	WBGene00004259(0)		CAD-CDG;Uridine-responsive epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 50	GO:0005634;GO:0005737;GO:0016020;GO:0046872;GO:0000166;GO:0005524;GO:0016740;GO:0005654;GO:0016787;GO:0008270;GO:0016874;GO:0003824;GO:0008152;GO:0006807;GO:0016810;GO:0004088;GO:0006207;GO:0006541;GO:0006520;GO:0006221;GO:0042802;GO:0005829;GO:0016597;GO:0016743;GO:0070062;GO:0004070;GO:0016812;GO:0044205;GO:0019899;GO:0016363;GO:0004672;GO:0018107;GO:0042995;GO:0043025;GO:0019240;GO:0043195;GO:0046777;GO:0017144;GO:0046134;GO:0004151;GO:0070335;GO:0001889;GO:0006228;GO:0007507;GO:0007565;GO:0007595;GO:0014075;GO:0031000;GO:0031100;GO:0032868;GO:0033574;GO:0035690;GO:0042594;GO:0051414;GO:0071364;GO:0032991	metal ion binding;ATP binding;hydrolase activity;cellular amino acid metabolic process;'de novo' pyrimidine nucleobase biosynthetic process;aspartate carbamoyltransferase activity;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides;carboxyl- or carbamoyltransferase activity;nitrogen compound metabolic process;amino acid binding;carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity;glutamine metabolic process;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds;nucleus;cytoplasm;membrane;nucleotide binding;transferase activity;nucleoplasm;zinc ion binding;ligase activity;catalytic activity;metabolic process;pyrimidine nucleotide biosynthetic process;cytosol;identical protein binding;extracellular exosome;'de novo' UMP biosynthetic process;enzyme binding;nuclear matrix;protein kinase activity;peptidyl-threonine phosphorylation;cell projection;neuronal cell body;citrulline biosynthetic process;terminal bouton;protein autophosphorylation;drug metabolic process;pyrimidine nucleoside biosynthetic process;dihydroorotase activity;aspartate binding;liver development;UTP biosynthetic process;heart development;female pregnancy;lactation;response to amine;response to caffeine;animal organ regeneration;response to insulin;response to testosterone;cellular response to drug;response to starvation;response to cortisol;cellular response to epidermal growth factor stimulus;protein-containing complex	3D-structure;ATP-binding;Acetylation;Allosteric enzyme;Congenital disorder of glycosylation;Cytoplasm;Direct protein sequencing;Disease mutation;Epilepsy;Hydrolase;Ligase;Magnesium;Manganese;Metal-binding;Multifunctional enzyme;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Pyrimidine biosynthesis;Reference proteome;Repeat;Transferase;Zinc	R-HSA-1430728;R-HSA-15869;R-HSA-8956320;R-HSA-500753	Metabolism;Metabolism of nucleotides;Nucleobase biosynthesis;Pyrimidine biosynthesis
COQ2	positive	MRPL19	ENSG00000115364	COQ2	1	COQ2	1	0.00407595011845663	WBGene00022470	WBGene00022470(1)			GO:0005634;GO:0005739;GO:0003735;GO:0006412;GO:0005840;GO:0005515;GO:0031965;GO:0005762;GO:0005743;GO:0070125;GO:0070126;GO:0005622	structural constituent of ribosome;translation;ribosome;nucleus;mitochondrion;protein binding;nuclear membrane;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination	3D-structure;Mitochondrion;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ2	positive	RUVBL1	ENSG00000175792	COQ2	1	COQ2	1	0.00407595011845663	WBGene00007784;WBGene00020687	WBGene00007784(0)			GO:0005634;GO:0000166;GO:0005524;GO:0016787;GO:0031011;GO:0003678;GO:0032508;GO:0006281;GO:0006310;GO:0006974;GO:0035267;GO:0004386;GO:0043139;GO:0097255;GO:0005829;GO:0005654;GO:0005737;GO:0016020;GO:1903508;GO:0051301;GO:0006325;GO:0005856;GO:0005515;GO:0007049;GO:0003713;GO:0005815;GO:0006338;GO:0000812;GO:0006357;GO:0001094;GO:0043531;GO:0051117;GO:1990904;GO:0045296;GO:0070062;GO:0016887;GO:0040008;GO:0016579;GO:0034080;GO:0090263;GO:0043967;GO:1904837;GO:0016363;GO:0071339;GO:0007283;GO:1904874;GO:0043968;GO:0017025;GO:0016573;GO:0000492	nucleus;nucleotide binding;ATP binding;hydrolase activity;Ino80 complex;DNA helicase activity;DNA duplex unwinding;DNA repair;DNA recombination;cellular response to DNA damage stimulus;NuA4 histone acetyltransferase complex;helicase activity;5'-3' DNA helicase activity;R2TP complex;nucleoplasm;cytosol;cytoplasm;membrane;cytoskeleton;positive regulation of nucleic acid-templated transcription;cell division;chromatin organization;protein binding;cell cycle;ATPase activity;transcription coactivator activity;microtubule organizing center;chromatin remodeling;Swr1 complex;regulation of transcription by RNA polymerase II;TFIID-class transcription factor complex binding;ADP binding;ATPase binding;ribonucleoprotein complex;cadherin binding;extracellular exosome;regulation of growth;protein deubiquitination;CENP-A containing nucleosome assembly;positive regulation of canonical Wnt signaling pathway;histone H4 acetylation;beta-catenin-TCF complex assembly;nuclear matrix;MLL1 complex;spermatogenesis;positive regulation of telomerase RNA localization to Cajal body;histone H2A acetylation;TBP-class protein binding;histone acetylation;box C/D snoRNP assembly	3D-structure;ATP-binding;Acetylation;Activator;Alternative splicing;Cell cycle;Cell division;Chromatin regulator;Cytoplasm;Cytoskeleton;DNA damage;DNA recombination;DNA repair;Direct protein sequencing;Growth regulation;Helicase;Hydrolase;Isopeptide bond;Membrane;Mitosis;Nucleotide-binding;Nucleus;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-1640170;R-HSA-73894;R-HSA-195721;R-HSA-201681;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-606279;R-HSA-73886;R-HSA-774815;R-HSA-201722;R-HSA-3247509;R-HSA-4839726;R-HSA-157579;R-HSA-171319;R-HSA-180786;R-HSA-3214847;R-HSA-5696398;R-HSA-5696399;R-HSA-5696394	Metabolism of proteins;Post-translational protein modification;Signal Transduction;Cell Cycle;DNA Repair;Signaling by WNT;TCF dependent signaling in response to WNT;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly;Formation of the beta-catenin:TCF transactivating complex;Chromatin modifying enzymes;Chromatin organization;Telomere Maintenance;Telomere Extension By Telomerase;Extension of Telomeres;HATs acetylate histones;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);DNA Damage Recognition in GG-NER
COQ2	positive	DHFR	ENSG00000228716	COQ2	1	COQ2	1	0.00407595011845663	WBGene00007974	WBGene00007974(0)		Constitutional megaloblastic anemia with severe neurologic disease;Megaloblastic anemia due to dihydrofolate reductase deficiency;Megaloblastic anemia due to dihydrofolate reductase deficiency	GO:0003723;GO:0005737;GO:0016491;GO:0055114;GO:0005739;GO:0006730;GO:0005515;GO:0046654;GO:0003729;GO:0005829;GO:0004146;GO:0008144;GO:0051000;GO:0000083;GO:0046655;GO:0000900;GO:0005542;GO:0050661;GO:0051870;GO:0070402;GO:1990825;GO:0006729;GO:0017148;GO:0031103;GO:0031427;GO:0046452;GO:0046653;GO:2000121	oxidation-reduction process;tetrahydrofolate biosynthetic process;dihydrofolate reductase activity;RNA binding;cytoplasm;oxidoreductase activity;mitochondrion;one-carbon metabolic process;protein binding;mRNA binding;cytosol;drug binding;positive regulation of nitric-oxide synthase activity;regulation of transcription involved in G1/S transition of mitotic cell cycle;folic acid metabolic process;translation repressor activity, mRNA regulatory element binding;folic acid binding;NADP binding;methotrexate binding;NADPH binding;sequence-specific mRNA binding;tetrahydrobiopterin biosynthetic process;negative regulation of translation;axon regeneration;response to methotrexate;dihydrofolate metabolic process;tetrahydrofolate metabolic process;regulation of removal of superoxide radicals	3D-structure;Alternative splicing;Cytoplasm;Disease mutation;Methotrexate resistance;Mitochondrion;NADP;One-carbon metabolism;Oxidoreductase;RNA-binding;Reference proteome	R-HSA-1430728;R-HSA-1640170;R-HSA-69278;R-HSA-453279;R-HSA-69206;R-HSA-196854;R-HSA-196849;R-HSA-8978934;R-HSA-69205;R-HSA-196757;R-HSA-1474151	Metabolism;Cell Cycle;Cell Cycle, Mitotic;Mitotic G1 phase and G1/S transition;G1/S Transition;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Metabolism of cofactors;G1/S-Specific Transcription;Metabolism of folate and pterines;Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
COQ2	positive	R3HDM1	ENSG00000048991	COQ2	1	COQ2	1	0.00450190913827309	WBGene00022664				GO:0003676;GO:0003723	nucleic acid binding;RNA binding	Alternative splicing;Methylation;Phosphoprotein;Polymorphism;Reference proteome		
COQ2	positive	TIPIN	ENSG00000075131	COQ2	1	COQ2	1	0.00450190913827309	WBGene00017738	WBGene00017738(0)			GO:0005634;GO:0005737;GO:0043231;GO:0051301;GO:0005515;GO:0006974;GO:0007049;GO:0003677;GO:0005654;GO:0000076;GO:0048478;GO:0006260;GO:0008284;GO:0044770;GO:0031298;GO:0043111;GO:0000077;GO:0009411;GO:0031573;GO:0033262;GO:0000790	nucleus;cellular response to DNA damage stimulus;replication fork protection;DNA replication checkpoint;cytoplasm;cell division;protein binding;cell cycle;DNA binding;nucleoplasm;DNA replication;positive regulation of cell population proliferation;cell cycle phase transition;replication fork protection complex;replication fork arrest;DNA damage checkpoint;response to UV;intra-S DNA damage checkpoint;regulation of nuclear cell cycle DNA replication;nuclear chromatin	Cell cycle;Cell division;Cytoplasm;DNA damage;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-5693607	DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Processing of DNA double-strand break ends
COQ2	positive	MRPS15	ENSG00000116898	COQ2	1	COQ2	1	0.00450190913827309		WBGene00010624(0)			GO:0003723;GO:0006412;GO:0005634;GO:0005730;GO:0005739;GO:0003735;GO:0005840;GO:0032543;GO:0005743;GO:0070125;GO:0070126;GO:0005763;GO:0005761;GO:0005622	structural constituent of ribosome;translation;ribosome;RNA binding;nucleoplasm;nucleolus;mitochondrion;mitochondrial translation;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;mitochondrial small ribosomal subunit;mitochondrial ribosome	3D-structure;Mitochondrion;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ2	positive	FANCI	ENSG00000140525	COQ2	1	COQ2	1	0.00450190913827309		WBGene00020935(0)		Fanconi anemia;FANCI-Related Fanconi Anemia;Fanconi anemia;Fanconi anemia complementation group I	GO:0005634;GO:0016020;GO:0005829;GO:0005654;GO:0003677;GO:0006281;GO:0005515;GO:0006974;GO:0007049;GO:0036297;GO:0070182;GO:0031398	DNA repair;nucleus;membrane;nucleoplasm;cytosol;DNA binding;protein binding;cellular response to DNA damage stimulus;cell cycle;interstrand cross-link repair;DNA polymerase binding;positive regulation of protein ubiquitination	Alternative splicing;Cell cycle;DNA damage;DNA repair;DNA-binding;Direct protein sequencing;Disease mutation;Fanconi anemia;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-6783310;R-HSA-73894;R-HSA-6796648	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Fanconi Anemia Pathway;DNA Repair;TP53 Regulates Transcription of DNA Repair Genes
COQ2	positive	NUP205	ENSG00000155561	COQ2	1	COQ2	1	0.00450190913827309	WBGene00003789	WBGene00003789(0)		Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;NEPHROTIC SYNDROME TYPE 13	GO:0051028;GO:0005634;GO:0016020;GO:0015031;GO:0005643;GO:0005515;GO:0075733;GO:0043657;GO:0006110;GO:0006406;GO:0006409;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0031965;GO:0017056;GO:0006913;GO:0034399;GO:0051292	nuclear pore;mRNA transport;nucleus;membrane;protein transport;protein binding;intracellular transport of virus;host cell;regulation of glycolytic process;mRNA export from nucleus;tRNA export from nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope;nuclear membrane;structural constituent of nuclear pore;nucleocytoplasmic transport;nuclear periphery;nuclear pore complex assembly	3D-structure;Acetylation;Direct protein sequencing;Disease mutation;Membrane;Nuclear pore complex;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Translocation;Transport;mRNA transport	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-1430728;R-HSA-1640170;R-HSA-72306;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1280215;R-HSA-162909;R-HSA-2262752;R-HSA-5619115;R-HSA-68886;R-HSA-69278;R-HSA-8953897;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-165054;R-HSA-168253;R-HSA-168254;R-HSA-168255;R-HSA-168271;R-HSA-168273;R-HSA-168274;R-HSA-168276;R-HSA-168325;R-HSA-168333;R-HSA-170822;R-HSA-176033;R-HSA-177243;R-HSA-180746;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-211000;R-HSA-2980766;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-3232142;R-HSA-3301854;R-HSA-3371453;R-HSA-3371556;R-HSA-4085377;R-HSA-4551638;R-HSA-4570464;R-HSA-4615885;R-HSA-5578749;R-HSA-5619102;R-HSA-5619107;R-HSA-6784531;R-HSA-68875;R-HSA-72202;R-HSA-72203;R-HSA-913531	Immune System;Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Metabolism;Cell Cycle;tRNA processing;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Cellular responses to stress;Disorders of transmembrane transporters;M Phase;Cell Cycle, Mitotic;Cellular responses to external stimuli;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Rev-mediated nuclear export of HIV RNA;Host Interactions with Influenza Factors;Influenza Infection;Influenza Life Cycle;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);tRNA processing in the nucleus;Mitotic Prophase;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling
COQ2	positive	UQCRQ	ENSG00000164405	COQ2	1	COQ2	1	0.00450190913827309	WBGene00009739;WBGene00019937	WBGene00009739(0);WBGene00019937(0)		Isolated complex III deficiency;Mitochondrial Respiratory Chain Complex III Deficiency UQCRQ Related;MITOCHONDRIAL COMPLEX III DEFICIENCY NUCLEAR TYPE 4	GO:0016020;GO:0055114;GO:0005739;GO:0005743;GO:0070469;GO:0008121;GO:0006122;GO:0005750;GO:0021539;GO:0021548;GO:0021680;GO:0021766;GO:0021794;GO:0021854;GO:0021860;GO:0030901	ubiquinol-cytochrome-c reductase activity;membrane;integral component of membrane;oxidation-reduction process;mitochondrion;mitochondrial inner membrane;respirasome;mitochondrial electron transport, ubiquinol to cytochrome c;mitochondrial respiratory chain complex III;subthalamus development;pons development;cerebellar Purkinje cell layer development;hippocampus development;thalamus development;hypothalamus development;pyramidal neuron development;midbrain development	3D-structure;Acetylation;Direct protein sequencing;Disease mutation;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Primary mitochondrial disease;Reference proteome;Respiratory chain;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
COQ2	positive	DCTPP1	ENSG00000179958	COQ2	1	COQ2	1	0.00450190913827309					GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0016787;GO:0005739;GO:0005829;GO:0005515;GO:0000287;GO:0042802;GO:0047429;GO:0009143;GO:0042262;GO:0016462;GO:0032556;GO:0047840;GO:0006253	nucleoside-triphosphate diphosphatase activity;nucleoside triphosphate catabolic process;nucleus;cytoplasm;metal ion binding;nucleotide binding;hydrolase activity;mitochondrion;cytosol;protein binding;magnesium ion binding;identical protein binding;DNA protection;pyrophosphatase activity;pyrimidine deoxyribonucleotide binding;dCTP diphosphatase activity;dCTP catabolic process	Acetylation;Cytoplasm;Hydrolase;Magnesium;Metal-binding;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome	R-HSA-1430728;R-HSA-15869;R-HSA-499943	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
COQ2	positive	DNAJC9	ENSG00000213551	COQ2	1	COQ2	1	0.00450190913827309	WBGene00001041	WBGene00008122(0);WBGene00001020(0);WBGene00001025(0);WBGene00001046(0)			GO:0005634;GO:0005737;GO:0016020;GO:0005829;GO:0005654;GO:0005886;GO:0005615;GO:0005515;GO:0032781;GO:0031072	nucleus;cytoplasm;membrane;nucleoplasm;cytosol;plasma membrane;extracellular space;protein binding;positive regulation of ATPase activity;heat shock protein binding	Cell membrane;Chaperone;Cytoplasm;Membrane;Nucleus;Phosphoprotein;Reference proteome		
COQ2	positive	FAM136A	ENSG00000035141	COQ2	1	COQ2	1	0.00496718327655954	WBGene00014022	WBGene00014022(0)			GO:0005737	cytoplasm	Acetylation;Phosphoprotein;Reference proteome		
COQ2	positive	RFC5	ENSG00000111445	COQ2	1	COQ2	1	0.00496718327655954	WBGene00018409	WBGene00018409(1)			GO:0005634;GO:0000166;GO:0005524;GO:0003677;GO:0005515;GO:0032508;GO:0006281;GO:0006260;GO:0006261;GO:0005654;GO:0019899;GO:1901796;GO:0019985;GO:0006283;GO:0042276;GO:0017116;GO:0003689;GO:0042769;GO:0006296;GO:0033683;GO:0032201;GO:1900264;GO:0031390;GO:0006297;GO:0070987;GO:0005663	DNA binding;ATP binding;DNA replication;nucleus;nucleotide binding;protein binding;DNA duplex unwinding;DNA repair;DNA-dependent DNA replication;nucleoplasm;enzyme binding;regulation of signal transduction by p53 class mediator;translesion synthesis;transcription-coupled nucleotide-excision repair;error-prone translesion synthesis;single-stranded DNA helicase activity;DNA damage response, detection of DNA damage;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;telomere maintenance via semi-conservative replication;DNA clamp loader activity;positive regulation of DNA-directed DNA polymerase activity;Ctf18 RFC-like complex;nucleotide-excision repair, DNA gap filling;error-free translesion synthesis;DNA replication factor C complex	3D-structure;ATP-binding;Acetylation;Alternative splicing;DNA replication;Nucleotide-binding;Nucleus;Polymorphism;Reference proteome	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-73886;R-HSA-5633007;R-HSA-6804756;R-HSA-176187;R-HSA-157579;R-HSA-180786;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-5685938;R-HSA-110312;R-HSA-5655862;R-HSA-5656121;R-HSA-69190;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174411;R-HSA-174417;R-HSA-69091;R-HSA-69109;R-HSA-69186;R-HSA-110320;R-HSA-5696397	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Chromosome Maintenance;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Activation of ATR in response to replication stress;Telomere Maintenance;Extension of Telomeres;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);HDR through Single Strand Annealing (SSA);Translesion synthesis by REV1;Translesion synthesis by POLK;Translesion synthesis by POLI;DNA strand elongation;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Polymerase switching;Leading Strand Synthesis;Lagging Strand Synthesis;Translesion Synthesis by POLH;Gap-filling DNA repair synthesis and ligation in GG-NER
COQ2	positive	HAT1	ENSG00000128708	COQ2	1	COQ2	1	0.00496718327655954	WBGene00044069	WBGene00044069(1)			GO:0006325;GO:0005634;GO:0005737;GO:0043231;GO:0016740;GO:0005654;GO:0016746;GO:0000790;GO:0005515;GO:0042393;GO:0004402;GO:0016573;GO:0032991;GO:0000784;GO:0043967;GO:0016363;GO:0010485;GO:0006323;GO:0006335;GO:0006336;GO:0006348;GO:0006475;GO:0007584	chromatin organization;nucleus;histone acetyltransferase activity;histone acetylation;histone binding;chromatin silencing at telomere;cytoplasm;transferase activity;nucleoplasm;transferase activity, transferring acyl groups;nuclear chromatin;protein binding;protein-containing complex;nuclear chromosome, telomeric region;histone H4 acetylation;nuclear matrix;H4 histone acetyltransferase activity;DNA packaging;DNA replication-dependent nucleosome assembly;DNA replication-independent nucleosome assembly;internal protein amino acid acetylation;response to nutrient	3D-structure;Acetylation;Acyltransferase;Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transferase	R-HSA-3247509;R-HSA-4839726;R-HSA-3214847	Chromatin modifying enzymes;Chromatin organization;HATs acetylate histones
COQ2	positive	MRPL15	ENSG00000137547	COQ2	1	COQ2	1	0.00496718327655954	WBGene00022373	WBGene00022373(1)			GO:0003723;GO:0005739;GO:0003735;GO:0006412;GO:0005840;GO:0005515;GO:0015934;GO:0005762;GO:0005743;GO:0070125;GO:0070126;GO:1990830	structural constituent of ribosome;translation;large ribosomal subunit;RNA binding;mitochondrion;ribosome;protein binding;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;cellular response to leukemia inhibitory factor	3D-structure;Mitochondrion;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ2	positive	ATIC	ENSG00000138363	COQ2	1	COQ2	1	0.00496718327655954	WBGene00016957	WBGene00016957(0)		AICA-ribosiduria;AICA-RIBOSURIA;AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	GO:0016020;GO:0016740;GO:0005829;GO:0016787;GO:0003824;GO:0005886;GO:0042803;GO:0008152;GO:0006164;GO:0006189;GO:0045296;GO:0070062;GO:0003937;GO:0004643;GO:0006139;GO:0009168;GO:0003360;GO:0009116;GO:0009259;GO:0010035;GO:0021549;GO:0021987;GO:0031100;GO:0046452;GO:0046654;GO:0098761	catalytic activity;purine nucleotide biosynthetic process;IMP cyclohydrolase activity;phosphoribosylaminoimidazolecarboxamide formyltransferase activity;membrane;transferase activity;cytosol;plasma membrane;hydrolase activity;protein homodimerization activity;metabolic process;'de novo' IMP biosynthetic process;cadherin binding;extracellular exosome;nucleobase-containing compound metabolic process;purine ribonucleoside monophosphate biosynthetic process;brainstem development;nucleoside metabolic process;ribonucleotide metabolic process;response to inorganic substance;cerebellum development;cerebral cortex development;animal organ regeneration;dihydrofolate metabolic process;tetrahydrofolate biosynthetic process;cellular response to interleukin-7	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Disease mutation;Epilepsy;Hydrolase;Multifunctional enzyme;Polymorphism;Purine biosynthesis;Reference proteome;Transferase	R-HSA-1430728;R-HSA-15869;R-HSA-73817;R-HSA-8956320	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
COQ2	positive	DNAAF5	ENSG00000164818	COQ2	1	COQ2	1	0.00496718327655954				Primary ciliary dyskinesia;CILIARY DYSKINESIA PRIMARY 18;CILIARY DYSKINESIA PRIMARY 18	GO:0005737;GO:0045505;GO:0030030;GO:0003341;GO:0036159;GO:0036158;GO:0005515	cytoplasm;dynein intermediate chain binding;cell projection organization;cilium movement;inner dynein arm assembly;outer dynein arm assembly;protein binding	Acetylation;Alternative splicing;Ciliopathy;Cilium biogenesis/degradation;Cytoplasm;Direct protein sequencing;Disease mutation;Kartagener syndrome;Polymorphism;Primary ciliary dyskinesia;Reference proteome;Repeat		
COQ2	positive	HPRT1	ENSG00000165704	COQ2	1	COQ2	1	0.00496718327655954	WBGene00013690	WBGene00019890(0)		Hypoxanthine guanine phosphoribosyltransferase partial deficiency;LESCH-NYHAN SYNDROME;GOUT HPRT-RELATED;LESCH-NYHAN SYNDROME;KELLEY-SEEGMILLER SYNDROME;LESCH-NYHAN SYNDROME	GO:0005737;GO:0046872;GO:0000166;GO:0016740;GO:0005829;GO:0009116;GO:0016757;GO:0042803;GO:0005515;GO:0000287;GO:0006164;GO:0042802;GO:0006166;GO:0004422;GO:0052657;GO:0001913;GO:0001975;GO:0006168;GO:0006178;GO:0007625;GO:0007626;GO:0021756;GO:0021895;GO:0021954;GO:0032264;GO:0042417;GO:0046083;GO:0046100;GO:0046651;GO:0048813;GO:0070062;GO:0051289;GO:0043101;GO:0032263;GO:0043103;GO:0045964;GO:0046038;GO:0046040	nucleoside metabolic process;purine ribonucleoside salvage;hypoxanthine phosphoribosyltransferase activity;cytoplasm;metal ion binding;nucleotide binding;transferase activity;cytosol;transferase activity, transferring glycosyl groups;protein binding;identical protein binding;magnesium ion binding;purine nucleotide biosynthetic process;guanine phosphoribosyltransferase activity;T cell mediated cytotoxicity;response to amphetamine;adenine salvage;guanine salvage;grooming behavior;locomotory behavior;striatum development;cerebral cortex neuron differentiation;central nervous system neuron development;IMP salvage;dopamine metabolic process;adenine metabolic process;hypoxanthine metabolic process;lymphocyte proliferation;dendrite morphogenesis;extracellular exosome;protein homotetramerization;purine-containing compound salvage;GMP salvage;hypoxanthine salvage;positive regulation of dopamine metabolic process;GMP catabolic process;IMP metabolic process	3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Disease mutation;Glycosyltransferase;Gout;Isopeptide bond;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Purine salvage;Reference proteome;Transferase;Ubl conjugation	R-HSA-1430728;R-HSA-15869;R-HSA-8956321;R-HSA-74217	Metabolism;Metabolism of nucleotides;Nucleotide salvage;Purine salvage
COQ2	positive	DTYMK	ENSG00000168393	COQ2	1	COQ2	1	0.00496718327655954	WBGene00011272				GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005634;GO:0006165;GO:0005737;GO:0005739;GO:0005829;GO:0046940;GO:0009165;GO:0004798;GO:0006233;GO:0004550;GO:0015949;GO:0006235;GO:0009041;GO:0006227;GO:0043627;GO:0045445;GO:0046105;GO:0046686;GO:0071363;GO:0005758;GO:0005759	ATP binding;thymidylate kinase activity;dTDP biosynthetic process;nucleotide binding;kinase activity;transferase activity;phosphorylation;nucleus;cytosol;nucleoside diphosphate phosphorylation;cytoplasm;mitochondrion;nucleoside monophosphate phosphorylation;nucleotide biosynthetic process;nucleoside diphosphate kinase activity;nucleobase-containing small molecule interconversion;dTTP biosynthetic process;uridylate kinase activity;dUDP biosynthetic process;response to estrogen;myoblast differentiation;thymidine biosynthetic process;response to cadmium ion;cellular response to growth factor stimulus;mitochondrial intermembrane space;mitochondrial matrix	3D-structure;ATP-binding;Acetylation;Alternative splicing;Kinase;Nucleotide biosynthesis;Nucleotide-binding;Reference proteome;Transferase	R-HSA-1430728;R-HSA-15869;R-HSA-499943	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
COQ2	positive	RFC2	ENSG00000049541	COQ2	1	COQ2	1	0.00547482088903262	WBGene00004338	WBGene00004338(0)		Williams syndrome	GO:0005634;GO:0000166;GO:0005524;GO:0003677;GO:0005515;GO:0032508;GO:0006260;GO:0006261;GO:0005654;GO:1901796;GO:0019985;GO:0006283;GO:0042276;GO:0017116;GO:0003689;GO:0042769;GO:0006296;GO:0033683;GO:0032201;GO:1900264;GO:0031390;GO:0006297;GO:0070987;GO:0005663;GO:0019899	DNA binding;DNA replication;nucleus;nucleotide binding;ATP binding;protein binding;DNA duplex unwinding;DNA-dependent DNA replication;DNA repair;nucleoplasm;regulation of signal transduction by p53 class mediator;translesion synthesis;transcription-coupled nucleotide-excision repair;error-prone translesion synthesis;single-stranded DNA helicase activity;DNA damage response, detection of DNA damage;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;telomere maintenance via semi-conservative replication;DNA clamp loader activity;positive regulation of DNA-directed DNA polymerase activity;Ctf18 RFC-like complex;nucleotide-excision repair, DNA gap filling;error-free translesion synthesis;DNA replication factor C complex;enzyme binding	ATP-binding;Acetylation;Alternative splicing;DNA replication;Direct protein sequencing;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Williams-Beuren syndrome	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-73886;R-HSA-5633007;R-HSA-6804756;R-HSA-176187;R-HSA-157579;R-HSA-180786;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-5685938;R-HSA-110312;R-HSA-5655862;R-HSA-5656121;R-HSA-69190;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174411;R-HSA-174417;R-HSA-69091;R-HSA-69109;R-HSA-69186;R-HSA-110320;R-HSA-5696397	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Chromosome Maintenance;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Activation of ATR in response to replication stress;Telomere Maintenance;Extension of Telomeres;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);HDR through Single Strand Annealing (SSA);Translesion synthesis by REV1;Translesion synthesis by POLK;Translesion synthesis by POLI;DNA strand elongation;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Polymerase switching;Leading Strand Synthesis;Lagging Strand Synthesis;Translesion Synthesis by POLH;Gap-filling DNA repair synthesis and ligation in GG-NER
COQ2	positive	TPX2	ENSG00000088325	COQ2	1	COQ2	1	0.00547482088903262					GO:0005634;GO:0005737;GO:0005654;GO:0051301;GO:0045171;GO:0005856;GO:0005515;GO:0007049;GO:0006915;GO:0005815;GO:0005874;GO:0072686;GO:0000922;GO:0005819;GO:0005829;GO:0019901;GO:0010389;GO:0090307;GO:1901796;GO:0000278;GO:0032147;GO:0015630;GO:0060236;GO:0061676;GO:0043203	microtubule;activation of protein kinase activity;regulation of mitotic spindle organization;spindle;nucleus;cytoplasm;nucleoplasm;intercellular bridge;cytoskeleton;cell division;protein binding;cell cycle;apoptotic process;mitotic spindle;spindle pole;cytosol;protein kinase binding;regulation of G2/M transition of mitotic cell cycle;mitotic spindle assembly;regulation of signal transduction by p53 class mediator;mitotic cell cycle;negative regulation of microtubule depolymerization;microtubule cytoskeleton;importin-alpha family protein binding;axon hillock;microtubule nucleation	3D-structure;Acetylation;Alternative splicing;Apoptosis;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Isopeptide bond;Microtubule;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-453274;R-HSA-69275;R-HSA-69278;R-HSA-8854518;R-HSA-5633007;R-HSA-6804756	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation
COQ2	positive	CDC7	ENSG00000097046	COQ2	1	COQ2	1	0.00547482088903262	WBGene00016421	WBGene00016421(0)			GO:0005634;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005654;GO:0051301;GO:0045171;GO:0005515;GO:0007049;GO:0072686;GO:0005737;GO:0018105;GO:0000082;GO:0000727;GO:0006260;GO:0008284;GO:0010571;GO:0010971;GO:0044770;GO:0070317	ATP binding;protein phosphorylation;protein kinase activity;nucleus;metal ion binding;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;nucleoplasm;intercellular bridge;cell division;protein binding;cell cycle;mitotic spindle;cytoplasm;peptidyl-serine phosphorylation;G1/S transition of mitotic cell cycle;double-strand break repair via break-induced replication;DNA replication;positive regulation of cell population proliferation;positive regulation of nuclear cell cycle DNA replication;positive regulation of G2/M transition of mitotic cell cycle;cell cycle phase transition;negative regulation of G0 to G1 transition	3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Isopeptide bond;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-69002;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-453279;R-HSA-69206;R-HSA-176187;R-HSA-68962;R-HSA-8953750	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;DNA Replication Pre-Initiation;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;Transcriptional Regulation by E2F6
COQ2	positive	POLD2	ENSG00000106628	COQ2	1	COQ2	1	0.00547482088903262	WBGene00008722	WBGene00008722(0)			GO:0005634;GO:0005654;GO:0003677;GO:0005515;GO:0006281;GO:0006974;GO:0006260;GO:0003887;GO:0043625;GO:0019985;GO:0006283;GO:0016035;GO:0042769;GO:0006296;GO:0033683;GO:0032201;GO:0006297;GO:0000723;GO:0006298;GO:0006271;GO:0071897;GO:0006261	DNA binding;DNA replication;DNA-directed DNA polymerase activity;nucleus;nucleoplasm;protein binding;DNA repair;cellular response to DNA damage stimulus;delta DNA polymerase complex;DNA biosynthetic process;translesion synthesis;transcription-coupled nucleotide-excision repair;zeta DNA polymerase complex;DNA damage response, detection of DNA damage;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;telomere maintenance via semi-conservative replication;nucleotide-excision repair, DNA gap filling;telomere maintenance;mismatch repair;DNA strand elongation involved in DNA replication;DNA polymerase complex;DNA-dependent DNA replication	3D-structure;Acetylation;DNA damage;DNA excision;DNA repair;DNA replication;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-73886;R-HSA-157579;R-HSA-180786;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-69190;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174411;R-HSA-174417;R-HSA-69091;R-HSA-69109;R-HSA-69166;R-HSA-69183;R-HSA-69186;R-HSA-5696397;R-HSA-174414;R-HSA-174437;R-HSA-5358508;R-HSA-5358565;R-HSA-5358606	Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Chromosome Maintenance;Telomere Maintenance;Extension of Telomeres;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);DNA strand elongation;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;Gap-filling DNA repair synthesis and ligation in GG-NER;Processive synthesis on the C-strand of the telomere;Removal of the Flap Intermediate from the C-strand;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
COQ2	positive	CSE1L	ENSG00000124207	COQ2	1	COQ2	1	0.00547482088903262	WBGene00002079	WBGene00002079(0)			GO:0005634;GO:0005737;GO:0016020;GO:0006886;GO:0015031;GO:0005829;GO:0005654;GO:0005515;GO:0008536;GO:0070062;GO:0005635;GO:0006606;GO:0005049;GO:0006611	protein binding;intracellular protein transport;Ran GTPase binding;nucleus;cytoplasm;membrane;protein transport;nucleoplasm;cytosol;extracellular exosome;nuclear envelope;protein import into nucleus;nuclear export signal receptor activity;protein export from nucleus	Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport		
COQ2	positive	SKP2	ENSG00000145604	COQ2	1	COQ2	1	0.00547482088903262	WBGene00018613	WBGene00007206(0);WBGene00007208(0);WBGene00007887(0);WBGene00010585(0);WBGene00018561(0);WBGene00021463(0);WBGene00013511(0);WBGene00009689(0);WBGene00018613(0);WBGene00021053(0);WBGene00044459(0);WBGene00008177(0);WBGene00018766(0);WBGene00019239(0);WBGene00009823(0);WBGene00045058(0);WBGene00010365(0);WBGene00021180(0);WBGene00011331(0);WBGene00020884(0)			GO:0005634;GO:0005737;GO:0005730;GO:0005829;GO:0016567;GO:0005515;GO:0002376;GO:0045087;GO:0042802;GO:0051607;GO:0070936;GO:0061630;GO:0051726;GO:0005654;GO:0000209;GO:0016579;GO:0043687;GO:0016032;GO:0000086;GO:0031146;GO:0019005;GO:0042981;GO:0043161;GO:0000082;GO:0016301;GO:0016310;GO:0006511;GO:0033148;GO:0048661;GO:0071460;GO:1902916	protein binding;nucleus;cytoplasm;nucleoplasm;nucleolus;cytosol;protein ubiquitination;immune system process;innate immune response;identical protein binding;defense response to virus;protein K48-linked ubiquitination;ubiquitin protein ligase activity;regulation of cell cycle;protein polyubiquitination;protein deubiquitination;post-translational protein modification;viral process;G2/M transition of mitotic cell cycle;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;SCF ubiquitin ligase complex;regulation of apoptotic process;proteasome-mediated ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;kinase activity;phosphorylation;ubiquitin-dependent protein catabolic process;positive regulation of intracellular estrogen receptor signaling pathway;positive regulation of smooth muscle cell proliferation;cellular response to cell-matrix adhesion;positive regulation of protein polyubiquitination	3D-structure;Acetylation;Alternative splicing;Antiviral defense;Cytoplasm;Direct protein sequencing;Host-virus interaction;Immunity;Innate immunity;Leucine-rich repeat;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1640170;R-HSA-174143;R-HSA-174178;R-HSA-453276;R-HSA-5688426;R-HSA-5689880;R-HSA-68949;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-8878166;R-HSA-8939902;R-HSA-8951664;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-69231;R-HSA-69236	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Regulation of mitotic cell cycle;Deubiquitination;Ub-specific processing proteases;Orc1 removal from chromatin;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Neddylation;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Cyclin D associated events in G1;G1 Phase
COQ2	positive	GEMIN6	ENSG00000152147	COQ2	1	COQ2	1	0.00547482088903262		WBGene00017002(0)			GO:0005634;GO:0000245;GO:0006397;GO:0008380;GO:0005737;GO:0005654;GO:0005829;GO:0005515;GO:0016604;GO:0000387;GO:0000398;GO:0032797;GO:0051170;GO:0034719;GO:0097504	nucleus;spliceosomal complex assembly;mRNA processing;RNA splicing;cytoplasm;nucleoplasm;cytosol;protein binding;nuclear body;spliceosomal snRNP assembly;mRNA splicing, via spliceosome;SMN complex;import into nucleus;SMN-Sm protein complex;Gemini of coiled bodies	3D-structure;Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-191859;R-HSA-194441	Metabolism of RNA;snRNP Assembly;Metabolism of non-coding RNA
COQ2	positive	MRPL58	ENSG00000167862	COQ2	1	COQ2	1	0.00547482088903262	WBGene00019838				GO:0003747;GO:0006415;GO:0006412;GO:0016787;GO:0005739;GO:0005840;GO:0005759;GO:0005762;GO:0005743;GO:0070125;GO:0070126;GO:0004045;GO:0016150	translation release factor activity;translational termination;translation;hydrolase activity;mitochondrion;ribosome;mitochondrial matrix;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;aminoacyl-tRNA hydrolase activity;translation release factor activity, codon nonspecific	3D-structure;Hydrolase;Mitochondrion;Polymorphism;Protein biosynthesis;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ2	positive	SF3B3	ENSG00000189091	COQ2	1	COQ2	1	0.00547482088903262	WBGene00019323	WBGene00019323(0)			GO:0005634;GO:0003676;GO:0006397;GO:0008380;GO:0005730;GO:0005515;GO:0005681;GO:0000398;GO:0071013;GO:0005654;GO:0000375;GO:0044877;GO:0071005;GO:0005689;GO:0042177	nucleus;protein binding;nucleic acid binding;mRNA processing;RNA splicing;nucleoplasm;nucleolus;spliceosomal complex;mRNA splicing, via spliceosome;catalytic step 2 spliceosome;RNA splicing, via transesterification reactions;protein-containing complex binding;U2-type precatalytic spliceosome;U12-type spliceosomal complex;negative regulation of protein catabolic process	3D-structure;Alternative splicing;Direct protein sequencing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Spliceosome;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-72203;R-HSA-72163;R-HSA-72172;R-HSA-72165	Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA Splicing - Minor Pathway
COQ2	positive	NCAPD2	ENSG00000010292	COQ2	1	COQ2	1	0.00602804672946145	WBGene00001087			Microcephaly with short stature;MICROCEPHALY 21 PRIMARY AUTOSOMAL RECESSIVE	GO:0005634;GO:0005737;GO:0016020;GO:0005829;GO:0005654;GO:0051301;GO:0005694;GO:0005515;GO:0007049;GO:0000278;GO:0030261;GO:0042393;GO:0007076;GO:0003682;GO:0000228;GO:0000796;GO:0010032;GO:0051304;GO:0000779;GO:0000799;GO:0000793;GO:0000797	nucleus;mitotic cell cycle;chromosome condensation;mitotic chromosome condensation;cytoplasm;membrane;nucleoplasm;cytosol;cell division;chromosome;protein binding;cell cycle;histone binding;chromatin binding;nuclear chromosome;condensin complex;condensin core heterodimer;meiotic chromosome condensation;chromosome separation;condensed chromosome, centromeric region;nuclear condensin complex;condensed chromosome	Cell cycle;Cell division;Chromosome;Cytoplasm;DNA condensation;Direct protein sequencing;Disease mutation;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Primary microcephaly;Reference proteome	R-HSA-1640170;R-HSA-68886;R-HSA-69278;R-HSA-68877;R-HSA-2514853	Cell Cycle;M Phase;Cell Cycle, Mitotic;Mitotic Prometaphase;Condensation of Prometaphase Chromosomes
COQ2	positive	MTHFD1	ENSG00000100714	COQ2	1	COQ2	1	0.00602804672946145	WBGene00019492;WBGene00000929			Cervical spina bifida aperta;Cervical spina bifida cystica;Cervicothoracic spina bifida aperta;Cervicothoracic spina bifida cystica;Lumbosacral spina bifida aperta;Lumbosacral spina bifida cystica;Thoracolumbosacral spina bifida aperta;Thoracolumbosacral spina bifida cystica;Total spina bifida aperta;Total spina bifida cystica;Upper thoracic spina bifida aperta;Upper thoracic spina bifida cystica;COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUTHYPERHOMOCYSTEINEMIA;Neural tube defects folate-sensitive	GO:0005524;GO:0005829;GO:0055114;GO:0003824;GO:0004488;GO:0004329;GO:0005737;GO:0016020;GO:0000166;GO:0016491;GO:0016787;GO:0006730;GO:0016874;GO:0005515;GO:0008152;GO:0008652;GO:0006164;GO:0035999;GO:0070062;GO:0005739;GO:0001843;GO:0007507;GO:0046655;GO:0004477;GO:0004486;GO:0004487;GO:0000105;GO:0006555;GO:0009069;GO:0009070;GO:0009086;GO:0009113;GO:0009257;GO:0048702;GO:0048703;GO:0061053;GO:0001780;GO:0019346	ATP binding;oxidation-reduction process;catalytic activity;formate-tetrahydrofolate ligase activity;methylenetetrahydrofolate dehydrogenase (NADP+) activity;cytosol;cytoplasm;membrane;nucleotide binding;oxidoreductase activity;hydrolase activity;one-carbon metabolic process;ligase activity;protein binding;metabolic process;cellular amino acid biosynthetic process;purine nucleotide biosynthetic process;tetrahydrofolate interconversion;extracellular exosome;mitochondrion;neural tube closure;heart development;purine nucleobase biosynthetic process;folic acid metabolic process;methenyltetrahydrofolate cyclohydrolase activity;methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity;methylenetetrahydrofolate dehydrogenase (NAD+) activity;histidine biosynthetic process;methionine metabolic process;serine family amino acid metabolic process;serine family amino acid biosynthetic process;methionine biosynthetic process;10-formyltetrahydrofolate biosynthetic process;embryonic neurocranium morphogenesis;embryonic viscerocranium morphogenesis;somite development;neutrophil homeostasis;transsulfuration	3D-structure;ATP-binding;Acetylation;Amino-acid biosynthesis;Cytoplasm;Direct protein sequencing;Disease mutation;Histidine biosynthesis;Hydrolase;Ligase;Methionine biosynthesis;Multifunctional enzyme;NADP;Nucleotide-binding;One-carbon metabolism;Oxidoreductase;Phosphoprotein;Polymorphism;Purine biosynthesis;Reference proteome	R-HSA-1430728;R-HSA-196854;R-HSA-196849;R-HSA-196757	Metabolism;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Metabolism of folate and pterines
COQ2	positive	NUP107	ENSG00000111581	COQ2	1	COQ2	1	0.00602804672946145		WBGene00003791(0)		46XX gonadal dysgenesis;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;GALLOWAY-MOWAT SYNDROME;EARLY-CHILDHOOD-ONSET STEROID-RESISTANT NEPHROTIC SYNDROME;GALLOWAY-MOWAT SYNDROME 7;Nephrotic syndrome type 11;OVARIAN DYSGENESIS 6	GO:0051028;GO:0005634;GO:0016020;GO:0015031;GO:0017056;GO:0005643;GO:0005694;GO:0005515;GO:0006406;GO:0000775;GO:0000776;GO:0000777;GO:0005829;GO:0075733;GO:0043657;GO:0008585;GO:0006110;GO:0006409;GO:0006606;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0031965;GO:0031080;GO:0072006;GO:0034399;GO:0051292;GO:0000973	structural constituent of nuclear pore;nuclear pore;mRNA transport;nucleus;membrane;protein transport;chromosome;protein binding;mRNA export from nucleus;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;regulation of transcription, DNA-templated;cytosol;intracellular transport of virus;host cell;female gonad development;regulation of glycolytic process;tRNA export from nucleus;protein import into nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope;nuclear membrane;nuclear pore outer ring;nephron development;nuclear periphery;nuclear pore complex assembly;posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery	3D-structure;Acetylation;Alternative splicing;Centromere;Chromosome;Disease mutation;Epilepsy;Kinetochore;Membrane;Mental retardation;Methylation;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Translocation;Transport;mRNA transport	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-1430728;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-72306;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1280215;R-HSA-162909;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-5619115;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-8953897;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-165054;R-HSA-168253;R-HSA-168254;R-HSA-168255;R-HSA-168271;R-HSA-168273;R-HSA-168274;R-HSA-168276;R-HSA-168325;R-HSA-168333;R-HSA-170822;R-HSA-176033;R-HSA-177243;R-HSA-180746;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-211000;R-HSA-2980766;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-3232142;R-HSA-3301854;R-HSA-3371453;R-HSA-3371556;R-HSA-4085377;R-HSA-4551638;R-HSA-4570464;R-HSA-4615885;R-HSA-5578749;R-HSA-5619102;R-HSA-5619107;R-HSA-6784531;R-HSA-68875;R-HSA-72202;R-HSA-72203;R-HSA-913531;R-HSA-141424;R-HSA-141444;R-HSA-69618	Immune System;Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Metabolism;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;tRNA processing;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Disorders of transmembrane transporters;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;Cellular responses to external stimuli;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Rev-mediated nuclear export of HIV RNA;Host Interactions with Influenza Factors;Influenza Infection;Influenza Life Cycle;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);tRNA processing in the nucleus;Mitotic Prophase;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
COQ2	positive	PAK1IP1	ENSG00000111845	COQ2	1	COQ2	1	0.00602804672946145		WBGene00013862(0);WBGene00006474(0)			GO:0005634;GO:0005515;GO:0042254;GO:0005730;GO:0008283;GO:0060021;GO:0042273;GO:0009968;GO:1901796	protein binding;nucleus;nucleolus;ribosome biogenesis;cell population proliferation;roof of mouth development;ribosomal large subunit biogenesis;negative regulation of signal transduction;regulation of signal transduction by p53 class mediator	Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribosome biogenesis;Signal transduction inhibitor;WD repeat		
COQ2	positive	TMPO	ENSG00000120802	COQ2	1	COQ2	1	0.00602804672946145		WBGene00001309(0)		Familial isolated dilated cardiomyopathy	GO:0005634;GO:0005737;GO:0016020;GO:0016021;GO:0003677;GO:0031965;GO:0005515;GO:0005637;GO:0005635;GO:0005521;GO:0005694;GO:0045296;GO:0000785;GO:0006355	DNA binding;nucleus;cytoplasm;membrane;integral component of membrane;nuclear membrane;protein binding;nuclear inner membrane;nuclear envelope;lamin binding;chromosome;cadherin binding;chromatin;regulation of transcription, DNA-templated	Acetylation;Alternative splicing;Citrullination;Cytoplasm;DNA-binding;Isopeptide bond;Membrane;Methylation;Nucleus;Pharmaceutical;Phosphoprotein;Polymorphism;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix;Ubl conjugation;3D-structure;Acetylation;Alternative splicing;Cardiomyopathy;Chromosome;Coiled coil;DNA-binding;Direct protein sequencing;Methylation;Nucleus;Pharmaceutical;Phosphoprotein;Polymorphism;Reference proteome		
COQ2	positive	ACTL6A	ENSG00000136518	COQ2	1	COQ2	1	0.00602804672946145	WBGene00022774			Non-specific syndromic intellectual disability	GO:0005634;GO:0005654;GO:1903508;GO:0006325;GO:0000790;GO:0005515;GO:0006281;GO:0006310;GO:0006974;GO:0007399;GO:0043044;GO:0006357;GO:0040008;GO:0016579;GO:0032991;GO:0003682;GO:0007165;GO:0043967;GO:0003713;GO:0000980;GO:0000978;GO:0006338;GO:0016514;GO:0071564;GO:0005886;GO:0031492;GO:0035267;GO:0043968;GO:0001825;GO:0003407;GO:0021510;GO:0031011	nucleus;nucleoplasm;positive regulation of nucleic acid-templated transcription;chromatin organization;nuclear chromatin;protein binding;DNA repair;DNA recombination;cellular response to DNA damage stimulus;nervous system development;ATP-dependent chromatin remodeling;regulation of transcription by RNA polymerase II;regulation of growth;protein deubiquitination;protein-containing complex;chromatin binding;signal transduction;histone H4 acetylation;transcription coactivator activity;RNA polymerase II cis-regulatory region sequence-specific DNA binding;chromatin remodeling;SWI/SNF complex;npBAF complex;plasma membrane;nucleosomal DNA binding;NuA4 histone acetyltransferase complex;histone H2A acetylation;blastocyst formation;neural retina development;spinal cord development;Ino80 complex	Acetylation;Activator;Alternative splicing;Chromatin regulator;DNA damage;DNA recombination;DNA repair;Direct protein sequencing;Disease mutation;Growth regulation;Isopeptide bond;Mental retardation;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-73894;R-HSA-5688426;R-HSA-5689603;R-HSA-8878171;R-HSA-8939243;R-HSA-3247509;R-HSA-4839726;R-HSA-3214858;R-HSA-3214847;R-HSA-5696398;R-HSA-5696399;R-HSA-5696394	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);DNA Repair;Deubiquitination;UCH proteinases;Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Chromatin modifying enzymes;Chromatin organization;RMTs methylate histone arginines;HATs acetylate histones;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);DNA Damage Recognition in GG-NER
COQ2	positive	KIF11	ENSG00000138160	COQ2	1	COQ2	1	0.00602804672946145	WBGene00000257	WBGene00000257(1)		Microcephaly-lymphedema-chorioretinopathy syndrome;Autosomal-dominant microcephaly associated with lymphedema and/or chorioretinopathy;Microcephaly with or without chorioretinopathy lymphedema or mental retardation	GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0005829;GO:0051301;GO:0003777;GO:0005856;GO:0007049;GO:0008017;GO:0005874;GO:0007018;GO:0072686;GO:0000922;GO:0005819;GO:0005634;GO:0016887;GO:0019901;GO:0006890;GO:0032991;GO:0019886;GO:0090307;GO:0005871;GO:0008574;GO:0046602;GO:0000278;GO:0007051;GO:0005876;GO:0007052;GO:0007100;GO:0051225	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;cytoplasm;membrane;nucleotide binding;cytosol;cytoskeleton;cell division;cell cycle;mitotic spindle;microtubule;spindle pole;spindle;nucleus;ATPase activity;protein kinase binding;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;protein-containing complex;antigen processing and presentation of exogenous peptide antigen via MHC class II;mitotic spindle assembly;kinesin complex;regulation of mitotic centrosome separation;mitotic cell cycle;spindle organization;ATP-dependent microtubule motor activity, plus-end-directed;mitotic spindle organization;spindle microtubule;mitotic centrosome separation;spindle assembly	3D-structure;ATP-binding;Acetylation;Cell cycle;Cell division;Coiled coil;Cytoplasm;Cytoskeleton;Disease mutation;Isopeptide bond;Microtubule;Mitosis;Motor protein;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-2132295;R-HSA-983189;R-HSA-983231	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;MHC class II antigen presentation;Kinesins;Factors involved in megakaryocyte development and platelet production
COQ2	positive	WDR12	ENSG00000138442	COQ2	1	COQ2	1	0.00602804672946145	WBGene00018893	WBGene00018893(1)			GO:0005634;GO:0005515;GO:0042254;GO:0005654;GO:0005730;GO:0006364;GO:0030687;GO:0008283;GO:0043021;GO:0000463;GO:0000466;GO:0042273;GO:0070545;GO:0007219	protein binding;ribosome biogenesis;nucleus;nucleoplasm;nucleolus;rRNA processing;preribosome, large subunit precursor;maturation of 5.8S rRNA;maturation of LSU-rRNA;regulation of cell cycle;ribonucleoprotein complex binding;maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);ribosomal large subunit biogenesis;PeBoW complex;Notch signaling pathway	3D-structure;Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ribosome biogenesis;Ubl conjugation;WD repeat;rRNA processing	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol
COQ2	positive	CCT5	ENSG00000150753	COQ2	1	COQ2	1	0.00602804672946145	WBGene00000380	WBGene00000380(0)		Mutilating hereditary sensory neuropathy with spastic paraplegia;NEUROPATHY HEREDITARY SENSORY WITH SPASTIC PARAPLEGIA AUTOSOMAL RECESSIVE	GO:0050821;GO:0005737;GO:0000166;GO:0005524;GO:0005730;GO:0005829;GO:0006457;GO:0005856;GO:0005515;GO:0005874;GO:0051082;GO:0005815;GO:0070062;GO:0009615;GO:0032212;GO:0048487;GO:0005813;GO:1904851;GO:1904871;GO:1904874;GO:0003730;GO:0048027;GO:0031681;GO:0005832;GO:0007339;GO:1901998;GO:0044297	ATP binding;protein folding;unfolded protein binding;protein stabilization;cytoplasm;nucleotide binding;cytoskeleton;protein binding;microtubule;microtubule organizing center;cytosol;extracellular exosome;response to virus;positive regulation of telomere maintenance via telomerase;beta-tubulin binding;centrosome;positive regulation of establishment of protein localization to telomere;positive regulation of protein localization to Cajal body;positive regulation of telomerase RNA localization to Cajal body;mRNA 3'-UTR binding;mRNA 5'-UTR binding;G-protein beta-subunit binding;chaperonin-containing T-complex;binding of sperm to zona pellucida;toxin transport;cell body	3D-structure;ATP-binding;Acetylation;Alternative splicing;Chaperone;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;Isopeptide bond;Neuropathy;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-1852241;R-HSA-5617833;R-HSA-392499;R-HSA-389958;R-HSA-389960;R-HSA-390466;R-HSA-391251;R-HSA-5620920;R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-389957;R-HSA-390450	Organelle biogenesis and maintenance;Cilium Assembly;Metabolism of proteins;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Chaperonin-mediated protein folding;Protein folding;Cargo trafficking to the periciliary membrane;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;BBSome-mediated cargo-targeting to cilium;Association of TriC/CCT with target proteins during biosynthesis;Prefoldin mediated transfer of substrate  to CCT/TriC;Folding of actin by CCT/TriC
COQ2	positive	ATP5MC1	ENSG00000159199	COQ2	1	COQ2	1	0.00602804672946145	WBGene00022336				GO:0016020;GO:0016021;GO:0005739;GO:1902600;GO:0006811;GO:0005515;GO:0015078;GO:0008289;GO:0015986;GO:0031966;GO:0045263;GO:0033177;GO:0005743;GO:0046933;GO:0006754;GO:0042407;GO:0042776;GO:0005753;GO:0000276	ATP synthesis coupled proton transport;proton transmembrane transporter activity;proton transmembrane transport;proton-transporting ATP synthase complex, coupling factor F(o);proton-transporting two-sector ATPase complex, proton-transporting domain;membrane;integral component of membrane;mitochondrion;ion transport;protein binding;lipid binding;mitochondrial membrane;mitochondrial inner membrane;ATP biosynthetic process;cristae formation;mitochondrial ATP synthesis coupled proton transport;mitochondrial proton-transporting ATP synthase complex;mitochondrial proton-transporting ATP synthase complex, coupling factor F(o);proton-transporting ATP synthase activity, rotational mechanism	CF(0);Hydrogen ion transport;Ion transport;Lipid-binding;Membrane;Methylation;Mitochondrion;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix;Transport	R-HSA-1852241;R-HSA-1430728;R-HSA-9609507;R-HSA-1428517;R-HSA-163200;R-HSA-1592230;R-HSA-1268020;R-HSA-8949613;R-HSA-163210	Organelle biogenesis and maintenance;Metabolism;Protein localization;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Mitochondrial biogenesis;Mitochondrial protein import;Cristae formation;Formation of ATP by chemiosmotic coupling
COQ2	positive	RRM1	ENSG00000167325	COQ2	1	COQ2	1	0.00602804672946145	WBGene00004391	WBGene00004391(0)			GO:0005737;GO:0000166;GO:0005524;GO:0005829;GO:0016491;GO:0055114;GO:0005515;GO:0003824;GO:0008152;GO:0006260;GO:0042802;GO:0004748;GO:0009263;GO:0015949;GO:0017076;GO:0097718;GO:0000278;GO:0006206;GO:0008584;GO:0010212;GO:0021846;GO:0051290;GO:0060041;GO:0005635;GO:0005971;GO:0042995;GO:0043025;GO:0016020;GO:0016021	ATP binding;oxidation-reduction process;DNA replication;ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor;cytoplasm;nucleotide binding;cytosol;oxidoreductase activity;protein binding;catalytic activity;metabolic process;identical protein binding;deoxyribonucleotide biosynthetic process;nucleobase-containing small molecule interconversion;purine nucleotide binding;ribonucleoside-diphosphate reductase activity;disordered domain specific binding;mitotic cell cycle;pyrimidine nucleobase metabolic process;male gonad development;response to ionizing radiation;cell proliferation in forebrain;protein heterotetramerization;retina development in camera-type eye;nuclear envelope;ribonucleoside-diphosphate reductase complex;cell projection;neuronal cell body;membrane;integral component of membrane	3D-structure;ATP-binding;Acetylation;Allosteric enzyme;Cytoplasm;DNA replication;Disulfide bond;Nucleotide-binding;Oxidoreductase;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-15869;R-HSA-499943	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
COQ2	positive	MRPL11	ENSG00000174547	COQ2	1	COQ2	1	0.00602804672946145	WBGene00015133	WBGene00015133(1)			GO:0003723;GO:0006412;GO:0005739;GO:0003735;GO:0005840;GO:0005515;GO:0000027;GO:0005762;GO:0005743;GO:0070125;GO:0070126;GO:0005761;GO:0019843;GO:0070180;GO:0015934	structural constituent of ribosome;translation;ribosome;RNA binding;mitochondrion;protein binding;rRNA binding;ribosomal large subunit assembly;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;mitochondrial ribosome;large ribosomal subunit rRNA binding;large ribosomal subunit	3D-structure;Alternative splicing;Mitochondrion;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ2	positive	SDHAF3	ENSG00000196636	COQ2	1	COQ2	1	0.00602804672946145	WBGene00009139	WBGene00009139(1)			GO:0005739;GO:0005759;GO:0034553;GO:0006111;GO:0005758;GO:0006105	mitochondrion;mitochondrial respiratory chain complex II assembly;mitochondrial matrix;regulation of gluconeogenesis;mitochondrial intermembrane space;succinate metabolic process	Chaperone;Mitochondrion;Reference proteome;Transit peptide		
COQ2	positive	C1orf112	ENSG00000000460	COQ2	1	COQ2	1	0.00663026635781661							Acetylation;Alternative splicing;Phosphoprotein;Polymorphism;Reference proteome		
COQ2	positive	DCPS	ENSG00000110063	COQ2	1	COQ2	1	0.00663026635781661	WBGene00000940	WBGene00000940(1)		Autosomal recessive non-syndromic intellectual disability;AL-RAQAD SYNDROME	GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0016787;GO:0005739;GO:0090503;GO:0000290;GO:0000932;GO:0000288;GO:0005515;GO:0000340;GO:0043928;GO:0045292;GO:0050072;GO:0043069;GO:0004532;GO:0036245	hydrolase activity;deadenylation-dependent decapping of nuclear-transcribed mRNA;mRNA processing;RNA splicing;nucleus;cytoplasm;nucleoplasm;cytosol;mitochondrion;RNA phosphodiester bond hydrolysis, exonucleolytic;protein binding;P-body;nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;RNA 7-methylguanosine cap binding;exonucleolytic catabolism of deadenylated mRNA;mRNA cis splicing, via spliceosome;m7G(5')pppN diphosphatase activity;negative regulation of programmed cell death;exoribonuclease activity;cellular response to menadione	3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Disease mutation;Hydrolase;Mental retardation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-429914;R-HSA-429958	Metabolism of RNA;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease
COQ2	positive	DNA2	ENSG00000138346	COQ2	1	COQ2	1	0.00663026635781661	WBGene00001016	WBGene00014965(0);WBGene00016566(0);WBGene00016565(0)		DNA2-related mitochondrial DNA deletion syndrome;PRIMORDIAL DWARFISM SECKEL SYNDROME 8;Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant 6;Seckel syndrome 8	GO:0005634;GO:0005739;GO:0032508;GO:0017108;GO:0017116;GO:0033567;GO:0046872;GO:0000166;GO:0005524;GO:0016787;GO:0003677;GO:0003824;GO:0008152;GO:0006281;GO:0006974;GO:0004519;GO:0004518;GO:0051536;GO:0051539;GO:0006260;GO:0003678;GO:0004386;GO:0003723;GO:0005737;GO:0005515;GO:0005654;GO:0016887;GO:0000784;GO:0006284;GO:1901796;GO:0045740;GO:0090656;GO:0042645;GO:0000723;GO:0032201;GO:1902990;GO:0043139;GO:0044806;GO:0016890;GO:0043137;GO:0005760;GO:0000076;GO:0000729;GO:0006264;GO:0043504;GO:0071932;GO:0090305	5'-flap endonuclease activity;single-stranded DNA helicase activity;DNA replication, Okazaki fragment processing;nucleoplasm;mitochondrion;DNA duplex unwinding;nucleus;metal ion binding;nucleotide binding;ATP binding;hydrolase activity;DNA binding;catalytic activity;metabolic process;DNA repair;cellular response to DNA damage stimulus;nuclease activity;endonuclease activity;iron-sulfur cluster binding;4 iron, 4 sulfur cluster binding;DNA replication;ATPase activity;DNA helicase activity;helicase activity;protein binding;RNA binding;cytoplasm;nuclear chromosome, telomeric region;base-excision repair;DNA replication checkpoint;regulation of signal transduction by p53 class mediator;positive regulation of DNA replication;t-circle formation;mitochondrial nucleoid;telomere maintenance;telomere maintenance via semi-conservative replication;mitotic telomere maintenance via semi-conservative replication;5'-3' DNA helicase activity;G-quadruplex DNA unwinding;site-specific endodeoxyribonuclease activity, specific for altered base;DNA replication, removal of RNA primer;gamma DNA polymerase complex;DNA double-strand break processing;mitochondrial DNA replication;mitochondrial DNA repair;replication fork reversal;nucleic acid phosphodiester bond hydrolysis	3D-structure;4Fe-4S;ATP-binding;Acetylation;Alternative splicing;DNA damage;DNA repair;DNA replication;DNA-binding;Disease mutation;Dwarfism;Endonuclease;Helicase;Hydrolase;Iron;Iron-sulfur;Mental retardation;Metal-binding;Mitochondrion;Multifunctional enzyme;Nuclease;Nucleotide-binding;Nucleus;Primary mitochondrial disease;Progressive external ophthalmoplegia;Reference proteome	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-73886;R-HSA-5633007;R-HSA-6804756;R-HSA-157579;R-HSA-180786;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-5693554;R-HSA-5685938;R-HSA-69190;R-HSA-174417;R-HSA-69166;R-HSA-69183;R-HSA-69186;R-HSA-174414;R-HSA-174437	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Chromosome Maintenance;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Telomere Maintenance;Extension of Telomeres;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Single Strand Annealing (SSA);DNA strand elongation;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;Processive synthesis on the C-strand of the telomere;Removal of the Flap Intermediate from the C-strand
COQ2	positive	CENPE	ENSG00000138778	COQ2	1	COQ2	1	0.00663026635781661	WBGene00016800;WBGene00000140;WBGene00010302;WBGene00010306;WBGene00018051			Seckel syndrome;Microcephaly 13 primary autosomal recessive	GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0005829;GO:0005654;GO:0051301;GO:0005694;GO:0015630;GO:0003777;GO:0005856;GO:0005515;GO:0007049;GO:0008017;GO:0007275;GO:0005874;GO:0007018;GO:0005819;GO:0030496;GO:0007059;GO:0000775;GO:0000776;GO:0000777;GO:0016887;GO:0006890;GO:0051233;GO:0000779;GO:0007052;GO:0019886;GO:0005871;GO:1990023;GO:0000278;GO:0051310;GO:0051315;GO:0045860;GO:0007080;GO:0005828;GO:0051382;GO:0030071;GO:0043515;GO:0007079;GO:0099606;GO:0099607;GO:0003774	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;cell;nucleus;cytoplasm;membrane;nucleotide binding;nucleoplasm;cytosol;cytoskeleton;cell division;chromosome;microtubule cytoskeleton;protein binding;cell cycle;multicellular organism development;microtubule;spindle;midbody;chromosome segregation;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;ATPase activity;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;spindle midzone;condensed chromosome, centromeric region;mitotic spindle organization;antigen processing and presentation of exogenous peptide antigen via MHC class II;kinesin complex;mitotic spindle midzone;mitotic cell cycle;metaphase plate congression;attachment of mitotic spindle microtubules to kinetochore;positive regulation of protein kinase activity;mitotic metaphase plate congression;kinetochore microtubule;kinetochore assembly;regulation of mitotic metaphase/anaphase transition;kinetochore binding;mitotic chromosome movement towards spindle pole;microtubule plus-end directed mitotic chromosome migration;lateral attachment of mitotic spindle microtubules to kinetochore;motor activity	3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Cytoplasm;Cytoskeleton;Developmental protein;Direct protein sequencing;Disease mutation;Kinetochore;Lipoprotein;Methylation;Microtubule;Mitosis;Motor protein;Nucleotide-binding;Phosphoprotein;Polymorphism;Prenylation;Primary microcephaly;Reference proteome;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2132295;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-983189;R-HSA-983231;R-HSA-141424;R-HSA-141444;R-HSA-69618	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;MHC class II antigen presentation;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Kinesins;Factors involved in megakaryocyte development and platelet production;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
COQ2	positive	MRPL17	ENSG00000158042	COQ2	1	COQ2	1	0.00663026635781661	WBGene00021829	WBGene00021829(1)			GO:0005739;GO:0003735;GO:0006412;GO:0005840;GO:0005762;GO:0019904;GO:0005743;GO:0070125;GO:0070126;GO:0005622	structural constituent of ribosome;translation;ribosome;mitochondrion;mitochondrial large ribosomal subunit;protein domain specific binding;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;large ribosomal subunit	3D-structure;Mitochondrion;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ2	positive	POLR3K	ENSG00000161980	COQ2	1	COQ2	1	0.00663026635781661	WBGene00022309	WBGene00022309(1)			GO:0003676;GO:0005634;GO:0008270;GO:0046872;GO:0006351;GO:0002376;GO:0045087;GO:0005730;GO:0003899;GO:0051607;GO:0005666;GO:0005654;GO:0005829;GO:0042779;GO:0001056;GO:0032481;GO:0006383;GO:0006386	zinc ion binding;transcription, DNA-templated;nucleic acid binding;tRNA 3'-trailer cleavage;nucleus;metal ion binding;immune system process;innate immune response;nucleolus;DNA-directed 5'-3' RNA polymerase activity;defense response to virus;RNA polymerase III complex;nucleoplasm;cytosol;positive regulation of type I interferon production;transcription by RNA polymerase III;termination of RNA polymerase III transcription	Antiviral defense;DNA-directed RNA polymerase;Immunity;Innate immunity;Metal-binding;Nucleus;Polymorphism;Reference proteome;Transcription;Zinc;Zinc-finger	R-HSA-168249;R-HSA-168256;R-HSA-74160;R-HSA-74158;R-HSA-749476;R-HSA-76046;R-HSA-76061;R-HSA-76066;R-HSA-76071;R-HSA-73980;R-HSA-1834949;R-HSA-73780	Innate Immune System;Immune System;Gene expression (Transcription);RNA Polymerase III Transcription;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase III Transcription Termination;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation
COQ2	positive	LSM3	ENSG00000170860	COQ2	1	COQ2	1	0.00663026635781661	WBGene00003077	WBGene00003077(1)			GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0005515;GO:0005681;GO:0000398;GO:0071013;GO:0000932;GO:0000956;GO:0005654;GO:0005829;GO:0046540;GO:0033962;GO:0043928;GO:1990726;GO:0071005;GO:0005688;GO:0120115	RNA binding;mRNA splicing, via spliceosome;nuclear-transcribed mRNA catabolic process;mRNA processing;RNA splicing;nucleus;protein binding;spliceosomal complex;catalytic step 2 spliceosome;P-body;nucleoplasm;cytosol;U4/U6 x U5 tri-snRNP complex;cytoplasmic mRNA processing body assembly;exonucleolytic catabolism of deadenylated mRNA;Lsm1-7-Pat1 complex;U2-type precatalytic spliceosome;precatalytic spliceosome;U6 snRNP;Lsm2-8 complex;U6 snRNA 3'-end binding	3D-structure;Acetylation;Direct protein sequencing;Nucleus;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-429914;R-HSA-72203;R-HSA-72163;R-HSA-72172;R-HSA-430039	Metabolism of RNA;Deadenylation-dependent mRNA decay;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA decay by 5' to 3' exoribonuclease
COQ2	positive	POLD3	ENSG00000077514	COQ2	1	COQ2	1	0.00728507008197343	WBGene00011016				GO:0005634;GO:0006260;GO:0003887;GO:0071897;GO:0043625;GO:0005737;GO:0005515;GO:0006281;GO:0006974;GO:0006298;GO:0005654;GO:0019985;GO:0006283;GO:0016035;GO:0042769;GO:0006296;GO:0033683;GO:0000731;GO:0032201;GO:0006297;GO:0000723;GO:0006271;GO:1904161	nucleus;DNA replication;DNA-directed DNA polymerase activity;delta DNA polymerase complex;DNA biosynthetic process;cytoplasm;nucleoplasm;protein binding;DNA repair;cellular response to DNA damage stimulus;mismatch repair;protein binding, bridging;translesion synthesis;transcription-coupled nucleotide-excision repair;zeta DNA polymerase complex;DNA damage response, detection of DNA damage;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;DNA synthesis involved in DNA repair;telomere maintenance via semi-conservative replication;nucleotide-excision repair, DNA gap filling;telomere maintenance;DNA strand elongation involved in DNA replication;DNA synthesis involved in UV-damage excision repair	3D-structure;Acetylation;Alternative splicing;Cytoplasm;DNA damage;DNA excision;DNA repair;DNA replication;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-73886;R-HSA-157579;R-HSA-180786;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-69190;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174411;R-HSA-174417;R-HSA-69091;R-HSA-69109;R-HSA-69166;R-HSA-69183;R-HSA-69186;R-HSA-5696397;R-HSA-174414;R-HSA-174437;R-HSA-5358508;R-HSA-5358565;R-HSA-5358606	Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Chromosome Maintenance;Telomere Maintenance;Extension of Telomeres;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);DNA strand elongation;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;Gap-filling DNA repair synthesis and ligation in GG-NER;Processive synthesis on the C-strand of the telomere;Removal of the Flap Intermediate from the C-strand;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
COQ2	positive	PCCB	ENSG00000114054	COQ2	1	COQ2	1	0.00728507008197343	WBGene00018701	WBGene00018701(1)		PROPIONIC ACIDEMIA;PROPIONIC ACIDEMIA;PROPIONIC ACIDEMIA	GO:0000166;GO:0005524;GO:0005739;GO:0005759;GO:0016874;GO:0005515;GO:0005829;GO:0004658;GO:0006768;GO:0019626;GO:0003989;GO:0006633;GO:0009317	ligase activity;nucleotide binding;ATP binding;mitochondrion;mitochondrial matrix;protein binding;cytosol;propionyl-CoA carboxylase activity;biotin metabolic process;short-chain fatty acid catabolic process;acetyl-CoA carboxylase activity;fatty acid biosynthetic process;acetyl-CoA carboxylase complex	ATP-binding;Acetylation;Alternative splicing;Direct protein sequencing;Disease mutation;Ligase;Mitochondrion;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-1643685;R-HSA-77289;R-HSA-196854;R-HSA-196780;R-HSA-196849;R-HSA-3296482;R-HSA-5668914;R-HSA-3323169;R-HSA-3371599;R-HSA-71032	Metabolism;Metabolism of lipids;Fatty acid metabolism;Disease;Mitochondrial Fatty Acid Beta-Oxidation;Metabolism of vitamins and cofactors;Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Defects in vitamin and cofactor metabolism;Diseases of metabolism;Defects in biotin (Btn) metabolism;Defective HLCS causes multiple carboxylase deficiency;Propionyl-CoA catabolism
COQ2	positive	TIMM10	ENSG00000134809	COQ2	1	COQ2	1	0.00728507008197343	WBGene00006573	WBGene00006573(0)			GO:0016020;GO:0015031;GO:0046872;GO:0005739;GO:0005743;GO:0008270;GO:0005744;GO:0005515;GO:0007605;GO:0042803;GO:0005758;GO:0051087;GO:0072321;GO:0006626;GO:0045039;GO:0140318;GO:0042719;GO:0008565	protein insertion into mitochondrial inner membrane;mitochondrial intermembrane space protein transporter complex;membrane;protein transport;metal ion binding;mitochondrion;mitochondrial inner membrane;zinc ion binding;TIM23 mitochondrial import inner membrane translocase complex;protein binding;sensory perception of sound;protein homodimerization activity;mitochondrial intermembrane space;chaperone binding;chaperone-mediated protein transport;protein targeting to mitochondrion;protein transporter activity	3D-structure;Chaperone;Disulfide bond;Membrane;Metal-binding;Mitochondrion;Mitochondrion inner membrane;Protein transport;Reference proteome;Translocation;Transport;Zinc	R-HSA-9609507;R-HSA-1268020	Protein localization;Mitochondrial protein import
COQ2	positive	ITGB3BP	ENSG00000142856	COQ2	1	COQ2	1	0.00728507008197343					GO:0005634;GO:0005737;GO:0005654;GO:0006355;GO:0051301;GO:0005694;GO:0005515;GO:0007049;GO:0006915;GO:0034080;GO:0000775;GO:0000776;GO:0000777;GO:0005829;GO:0007165;GO:0007155;GO:0016020;GO:0043065;GO:0008022	regulation of transcription, DNA-templated;CENP-A containing nucleosome assembly;nucleus;cytoplasm;nucleoplasm;cell division;chromosome;protein binding;cell cycle;apoptotic process;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cytosol;signal transduction;cell adhesion;membrane;positive regulation of apoptotic process;protein C-terminus binding	Activator;Alternative splicing;Apoptosis;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Cytoplasm;Isopeptide bond;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	R-HSA-162582;R-HSA-194315;R-HSA-193704;R-HSA-204998;R-HSA-73887;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-606279;R-HSA-73886;R-HSA-774815;R-HSA-141424;R-HSA-141444;R-HSA-69618;R-HSA-205043	Signal Transduction;Signaling by Rho GTPases;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;Death Receptor Signalling;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint;NRIF signals cell death from the nucleus
COQ2	positive	PARP1	ENSG00000143799	COQ2	1	COQ2	1	0.00728507008197343	WBGene00004049	WBGene00004049(1)	CDH1;E2F1;SERPINE1;THBD;VIM	Autosomal Recessive Mental Retardation	GO:0032869;GO:0005634;GO:0003723;GO:0016020;GO:0008270;GO:0046872;GO:0016740;GO:0003677;GO:0016757;GO:0005694;GO:0005515;GO:0051287;GO:0006281;GO:0006974;GO:0006915;GO:0003950;GO:0006471;GO:0006302;GO:0019899;GO:0030331;GO:0042826;GO:0046332;GO:0070412;GO:0007179;GO:0010332;GO:0010613;GO:0010990;GO:0016540;GO:0023019;GO:0033148;GO:0042769;GO:0044030;GO:0045944;GO:0051901;GO:0060391;GO:0070212;GO:0071294;GO:0071560;GO:1900182;GO:1901216;GO:1903376;GO:1904044;GO:1904646;GO:1904762;GO:2000679;GO:0005737;GO:0005730;GO:0042802;GO:0005654;GO:0019901;GO:0000784;GO:0035861;GO:0001228;GO:0032991;GO:0047485;GO:0005667;GO:0006366;GO:0005739;GO:0000977;GO:0005635;GO:0034644;GO:0007005;GO:0008134;GO:1903827;GO:0032993;GO:0000724;GO:0000122;GO:0000723;GO:1990404;GO:0070213;GO:1904357;GO:0030225;GO:0006293;GO:0006295;GO:0006296;GO:0033683;GO:0070911;GO:0140294;GO:0000715;GO:0000717;GO:0006294;GO:0018312;GO:0018424;GO:0030592;GO:0032042;GO:0034599;GO:0036211;GO:0043504;GO:0050790;GO:1903518;GO:1905168;GO:1990966;GO:2001170;GO:0090734	DNA binding;zinc ion binding;nucleus;protein ADP-ribosylation;NAD binding;NAD+ ADP-ribosyltransferase activity;cellular response to insulin stimulus;RNA binding;membrane;metal ion binding;transferase activity;nucleoplasm;nucleolus;transferase activity, transferring glycosyl groups;chromosome;protein binding;DNA repair;cellular response to DNA damage stimulus;nuclear body;apoptotic process;double-strand break repair;enzyme binding;estrogen receptor binding;histone deacetylase binding;SMAD binding;R-SMAD binding;transforming growth factor beta receptor signaling pathway;response to gamma radiation;positive regulation of cardiac muscle hypertrophy;regulation of SMAD protein complex assembly;protein autoprocessing;signal transduction involved in regulation of gene expression;positive regulation of intracellular estrogen receptor signaling pathway;DNA damage response, detection of DNA damage;regulation of DNA methylation;positive regulation of transcription by RNA polymerase II;positive regulation of mitochondrial depolarization;positive regulation of SMAD protein signal transduction;protein poly-ADP-ribosylation;cellular response to zinc ion;cellular response to transforming growth factor beta stimulus;positive regulation of protein localization to nucleus;positive regulation of neuron death;regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway;response to aldosterone;cellular response to amyloid-beta;positive regulation of myofibroblast differentiation;positive regulation of transcription regulatory region DNA binding;cytoplasm;identical protein binding;protein kinase binding;nuclear chromosome, telomeric region;site of double-strand break;DNA-binding transcription activator activity, RNA polymerase II-specific;protein-containing complex;protein N-terminus binding;transcription factor complex;transcription by RNA polymerase II;mitochondrion;RNA polymerase II regulatory region sequence-specific DNA binding;nuclear envelope;cellular response to UV;mitochondrion organization;transcription factor binding;regulation of cellular protein localization;protein-DNA complex;double-strand break repair via homologous recombination;negative regulation of transcription by RNA polymerase II;telomere maintenance;site of DNA damage;protein ADP-ribosylase activity;protein auto-ADP-ribosylation;negative regulation of telomere maintenance via telomere lengthening;macrophage differentiation;nucleotide-excision repair, preincision complex stabilization;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;global genome nucleotide-excision repair;NAD DNA ADP-ribosyltransferase activity;nucleotide-excision repair, DNA damage recognition;nucleotide-excision repair, DNA duplex unwinding;nucleotide-excision repair, preincision complex assembly;peptidyl-serine ADP-ribosylation;peptidyl-glutamic acid poly-ADP-ribosylation;DNA ADP-ribosylation;mitochondrial DNA metabolic process;cellular response to oxidative stress;protein modification process;mitochondrial DNA repair;regulation of catalytic activity;positive regulation of single strand break repair;positive regulation of double-strand break repair via homologous recombination;ATP generation from poly-ADP-D-ribose;negative regulation of ATP biosynthetic process	3D-structure;ADP-ribosylation;Acetylation;Chromosome;DNA damage;DNA repair;DNA-binding;Direct protein sequencing;Glycosyltransferase;Isopeptide bond;Metal-binding;NAD;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc;Zinc-finger	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-5693532;R-HSA-5693538;R-HSA-73894;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-9006936;R-HSA-170834;R-HSA-2173793;R-HSA-5696398;R-HSA-73884;R-HSA-73933;R-HSA-5685939;R-HSA-2173795;R-HSA-5696395;R-HSA-5696399;R-HSA-5696394;R-HSA-110362;R-HSA-110373;R-HSA-5696400	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;DNA Double-Strand Break Repair;Homology Directed Repair;DNA Repair;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Nucleotide Excision Repair;Base Excision Repair;Resolution of Abasic Sites (AP sites);HDR through MMEJ (alt-NHEJ);Downregulation of SMAD2/3:SMAD4 transcriptional activity;Formation of Incision Complex in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);DNA Damage Recognition in GG-NER;POLB-Dependent Long Patch Base Excision Repair;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Dual Incision in GG-NER
COQ2	positive	APEH	ENSG00000164062	COQ2	1	COQ2	1	0.00728507008197343	WBGene00001058;WBGene00001057;WBGene00001059	WBGene00001058(1)			GO:0003723;GO:0005737;GO:0005829;GO:0016787;GO:0031965;GO:0005515;GO:0006508;GO:0004252;GO:0008236;GO:0005576;GO:0042802;GO:0070062;GO:0043312;GO:1904813;GO:0050435;GO:0008242;GO:0006415	proteolysis;serine-type endopeptidase activity;serine-type peptidase activity;RNA binding;cytoplasm;cytosol;hydrolase activity;nuclear membrane;protein binding;extracellular region;identical protein binding;extracellular exosome;neutrophil degranulation;ficolin-1-rich granule lumen;amyloid-beta metabolic process;omega peptidase activity;translational termination	Acetylation;Cytoplasm;Direct protein sequencing;Hydrolase;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-168249;R-HSA-168256;R-HSA-392499;R-HSA-6798695;R-HSA-72766;R-HSA-72764	Innate Immune System;Immune System;Metabolism of proteins;Neutrophil degranulation;Translation;Eukaryotic Translation Termination
COQ2	positive	SNRPD1	ENSG00000167088	COQ2	1	COQ2	1	0.00728507008197343	WBGene00004916	WBGene00004916(0)			GO:0003723;GO:0006396;GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0005829;GO:0005515;GO:0005681;GO:0000387;GO:0000398;GO:0071013;GO:0005685;GO:0005654;GO:0046540;GO:0005686;GO:0005687;GO:0005682;GO:0034709;GO:0000245;GO:0051170;GO:0034719;GO:0071005;GO:0071007;GO:0005689;GO:0030532;GO:0000243;GO:0034715;GO:1990446	RNA processing;spliceosomal snRNP assembly;RNA binding;mRNA processing;RNA splicing;nucleus;cytoplasm;cytosol;protein binding;spliceosomal complex;mRNA splicing, via spliceosome;catalytic step 2 spliceosome;U1 snRNP;nucleoplasm;U4/U6 x U5 tri-snRNP complex;U2 snRNP;U4 snRNP;U5 snRNP;methylosome;spliceosomal complex assembly;import into nucleus;SMN-Sm protein complex;U2-type precatalytic spliceosome;U2-type catalytic step 2 spliceosome;U12-type spliceosomal complex;precatalytic spliceosome;small nuclear ribonucleoprotein complex;commitment complex;pICln-Sm protein complex;spliceosomal tri-snRNP complex;U1 snRNP binding	3D-structure;Cytoplasm;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-191859;R-HSA-194441;R-HSA-72203;R-HSA-72163;R-HSA-72172;R-HSA-72165	Metabolism of RNA;snRNP Assembly;Metabolism of non-coding RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA Splicing - Minor Pathway
COQ2	positive	UTP11	ENSG00000183520	COQ2	1	COQ2	1	0.00728507008197343	WBGene00007623	WBGene00007623(1)			GO:0005615;GO:0043065;GO:0005737;GO:0003723;GO:0005634;GO:0005515;GO:0005730;GO:0006364;GO:0032040;GO:0005654;GO:0007399	rRNA processing;small-subunit processome;extracellular space;positive regulation of apoptotic process;cytoplasm;RNA binding;nucleus;protein binding;nucleolus;nucleoplasm;nervous system development	Alternative splicing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;rRNA processing	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
COQ2	positive	UNG	ENSG00000076248	COQ2	1	COQ2	1	0.00799623636790925	WBGene00013241	WBGene00013241(1)		Hyper-IgM syndrome type 5;IMMUNODEFICIENCY WITH HYPER-IgM TYPE 5	GO:0005634;GO:0016787;GO:0005739;GO:0006281;GO:0005515;GO:0006974;GO:0016799;GO:0006284;GO:0005654;GO:0016032;GO:0004844;GO:0016446;GO:0016447;GO:0043066;GO:0045190;GO:0043024;GO:0003684;GO:0045008;GO:0097510	hydrolase activity, hydrolyzing N-glycosyl compounds;DNA repair;uracil DNA N-glycosylase activity;base-excision repair;nucleus;hydrolase activity;mitochondrion;protein binding;cellular response to DNA damage stimulus;nucleoplasm;viral process;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;negative regulation of apoptotic process;isotype switching;ribosomal small subunit binding;damaged DNA binding;depyrimidination;base-excision repair, AP site formation via deaminated base removal	3D-structure;Acetylation;Alternative splicing;DNA damage;DNA repair;Direct protein sequencing;Disease mutation;Host-virus interaction;Hydrolase;Mitochondrion;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
COQ2	positive	KIF22	ENSG00000079616	COQ2	1	COQ2	1	0.00799623636790925				Spondyloepimetaphyseal dysplasia with multiple dislocations;SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY TYPE 2;SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY TYPE 2	GO:0005634;GO:0005737;GO:0016607;GO:0000166;GO:0005524;GO:0005829;GO:0003677;GO:0003774;GO:0006281;GO:0003777;GO:0005856;GO:0008017;GO:0005874;GO:0007018;GO:0016887;GO:0005515;GO:0006890;GO:0072686;GO:0019886;GO:0005871;GO:0000278;GO:0051310;GO:0007080;GO:0007062;GO:0000776;GO:0000785;GO:0005819	DNA binding;ATP binding;DNA repair;microtubule binding;microtubule motor activity;microtubule-based movement;cell;nucleus;cytoplasm;nuclear speck;nucleotide binding;cytosol;motor activity;cytoskeleton;microtubule;protein binding;ATPase activity;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;mitotic spindle;antigen processing and presentation of exogenous peptide antigen via MHC class II;kinesin complex;mitotic cell cycle;metaphase plate congression;mitotic metaphase plate congression;sister chromatid cohesion;kinetochore;chromatin;spindle	3D-structure;ATP-binding;Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;DNA-binding;Disease mutation;Dwarfism;Isopeptide bond;Microtubule;Motor protein;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-2132295;R-HSA-983189;R-HSA-983231	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;MHC class II antigen presentation;Kinesins;Factors involved in megakaryocyte development and platelet production
COQ2	positive	ZMPSTE24	ENSG00000084073	COQ2	1	COQ2	1	0.00799623636790925	WBGene00001405	WBGene00001405(0)		HUTCHINSON-GILFORD PROGERIA SYNDROME;MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY;Restrictive dermopathy;Lethal Restrictive Dermopathy ZMPSTE24-Related;MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY;MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY;RESTRICTIVE DERMOPATHY LETHAL	GO:0005634;GO:0016020;GO:0016021;GO:0046872;GO:0005783;GO:0005789;GO:0016787;GO:0005515;GO:0008233;GO:0006508;GO:0004222;GO:0008237;GO:0070062;GO:0005637;GO:0030176;GO:0032991;GO:0071586;GO:0003690;GO:0004175;GO:0008235;GO:0001889;GO:0001942;GO:0003007;GO:0003229;GO:0003231;GO:0003417;GO:0006281;GO:0006325;GO:0006355;GO:0006925;GO:0006974;GO:0006997;GO:0006998;GO:0007346;GO:0007628;GO:0008016;GO:0008340;GO:0008360;GO:0008544;GO:0010506;GO:0010628;GO:0010629;GO:0010906;GO:0016485;GO:0019216;GO:0030282;GO:0030327;GO:0030500;GO:0032006;GO:0032350;GO:0035264;GO:0040014;GO:0043007;GO:0043516;GO:0043969;GO:0043979;GO:0044029;GO:0044030;GO:0044255;GO:0048145;GO:0048538;GO:0048739;GO:0050688;GO:0050905;GO:0051276;GO:0060307;GO:0060993;GO:0061337;GO:0061762;GO:0070302;GO:0071480;GO:0072423;GO:0090239;GO:1903025;GO:1903463;GO:1903522;GO:1903799;GO:1990036;GO:1990164;GO:2000618;GO:2000730;GO:2000772;GO:0005635	proteolysis;metalloendopeptidase activity;peptidase activity;CAAX-box protein processing;nucleus;membrane;integral component of membrane;metal ion binding;endoplasmic reticulum;endoplasmic reticulum membrane;hydrolase activity;protein binding;metallopeptidase activity;extracellular exosome;nuclear inner membrane;integral component of endoplasmic reticulum membrane;protein-containing complex;double-stranded DNA binding;endopeptidase activity;metalloexopeptidase activity;liver development;hair follicle development;heart morphogenesis;ventricular cardiac muscle tissue development;cardiac ventricle development;growth plate cartilage development;DNA repair;chromatin organization;regulation of transcription, DNA-templated;inflammatory cell apoptotic process;cellular response to DNA damage stimulus;nucleus organization;nuclear envelope organization;regulation of mitotic cell cycle;adult walking behavior;regulation of heart contraction;determination of adult lifespan;regulation of cell shape;epidermis development;regulation of autophagy;positive regulation of gene expression;negative regulation of gene expression;regulation of glucose metabolic process;protein processing;regulation of lipid metabolic process;bone mineralization;prenylated protein catabolic process;regulation of bone mineralization;regulation of TOR signaling;regulation of hormone metabolic process;multicellular organism growth;regulation of multicellular organism growth;maintenance of rDNA;regulation of DNA damage response, signal transduction by p53 class mediator;histone H2B acetylation;histone H2B-K5 acetylation;hypomethylation of CpG island;regulation of DNA methylation;cellular lipid metabolic process;regulation of fibroblast proliferation;thymus development;cardiac muscle fiber development;regulation of defense response to virus;neuromuscular process;chromosome organization;regulation of ventricular cardiac muscle cell membrane repolarization;kidney morphogenesis;cardiac conduction;CAMKK-AMPK signaling cascade;regulation of stress-activated protein kinase signaling cascade;cellular response to gamma radiation;response to DNA damage checkpoint signaling;regulation of histone H4 acetylation;regulation of RNA polymerase II regulatory region sequence-specific DNA binding;regulation of mitotic cell cycle DNA replication;regulation of blood circulation;negative regulation of production of miRNAs involved in gene silencing by miRNA;calcium ion import into sarcoplasmic reticulum;histone H2A phosphorylation;regulation of histone H4-K16 acetylation;regulation of termination of RNA polymerase I transcription;regulation of cellular senescence;nuclear envelope	3D-structure;Disease mutation;Endoplasmic reticulum;Hydrolase;Membrane;Metal-binding;Metalloprotease;Nucleus;Polymorphism;Protease;Reference proteome;Transmembrane;Transmembrane helix;Zinc		
COQ2	positive	EXOSC8	ENSG00000120699	COQ2	1	COQ2	1	0.00799623636790925	WBGene00018305;WBGene00018154	WBGene00018305(0)		Pontocerebellar hypoplasia type 1;PONTOCEREBELLAR HYPOPLASIA TYPE 1C	GO:0003723;GO:0006396;GO:0005634;GO:0005737;GO:0005515;GO:0006401;GO:0005730;GO:0006364;GO:0042802;GO:0005654;GO:0005829;GO:0008150;GO:0000178;GO:0043488;GO:0043928;GO:0000467;GO:0016075;GO:0035925;GO:0071035;GO:0071038;GO:0000176;GO:0034427;GO:0034473;GO:0034475;GO:0034476;GO:0071028;GO:0071042;GO:0000177	RNA processing;RNA catabolic process;exosome (RNase complex);RNA binding;nucleus;cytoplasm;intracellular membrane-bounded organelle;nucleoplasm;cytosol;fibrillar center;protein binding;nucleolus;identical protein binding;rRNA processing;biological_process;regulation of mRNA stability;exonucleolytic catabolism of deadenylated mRNA;exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);AU-rich element binding;rRNA catabolic process;mRNA 3'-UTR AU-rich region binding;nuclear polyadenylation-dependent rRNA catabolic process;nuclear polyadenylation-dependent tRNA catabolic process;nuclear exosome (RNase complex);nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5';U1 snRNA 3'-end processing;U4 snRNA 3'-end processing;U5 snRNA 3'-end processing;nuclear mRNA surveillance;nuclear polyadenylation-dependent mRNA catabolic process;cytoplasmic exosome (RNase complex)	3D-structure;Acetylation;Cytoplasm;Disease mutation;Exosome;Neurodegeneration;Nucleus;RNA-binding;Reference proteome;rRNA processing	R-HSA-392499;R-HSA-8953854;R-HSA-450531;R-HSA-429914;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-381119;R-HSA-380994;R-HSA-381042;R-HSA-450604;R-HSA-450513;R-HSA-450385;R-HSA-429958	Metabolism of proteins;Metabolism of RNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Deadenylation-dependent mRNA decay;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Unfolded Protein Response (UPR);ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;KSRP (KHSRP) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;mRNA decay by 3' to 5' exoribonuclease
COQ2	positive	GTF3A	ENSG00000122034	COQ2	1	COQ2	1	0.00799623636790925		WBGene00003933(0)	BAG3		GO:0003676;GO:0003723;GO:0005634;GO:0046872;GO:0003677;GO:0042254;GO:0005654;GO:0042273;GO:0009303;GO:0006383;GO:0008097	nucleic acid binding;nucleoplasm	Alternative splicing;DNA-binding;Metal-binding;Nucleus;Polymorphism;RNA-binding;Reference proteome;Repeat;Ribosome biogenesis;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-74160;R-HSA-74158;R-HSA-749476;R-HSA-76046;R-HSA-76061	Gene expression (Transcription);RNA Polymerase III Transcription;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter
COQ2	positive	RPP40	ENSG00000124787	COQ2	1	COQ2	1	0.00799623636790925					GO:0003723;GO:0005634;GO:0008033;GO:0016787;GO:0090501;GO:0090502;GO:0005730;GO:0006364;GO:0005654;GO:0004526;GO:0033204;GO:0001682;GO:0030681;GO:0005655	RNA binding;nucleus;tRNA processing;hydrolase activity;RNA phosphodiester bond hydrolysis;RNA phosphodiester bond hydrolysis, endonucleolytic;nucleolus;rRNA processing;nucleoplasm;ribonuclease P activity;ribonuclease P RNA binding;tRNA 5'-leader removal;multimeric ribonuclease P complex;nucleolar ribonuclease P complex	3D-structure;Alternative splicing;Direct protein sequencing;Hydrolase;Nucleus;Polymorphism;RNA-binding;Reference proteome;rRNA processing;tRNA processing	R-HSA-72306;R-HSA-8953854;R-HSA-6784531;R-HSA-6791226;R-HSA-72312;R-HSA-8868773	tRNA processing;Metabolism of RNA;tRNA processing in the nucleus;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol
COQ2	positive	HNRNPR	ENSG00000125944	COQ2	1	COQ2	1	0.00799623636790925	WBGene00002000				GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0005654;GO:0005783;GO:0043231;GO:0005515;GO:0005681;GO:0000398;GO:0071013;GO:0003729;GO:1990904;GO:0016070;GO:0003730;GO:0007623;GO:0043086;GO:0061014;GO:0061157;GO:0030425;GO:0030426;GO:0043679	nucleic acid binding;RNA binding;mRNA processing;RNA splicing;nucleus;cytoplasm;nucleoplasm;endoplasmic reticulum;intracellular membrane-bounded organelle;protein binding;spliceosomal complex;mRNA splicing, via spliceosome;catalytic step 2 spliceosome;mRNA binding;ribonucleoprotein complex;RNA metabolic process;mRNA 3'-UTR binding;circadian rhythm;negative regulation of catalytic activity;positive regulation of mRNA catabolic process;mRNA destabilization;dendrite;growth cone;axon terminus	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Endoplasmic reticulum;Isopeptide bond;Microsome;Nucleus;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-72203;R-HSA-72163;R-HSA-72172	Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing
COQ2	positive	SNRPF	ENSG00000139343	COQ2	1	COQ2	1	0.00799623636790925	WBGene00004918	WBGene00004918(0)			GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0005829;GO:0005515;GO:0005681;GO:0000398;GO:0000387;GO:0071013;GO:0005685;GO:0005732;GO:0005654;GO:0046540;GO:0005687;GO:0034709;GO:0051170;GO:0034719;GO:0071005;GO:0071007;GO:0006369;GO:0005689;GO:0008334;GO:0005683;GO:0034715;GO:0030532	spliceosomal snRNP assembly;mRNA splicing, via spliceosome;spliceosomal complex;small nucleolar ribonucleoprotein complex;RNA binding;mRNA processing;RNA splicing;nucleus;cytoplasm;cytosol;protein binding;catalytic step 2 spliceosome;U1 snRNP;nucleoplasm;U4/U6 x U5 tri-snRNP complex;U4 snRNP;methylosome;import into nucleus;SMN-Sm protein complex;U2-type precatalytic spliceosome;U2-type catalytic step 2 spliceosome;termination of RNA polymerase II transcription;U12-type spliceosomal complex;histone mRNA metabolic process;U7 snRNP;pICln-Sm protein complex;small nuclear ribonucleoprotein complex	3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Nucleus;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-191859;R-HSA-194441;R-HSA-72203;R-HSA-73856;R-HSA-72163;R-HSA-72172;R-HSA-72165;R-HSA-75067;R-HSA-111367;R-HSA-77588	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;snRNP Assembly;Metabolism of non-coding RNA;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA Splicing - Minor Pathway;Processing of Capped Intronless Pre-mRNA;SLBP independent Processing of Histone Pre-mRNAs;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
COQ2	positive	SERBP1	ENSG00000142864	COQ2	1	COQ2	1	0.00799623636790925	WBGene00006924				GO:0003723;GO:0005634;GO:0005737;GO:0016020;GO:0005829;GO:0005515;GO:0003730;GO:0048471;GO:0045296;GO:0070062;GO:0032183;GO:0030578;GO:0043488;GO:0042981;GO:0005886	RNA binding;mRNA 3'-UTR binding;nucleus;cytoplasm;membrane;cytosol;protein binding;perinuclear region of cytoplasm;cadherin binding;extracellular exosome;SUMO binding;PML body organization;regulation of mRNA stability;regulation of apoptotic process;plasma membrane	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation		
COQ2	positive	ENOPH1	ENSG00000145293	COQ2	1	COQ2	1	0.00799623636790925	WBGene00010286	WBGene00010286(1)			GO:0005634;GO:0005737;GO:0046872;GO:0000287;GO:0016787;GO:0016311;GO:0005515;GO:0008652;GO:0043874;GO:0019509;GO:0005829;GO:0009086;GO:0019284;GO:0043715;GO:0043716	magnesium ion binding;hydrolase activity;L-methionine salvage from methylthioadenosine;acireductone synthase activity;nucleus;cytoplasm;metal ion binding;dephosphorylation;protein binding;cellular amino acid biosynthetic process;cytosol;methionine biosynthetic process;L-methionine salvage from S-adenosylmethionine;2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity;2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity	3D-structure;Alternative splicing;Amino-acid biosynthesis;Cytoplasm;Hydrolase;Magnesium;Metal-binding;Methionine biosynthesis;Nucleus;Reference proteome	R-HSA-1430728;R-HSA-71291;R-HSA-1614635;R-HSA-1237112	Metabolism;Metabolism of amino acids and derivatives;Sulfur amino acid metabolism;Methionine salvage pathway
COQ2	positive	SSRP1	ENSG00000149136	COQ2	1	COQ2	1	0.00799623636790925	WBGene00001974;WBGene00001973	WBGene00008081(0)			GO:0005634;GO:0003723;GO:0003677;GO:0005694;GO:0005515;GO:0006281;GO:0006974;GO:0006260;GO:0003682;GO:0005730;GO:0042393;GO:0000790;GO:0005654;GO:0006366;GO:0006368;GO:1901796;GO:0031491;GO:0035101	DNA binding;nucleus;RNA binding;chromosome;protein binding;DNA repair;cellular response to DNA damage stimulus;DNA replication;chromatin binding;nucleolus;histone binding;nuclear chromatin;nucleoplasm;viral process;transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;regulation of signal transduction by p53 class mediator;nucleosome binding;regulation of chromatin organization;FACT complex	3D-structure;Acetylation;Chromosome;DNA damage;DNA repair;DNA replication;DNA-binding;Direct protein sequencing;Host-virus interaction;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-112382;R-HSA-167152;R-HSA-167169;R-HSA-167172;R-HSA-167200;R-HSA-167238;R-HSA-167243;R-HSA-167246;R-HSA-167287;R-HSA-167290;R-HSA-674695;R-HSA-6796648;R-HSA-75955;R-HSA-5633007;R-HSA-6804756	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Formation of RNA Pol II elongation complex ;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription Elongation;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation
COQ2	positive	VBP1	ENSG00000155959	COQ2	1	COQ2	1	0.00799623636790925	WBGene00006889	WBGene00006889(1)			GO:0005634;GO:0005737;GO:0043231;GO:0005829;GO:0006457;GO:0005515;GO:0007017;GO:0016272;GO:0015631;GO:0005844;GO:0007021	protein folding;prefoldin complex;nucleus;cytoplasm;intracellular membrane-bounded organelle;cytosol;protein binding;microtubule-based process;tubulin binding;polysome;tubulin complex assembly	3D-structure;Acetylation;Alternative splicing;Chaperone;Cytoplasm;Nucleus;Polymorphism;Reference proteome	R-HSA-392499;R-HSA-389958;R-HSA-390466;R-HSA-391251;R-HSA-389957	Metabolism of proteins;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Chaperonin-mediated protein folding;Protein folding;Prefoldin mediated transfer of substrate  to CCT/TriC
COQ2	positive	PPIH	ENSG00000171960	COQ2	1	COQ2	1	0.00799623636790925	WBGene00000887	WBGene00000887(1)			GO:0005737;GO:0006397;GO:0008380;GO:0005634;GO:0016607;GO:0016853;GO:0003755;GO:0000413;GO:0006457;GO:0005515;GO:0005681;GO:0016018;GO:0051082;GO:0042026;GO:0005654;GO:0065003;GO:0000398;GO:0071001;GO:0043021;GO:0001525;GO:0045070;GO:0046540	peptidyl-prolyl cis-trans isomerase activity;protein folding;protein peptidyl-prolyl isomerization;cytoplasm;mRNA processing;RNA splicing;nucleus;nuclear speck;isomerase activity;protein binding;spliceosomal complex;cyclosporin A binding;unfolded protein binding;protein refolding;nucleoplasm;protein-containing complex assembly;mRNA splicing, via spliceosome;U4/U6 snRNP;ribonucleoprotein complex binding;angiogenesis;positive regulation of viral genome replication;U4/U6 x U5 tri-snRNP complex	3D-structure;Acetylation;Alternative splicing;Chaperone;Cytoplasm;Direct protein sequencing;Isomerase;Nucleus;Reference proteome;Rotamase;Spliceosome;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-72203;R-HSA-72163;R-HSA-72172	Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing
COQ2	positive	RMI1	ENSG00000178966	COQ2	1	COQ2	1	0.00799623636790925	WBGene00011576	WBGene00011576(0);WBGene00019712(0)		Bloom Syndrome like Disorder	GO:0005654;GO:0016604;GO:0005634;GO:0005515;GO:0000166;GO:0006260;GO:0000712;GO:1901796;GO:0000724;GO:0002021;GO:0002023;GO:0009749;GO:0035264;GO:0042593;GO:0031422	nucleoplasm;nuclear body;nucleotide binding;nucleus;protein binding;DNA replication;resolution of meiotic recombination intermediates;regulation of signal transduction by p53 class mediator;double-strand break repair via homologous recombination;response to dietary excess;reduction of food intake in response to dietary excess;response to glucose;multicellular organism growth;glucose homeostasis;RecQ family helicase-topoisomerase III complex	3D-structure;Acetylation;DNA replication;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-69481;R-HSA-69620;R-HSA-5633007;R-HSA-6804756;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-5693554;R-HSA-5685938	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;G2/M Checkpoints;Cell Cycle Checkpoints;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Single Strand Annealing (SSA)
COQ2	positive	AURKB	ENSG00000178999	COQ2	1	COQ2	1	0.00799623636790925	WBGene00000099;WBGene00000098	WBGene00000099(1)			GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005654;GO:0051301;GO:0005694;GO:0005856;GO:0005515;GO:0007049;GO:0030496;GO:0005819;GO:0000775;GO:0000780;GO:0032133;GO:0032467;GO:0000122;GO:0032466;GO:0005829;GO:0031145;GO:0007094;GO:0000779;GO:0043988;GO:1901796;GO:0046777;GO:0032465;GO:0006511;GO:0032091;GO:0032212;GO:0051973;GO:1904355;GO:0008608;GO:0004712;GO:0035174;GO:0007051;GO:0007052;GO:0005876;GO:0031616;GO:0051233;GO:0034644;GO:0019900;GO:0034501;GO:0051983;GO:0051256;GO:0016570;GO:0002903;GO:0009838;GO:0036089;GO:0044878;GO:0007568;GO:0008283;GO:0000776;GO:0010369;GO:1990023	ATP binding;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;mitotic spindle assembly checkpoint;positive regulation of cytokinesis;histone H3-S28 phosphorylation;chromosome passenger complex;nucleus;cytoplasm;metal ion binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;nucleoplasm;cytoskeleton;cell division;chromosome;protein binding;cell cycle;midbody;spindle;chromosome, centromeric region;condensed nuclear chromosome, centromeric region;negative regulation of transcription by RNA polymerase II;negative regulation of cytokinesis;cytosol;anaphase-promoting complex-dependent catabolic process;condensed chromosome, centromeric region;regulation of signal transduction by p53 class mediator;protein autophosphorylation;regulation of cytokinesis;ubiquitin-dependent protein catabolic process;negative regulation of protein binding;positive regulation of telomere maintenance via telomerase;positive regulation of telomerase activity;positive regulation of telomere capping;attachment of spindle microtubules to kinetochore;protein serine/threonine/tyrosine kinase activity;histone serine kinase activity;spindle organization;mitotic spindle organization;spindle pole centrosome;spindle midzone;cellular response to UV;spindle microtubule;kinase binding;protein localization to kinetochore;regulation of chromosome segregation;mitotic spindle midzone assembly;histone modification;negative regulation of B cell apoptotic process;abscission;cleavage furrow formation;mitotic cytokinesis checkpoint;aging;cell population proliferation;positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore;kinetochore;chromocenter;mitotic spindle midzone	3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Kinase;Magnesium;Metal-binding;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-174143;R-HSA-174178;R-HSA-2467813;R-HSA-2555396;R-HSA-453276;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-2990846;R-HSA-3108232;R-HSA-4615885;R-HSA-141424;R-HSA-141444;R-HSA-69618;R-HSA-5633007;R-HSA-8986944;R-HSA-6804756;R-HSA-9022692	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Signaling by Rho GTPases;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of DNA replication proteins;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint;Regulation of TP53 Activity;Transcriptional Regulation by MECP2;Regulation of TP53 Activity through Phosphorylation;Regulation of MECP2 expression and activity
COQ2	positive	BRCA1	ENSG00000012048	COQ2	1	COQ2	1	0.00876773465137304		WBGene00018327(0)	ASPM;ATM;CDKN1A;CDKN1B;CYP19A1;DDB2;DDIT3;EP300;ESR1;FST;GADD45A;IFNA1;IRF7;IRF9;MAD2L1;MDM2;RNASEL;S100A2;SIRT1;STAT1;STAT2;VEGFA	Familial pancreatic carcinoma;Familial prostate cancer;Fanconi anemia;Hereditary breast and ovarian cancer syndrome;Hereditary breast cancer;Hereditary site-specific ovarian cancer syndrome;Primary peritoneal carcinoma;Intellectual disability;Breast Cancer;BREAST-OVARIAN CANCER FAMILIAL SUSCEPTIBILITY TO 1;FANCONI ANEMIA COMPLEMENTATION GROUP S;PANCREATIC CANCER SUSCEPTIBILITY TO 4	GO:0010628;GO:0045766;GO:0071158;GO:0045944;GO:0071356;GO:0044212;GO:0005634;GO:0005737;GO:0008270;GO:0046872;GO:0016740;GO:0016567;GO:0003677;GO:0006629;GO:0004842;GO:0005694;GO:0006631;GO:0006633;GO:0006281;GO:0005515;GO:0006310;GO:0006974;GO:0007049;GO:0051865;GO:0085020;GO:0031436;GO:0006915;GO:0006302;GO:0003713;GO:0045893;GO:0042802;GO:0007059;GO:0005886;GO:0005654;GO:0016579;GO:0032991;GO:0006357;GO:0045739;GO:0031625;GO:0031398;GO:0042127;GO:0042981;GO:0019899;GO:0045892;GO:1901796;GO:0006260;GO:0070317;GO:0015631;GO:0000151;GO:0030521;GO:0043627;GO:0072425;GO:1990904;GO:0000724;GO:1902042;GO:0050681;GO:0008630;GO:0070063;GO:0000729;GO:0006303;GO:0045717;GO:0035066;GO:0010212;GO:0003723;GO:0046600;GO:0010575;GO:0006978;GO:0071681;GO:0051571;GO:0006301;GO:0006359;GO:0009048;GO:0033147;GO:0035067;GO:0043009;GO:0051573;GO:0070512;GO:2000378;GO:2000617;GO:2000620;GO:0000800;GO:0008274;GO:0070531;GO:0003684;GO:0006349;GO:0007098;GO:0044030;GO:0044818;GO:0051572;GO:0051574;GO:0000793;GO:0000794;GO:0016020;GO:0016021	DNA binding;zinc ion binding;nucleus;metal ion binding;DNA repair;ubiquitin-protein transferase activity;cellular response to DNA damage stimulus;positive regulation of gene expression;positive regulation of angiogenesis;positive regulation of cell cycle arrest;positive regulation of transcription by RNA polymerase II;cellular response to tumor necrosis factor;transcription regulatory region DNA binding;cytoplasm;transferase activity;nucleoplasm;protein ubiquitination;lipid metabolic process;chromosome;fatty acid metabolic process;fatty acid biosynthetic process;protein binding;DNA recombination;cell cycle;protein autoubiquitination;protein K6-linked ubiquitination;BRCA1-BARD1 complex;nuclear body;apoptotic process;double-strand break repair;transcription coactivator activity;positive regulation of transcription, DNA-templated;plasma membrane;identical protein binding;chromosome segregation;protein deubiquitination;protein-containing complex;regulation of transcription by RNA polymerase II;positive regulation of DNA repair;ubiquitin protein ligase binding;positive regulation of protein ubiquitination;regulation of cell population proliferation;regulation of apoptotic process;enzyme binding;negative regulation of transcription, DNA-templated;regulation of signal transduction by p53 class mediator;DNA replication;negative regulation of G0 to G1 transition;tubulin binding;ubiquitin ligase complex;androgen receptor signaling pathway;response to estrogen;signal transduction involved in G2 DNA damage checkpoint;ribonucleoprotein complex;double-strand break repair via homologous recombination;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;androgen receptor binding;intrinsic apoptotic signaling pathway in response to DNA damage;RNA polymerase binding;DNA double-strand break processing;double-strand break repair via nonhomologous end joining;negative regulation of fatty acid biosynthetic process;positive regulation of histone acetylation;response to ionizing radiation;RNA binding;negative regulation of centriole replication;positive regulation of vascular endothelial growth factor production;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;cellular response to indole-3-methanol;positive regulation of histone H3-K4 methylation;postreplication repair;regulation of transcription by RNA polymerase III;dosage compensation by inactivation of X chromosome;negative regulation of intracellular estrogen receptor signaling pathway;negative regulation of histone acetylation;chordate embryonic development;negative regulation of histone H3-K9 methylation;positive regulation of histone H4-K20 methylation;negative regulation of reactive oxygen species metabolic process;positive regulation of histone H3-K9 acetylation;positive regulation of histone H4-K16 acetylation;lateral element;gamma-tubulin ring complex;BRCA1-A complex;damaged DNA binding;regulation of gene expression by genetic imprinting;centrosome cycle;regulation of DNA methylation;mitotic G2/M transition checkpoint;negative regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 methylation;condensed chromosome;condensed nuclear chromosome;membrane;integral component of membrane	3D-structure;Acetylation;Activator;Alternative initiation;Alternative splicing;Cell cycle;Chromosome;Cytoplasm;DNA damage;DNA recombination;DNA repair;DNA-binding;Direct protein sequencing;Disease mutation;Fanconi anemia;Fatty acid biosynthesis;Fatty acid metabolism;Isopeptide bond;Lipid biosynthesis;Lipid metabolism;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Transferase;Tumor suppressor;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1221632;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-5688426;R-HSA-69481;R-HSA-69620;R-HSA-6796648;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-5633007;R-HSA-5693565;R-HSA-5693606;R-HSA-6804756;R-HSA-8953750;R-HSA-5689901;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-5693554;R-HSA-912446;R-HSA-5685938;R-HSA-5693571	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Meiotic synapsis;Reproduction;Meiosis;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;Deubiquitination;G2/M Checkpoints;Cell Cycle Checkpoints;TP53 Regulates Transcription of DNA Repair Genes;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Regulation of TP53 Activity;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Regulation of TP53 Activity through Phosphorylation;Transcriptional Regulation by E2F6;Metalloprotease DUBs;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Meiotic recombination;HDR through Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ)
COQ2	positive	HPF1	ENSG00000056050	COQ2	1	COQ2	1	0.00876773465137304	WBGene00010439	WBGene00010439(0)			GO:0006974;GO:0005634;GO:0042393;GO:0005515;GO:0008270;GO:0018312;GO:0010835;GO:0072572	cellular response to DNA damage stimulus;nucleus;protein binding;histone binding;zinc ion binding;peptidyl-serine ADP-ribosylation;regulation of protein ADP-ribosylation;poly-ADP-D-ribose binding	ADP-ribosylation;Acetylation;Polymorphism;Reference proteome		
COQ2	positive	SEPHS1	ENSG00000086475	COQ2	1	COQ2	1	0.00876773465137304	WBGene00012867	WBGene00012867(1)			GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005886;GO:0005515;GO:0042802;GO:0031965;GO:0005525;GO:0006464;GO:0004756;GO:0001887;GO:0016260;GO:0070329	ATP binding;nucleus;cytoplasm;membrane;nucleotide binding;kinase activity;transferase activity;phosphorylation;plasma membrane;protein binding;identical protein binding;nuclear membrane;GTP binding;cellular protein modification process;selenide, water dikinase activity;selenocysteine biosynthetic process	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell membrane;Cytoplasm;Direct protein sequencing;Kinase;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Nucleus;Reference proteome;Selenium;Transferase		
COQ2	positive	FH	ENSG00000091483	COQ2	1	COQ2	1	0.00876773465137304	WBGene00001503	WBGene00001503(1)		Fumaric aciduria;HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER;Hereditary pheochromocytoma-paraganglioma;FUMARASE DEFICIENCY;FUMARASE DEFICIENCY;HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	GO:0005634;GO:0005737;GO:0006099;GO:0005739;GO:0003824;GO:0016829;GO:0005694;GO:0005829;GO:0005515;GO:0006281;GO:0006974;GO:0004333;GO:0006106;GO:0048873;GO:0120162;GO:0045239;GO:0070062;GO:0005759;GO:0006108	catalytic activity;lyase activity;tricarboxylic acid cycle;fumarate hydratase activity;fumarate metabolic process;tricarboxylic acid cycle enzyme complex;nucleus;cytoplasm;mitochondrion;chromosome;cytosol;protein binding;DNA repair;cellular response to DNA damage stimulus;malate metabolic process;homeostasis of number of cells within a tissue;positive regulation of cold-induced thermogenesis;extracellular exosome;mitochondrial matrix	3D-structure;Acetylation;Alternative initiation;Chromosome;Cytoplasm;DNA damage;DNA repair;Direct protein sequencing;Disease mutation;Lyase;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Transit peptide;Tricarboxylic acid cycle;Tumor suppressor	R-HSA-1430728;R-HSA-1428517;R-HSA-71406;R-HSA-71403	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Pyruvate metabolism and Citric Acid (TCA) cycle;Citric acid cycle (TCA cycle)
COQ2	positive	CDC23	ENSG00000094880	COQ2	1	COQ2	1	0.00876773465137304	WBGene00003134	WBGene00003134(0)			GO:0016567;GO:0051301;GO:0005515;GO:0004842;GO:0007049;GO:0005680;GO:0030071;GO:0005654;GO:0005829;GO:0031145;GO:1901990;GO:0006511;GO:0070979;GO:0000278;GO:0005622;GO:0007080;GO:0007096;GO:0007091	protein binding;regulation of mitotic metaphase/anaphase transition;anaphase-promoting complex;cell;protein ubiquitination;cell division;ubiquitin-protein transferase activity;cell cycle;cytoplasm;ubiquitin protein ligase activity;nucleoplasm;cytosol;anaphase-promoting complex-dependent catabolic process;regulation of mitotic cell cycle phase transition;ubiquitin-dependent protein catabolic process;protein K11-linked ubiquitination;mitotic cell cycle;intracellular;mitotic metaphase plate congression;metaphase/anaphase transition of mitotic cell cycle;positive regulation of mitotic metaphase/anaphase transition;regulation of exit from mitosis	3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Isopeptide bond;Mitosis;Phosphoprotein;Polymorphism;Reference proteome;Repeat;TPR repeat;Ubl conjugation;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169;R-HSA-1640170;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-453276;R-HSA-68882;R-HSA-68886;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69620;R-HSA-8953897;R-HSA-69618;R-HSA-174084;R-HSA-2559583;R-HSA-141405;R-HSA-141430;R-HSA-174048;R-HSA-176407;R-HSA-176412;R-HSA-179409;R-HSA-2559582	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Cell Cycle Checkpoints;Cellular responses to external stimuli;Mitotic Spindle Checkpoint;Autodegradation of Cdh1 by Cdh1:APC/C;Cellular Senescence;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;APC/C:Cdc20 mediated degradation of Cyclin B;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Phosphorylation of the APC/C;APC-Cdc20 mediated degradation of Nek2A;Senescence-Associated Secretory Phenotype (SASP)
COQ2	positive	PSMA7	ENSG00000101182	COQ2	1	COQ2	1	0.00876773465137304	WBGene00003925				GO:0005737;GO:0016787;GO:0008233;GO:0006508;GO:0000502;GO:0004298;GO:0051603;GO:0005839;GO:0019773;GO:0005634;GO:0005515;GO:0006511;GO:0004175;GO:0038095;GO:0042802;GO:0050852;GO:0098794;GO:0005654;GO:0005829;GO:0070062;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010498;GO:0010499;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043161;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0016032	proteolysis involved in cellular protein catabolic process;proteasome core complex;threonine-type endopeptidase activity;cytoplasm;hydrolase activity;peptidase activity;proteolysis;proteasome complex;proteasome core complex, alpha-subunit complex;endopeptidase activity;ubiquitin-dependent protein catabolic process;nucleus;protein binding;Fc-epsilon receptor signaling pathway;identical protein binding;T cell receptor signaling pathway;postsynapse;nucleoplasm;cytosol;extracellular exosome;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;proteasomal protein catabolic process;proteasomal ubiquitin-independent protein catabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;viral process	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Glycoprotein;Host-virus interaction;Hydrolase;Nucleus;Phosphoprotein;Polymorphism;Protease;Proteasome;Reference proteome;Threonine protease	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
COQ2	positive	TIMELESS	ENSG00000111602	COQ2	1	COQ2	1	0.00876773465137304	WBGene00006571	WBGene00006571(0)			GO:0005634;GO:0051301;GO:0005694;GO:0005515;GO:0006281;GO:0006974;GO:0007049;GO:0007623;GO:0048511;GO:0007275;GO:0000790;GO:0003677;GO:0005654;GO:0035861;GO:0045892;GO:0006260;GO:0044770;GO:0042752;GO:0031298;GO:0002009;GO:1905168;GO:0009582;GO:0043111;GO:0072711;GO:2000781;GO:0072719;GO:0048478;GO:1904976;GO:0000076;GO:0042803;GO:0046982;GO:0000122;GO:0030324;GO:0048754	nucleus;nucleoplasm;cell division;chromosome;protein binding;DNA repair;cellular response to DNA damage stimulus;cell cycle;circadian rhythm;rhythmic process;multicellular organism development;nuclear chromatin;DNA binding;site of double-strand break;negative regulation of transcription, DNA-templated;DNA replication;cell cycle phase transition;regulation of circadian rhythm;nuclear chromosome;replication fork protection complex;morphogenesis of an epithelium;positive regulation of double-strand break repair via homologous recombination;detection of abiotic stimulus;replication fork arrest;cellular response to hydroxyurea;positive regulation of double-strand break repair;cellular response to cisplatin;replication fork protection;DNA replication checkpoint;cellular response to bleomycin;negative regulation of transcription by RNA polymerase II;lung development;branching morphogenesis of an epithelial tube	3D-structure;Alternative splicing;Biological rhythms;Cell cycle;Cell division;Chromosome;DNA damage;DNA repair;Developmental protein;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation	R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-5693607	DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Processing of DNA double-strand break ends
COQ2	positive	EXOSC9	ENSG00000123737	COQ2	1	COQ2	1	0.00876773465137304	WBGene00018154	WBGene00018154(1)		Pontocerebellar hypoplasia type 1;Cerebellar Atrophy with Spinal Motor Neuronopathy;PONTOCEREBELLAR HYPOPLASIA TYPE 1D	GO:0003723;GO:0006396;GO:0005634;GO:0005737;GO:0005730;GO:0005515;GO:0006955;GO:0000175;GO:0005654;GO:0006364;GO:0000956;GO:0005829;GO:0070062;GO:0000178;GO:0043488;GO:0030307;GO:0043928;GO:0000176;GO:0000228;GO:0000467;GO:0071028;GO:0016075;GO:0035925;GO:0071035;GO:0071038;GO:0034427;GO:0034473;GO:0034475;GO:0034476;GO:0071042;GO:0000177;GO:0001102;GO:0045944	RNA processing;exosome (RNase complex);RNA binding;nucleus;cytoplasm;nucleolus;protein binding;immune response;3'-5'-exoribonuclease activity;nucleoplasm;rRNA processing;nuclear-transcribed mRNA catabolic process;cytosol;extracellular exosome;regulation of mRNA stability;positive regulation of cell growth;exonucleolytic catabolism of deadenylated mRNA;nuclear exosome (RNase complex);nuclear chromosome;exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);AU-rich element binding;nuclear mRNA surveillance;rRNA catabolic process;mRNA 3'-UTR AU-rich region binding;nuclear polyadenylation-dependent rRNA catabolic process;nuclear polyadenylation-dependent tRNA catabolic process;RNA polymerase II activating transcription factor binding;nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5';U1 snRNA 3'-end processing;U4 snRNA 3'-end processing;U5 snRNA 3'-end processing;positive regulation of transcription by RNA polymerase II;nuclear polyadenylation-dependent mRNA catabolic process;cytoplasmic exosome (RNase complex)	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Disease mutation;Exosome;Isopeptide bond;Neurodegeneration;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Ubl conjugation;rRNA processing	R-HSA-392499;R-HSA-8953854;R-HSA-450531;R-HSA-429914;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-381119;R-HSA-380994;R-HSA-381042;R-HSA-450604;R-HSA-450513;R-HSA-450385;R-HSA-429958	Metabolism of proteins;Metabolism of RNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Deadenylation-dependent mRNA decay;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Unfolded Protein Response (UPR);ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;KSRP (KHSRP) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;mRNA decay by 3' to 5' exoribonuclease
COQ2	positive	MED20	ENSG00000124641	COQ2	1	COQ2	1	0.00876773465137304	WBGene00007020	WBGene00007020(1)			GO:0005634;GO:0003712;GO:0006357;GO:0016592;GO:1903508;GO:0005515;GO:0003899;GO:0006351;GO:0003713;GO:0005654;GO:0006366;GO:0006367;GO:0061630;GO:0016567;GO:0000151	transcription coregulator activity;regulation of transcription by RNA polymerase II;mediator complex;nucleus;positive regulation of nucleic acid-templated transcription;protein binding;DNA-directed 5'-3' RNA polymerase activity;transcription, DNA-templated;transcription coactivator activity;nucleoplasm;transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;ubiquitin protein ligase activity;protein ubiquitination;ubiquitin ligase complex	Activator;Alternative splicing;Direct protein sequencing;Nucleus;Reference proteome;Transcription;Transcription regulation	R-HSA-1266738;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-381340;R-HSA-400206	Developmental Biology;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;Metabolism of lipids;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha
COQ2	positive	EMG1	ENSG00000126749	COQ2	1	COQ2	1	0.00876773465137304	WBGene00012652	WBGene00012652(0)		BOWEN-CONRADI SYNDROME;BOWEN-CONRADI SYNDROME	GO:0003723;GO:0005634;GO:0005737;GO:0016740;GO:0005730;GO:0008168;GO:0032259;GO:0005515;GO:0019843;GO:0042254;GO:0006364;GO:0042274;GO:0032040;GO:0005654;GO:0070475;GO:0070037;GO:0001824;GO:0017126	methyltransferase activity;RNA binding;nucleus;cytoplasm;transferase activity;nucleoplasm;nucleolus;methylation;protein binding;ribosome biogenesis;rRNA processing;ribosomal small subunit biogenesis;rRNA binding;small-subunit processome;rRNA base methylation;rRNA (pseudouridine) methyltransferase activity;blastocyst development;nucleologenesis	3D-structure;Acetylation;Direct protein sequencing;Disease mutation;Methyltransferase;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Ribosome biogenesis;S-adenosyl-L-methionine;Transferase;rRNA processing;rRNA-binding	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
COQ2	positive	PSME3	ENSG00000131467	COQ2	1	COQ2	1	0.00876773465137304	WBGene00013435	WBGene00013435(1)			GO:0000502;GO:0008537;GO:0005634;GO:0005737;GO:0016020;GO:0005829;GO:0005654;GO:0005515;GO:0007049;GO:0006915;GO:0038095;GO:0042802;GO:0050852;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043161;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0061133;GO:0061136;GO:0002039;GO:2001237;GO:0097371;GO:0010950;GO:2000045	proteasome activator complex;proteasome complex;nucleus;cytoplasm;membrane;nucleoplasm;cytosol;protein binding;cell cycle;apoptotic process;Fc-epsilon receptor signaling pathway;identical protein binding;T cell receptor signaling pathway;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;viral process;endopeptidase activator activity;regulation of proteasomal protein catabolic process;p53 binding;negative regulation of extrinsic apoptotic signaling pathway;MDM2/MDM4 family protein binding;positive regulation of endopeptidase activity;regulation of G1/S transition of mitotic cell cycle	Acetylation;Alternative splicing;Apoptosis;Cell cycle;Cytoplasm;Direct protein sequencing;Host-virus interaction;Nucleus;Phosphoprotein;Proteasome;Reference proteome	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
COQ2	positive	KIF20B	ENSG00000138182	COQ2	1	COQ2	1	0.00876773465137304					GO:0005634;GO:0005737;GO:0000166;GO:0005524;GO:0051301;GO:0042803;GO:0003777;GO:0005856;GO:0042995;GO:0007049;GO:0008017;GO:0048471;GO:0005874;GO:0007018;GO:0005654;GO:0005730;GO:0000922;GO:0005813;GO:0005815;GO:0005819;GO:0030496;GO:0007088;GO:0016887;GO:0005515;GO:0030424;GO:0048812;GO:2000114;GO:2001224;GO:0030426;GO:0007050;GO:0051233;GO:0008284;GO:0005871;GO:0097431;GO:1990023;GO:0032467;GO:0090316;GO:0035372;GO:0070938;GO:1903438;GO:0050699;GO:0008574;GO:0001843;GO:0070201;GO:2001222;GO:0015630;GO:0003774	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;regulation of mitotic nuclear division;nucleus;cytoplasm;nucleotide binding;nucleoplasm;cytosol;intercellular bridge;cytoskeleton;cell division;protein homodimerization activity;cell projection;cell cycle;perinuclear region of cytoplasm;midbody;microtubule;ATPase activity;nucleolus;spindle pole;centrosome;microtubule organizing center;spindle;protein binding;axon;neuron projection morphogenesis;regulation of establishment of cell polarity;positive regulation of neuron migration;growth cone;cell cycle arrest;spindle midzone;positive regulation of cell population proliferation;kinesin complex;mitotic spindle pole;mitotic spindle midzone;positive regulation of cytokinesis;positive regulation of intracellular protein transport;protein localization to microtubule;contractile ring;positive regulation of mitotic cytokinetic process;WW domain binding;ATP-dependent microtubule motor activity, plus-end-directed;neural tube closure;regulation of establishment of protein localization;regulation of neuron migration;microtubule cytoskeleton;motor activity	ATP-binding;Alternative splicing;Cell cycle;Cell division;Cell projection;Coiled coil;Cytoplasm;Cytoskeleton;Microtubule;Mitosis;Motor protein;Nucleotide-binding;Nucleus;Oncogene;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-109582;R-HSA-5653656;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-983189;R-HSA-983231	Hemostasis;Vesicle-mediated transport;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
COQ2	positive	BARD1	ENSG00000138376	COQ2	1	COQ2	1	0.00876773465137304	WBGene00000265;WBGene00010498	WBGene00011802(0)	ESR1	Hereditary breast and ovarian cancer syndrome;Breast Cancer	GO:0005634;GO:0005737;GO:0016607;GO:0046872;GO:0016740;GO:0043066;GO:0016567;GO:0042803;GO:0005515;GO:0004842;GO:0006281;GO:0006974;GO:0085020;GO:0031436;GO:0036464;GO:0005654;GO:0016579;GO:0007050;GO:0043065;GO:0046982;GO:1901796;GO:0006260;GO:0000151;GO:0019900;GO:0001894;GO:0042325;GO:0000729;GO:0006303;GO:0045732;GO:0003723;GO:0046826;GO:0070531;GO:0031441	protein binding;nucleus;cytoplasm;nuclear speck;metal ion binding;transferase activity;negative regulation of apoptotic process;protein ubiquitination;protein homodimerization activity;ubiquitin-protein transferase activity;DNA repair;cellular response to DNA damage stimulus;protein K6-linked ubiquitination;BRCA1-BARD1 complex;cytoplasmic ribonucleoprotein granule;nucleoplasm;protein deubiquitination;cell cycle arrest;positive regulation of apoptotic process;protein heterodimerization activity;regulation of signal transduction by p53 class mediator;DNA replication;ubiquitin ligase complex;kinase binding;tissue homeostasis;regulation of phosphorylation;DNA double-strand break processing;double-strand break repair via nonhomologous end joining;positive regulation of protein catabolic process;RNA binding;negative regulation of protein export from nucleus;BRCA1-A complex;negative regulation of mRNA 3'-end processing	3D-structure;ANK repeat;Alternative splicing;DNA damage;DNA repair;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-5688426;R-HSA-5689603;R-HSA-69481;R-HSA-69620;R-HSA-5633007;R-HSA-5693565;R-HSA-5693606;R-HSA-6804756;R-HSA-5689901;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-5693554;R-HSA-5685938;R-HSA-5693571	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;Deubiquitination;UCH proteinases;G2/M Checkpoints;Cell Cycle Checkpoints;Regulation of TP53 Activity;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Regulation of TP53 Activity through Phosphorylation;Metalloprotease DUBs;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ)
COQ2	positive	COPS3	ENSG00000141030	COQ2	1	COQ2	1	0.00876773465137304	WBGene00000815				GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0005515;GO:0008180;GO:0006511;GO:0043687;GO:0007165;GO:0000338;GO:0006283;GO:0000715;GO:0009416;GO:0001701	COP9 signalosome;nucleus;cytoplasm;nucleoplasm;cytosol;protein binding;ubiquitin-dependent protein catabolic process;post-translational protein modification;protein deneddylation;signal transduction;transcription-coupled nucleotide-excision repair;nucleotide-excision repair, DNA damage recognition;response to light stimulus;in utero embryonic development	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;Signalosome	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-73894;R-HSA-8951664;R-HSA-8856828;R-HSA-8856825;R-HSA-5696398;R-HSA-6781823;R-HSA-6781827;R-HSA-5696399;R-HSA-5696394	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;DNA Repair;Neddylation;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis;Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Global Genome Nucleotide Excision Repair (GG-NER);DNA Damage Recognition in GG-NER
COQ2	positive	CDC123	ENSG00000151465	COQ2	1	COQ2	1	0.00876773465137304					GO:0005737;GO:0051301;GO:0007049;GO:0007050;GO:0008284;GO:0045948;GO:1905143	cytoplasm;cell division;cell cycle;cell cycle arrest;positive regulation of cell population proliferation;positive regulation of translational initiation;eukaryotic translation initiation factor 2 complex assembly	Cell cycle;Cell division;Cytoplasm;Phosphoprotein;Reference proteome		
COQ2	positive	SPC25	ENSG00000152253	COQ2	1	COQ2	1	0.00876773465137304					GO:0005634;GO:0005829;GO:0051301;GO:0005694;GO:0005515;GO:0007049;GO:0007059;GO:0000775;GO:0000776;GO:0000777;GO:0007052;GO:0031262	nucleus;cytosol;cell division;chromosome;protein binding;cell cycle;chromosome segregation;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;mitotic spindle organization;Ndc80 complex	3D-structure;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
COQ2	positive	MRPL39	ENSG00000154719	COQ2	1	COQ2	1	0.00876773465137304	WBGene00006617;WBGene00044344	WBGene00044344(0)			GO:0003723;GO:0005739;GO:0005840;GO:0000166;GO:0005762;GO:0005743;GO:0070125;GO:0070126;GO:0005761	nucleotide binding;RNA binding;mitochondrion;ribosome;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;mitochondrial ribosome	3D-structure;Acetylation;Alternative splicing;Mitochondrion;Polymorphism;Reference proteome;Ribonucleoprotein;Ribosomal protein	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ2	positive	POP7	ENSG00000172336	COQ2	1	COQ2	1	0.00876773465137304	WBGene00013373	WBGene00302968(1)			GO:0005634;GO:0003676;GO:0003723;GO:0005737;GO:0008033;GO:0016787;GO:0005515;GO:0090501;GO:0090502;GO:0005730;GO:0006364;GO:0005654;GO:0004526;GO:0033204;GO:0001682;GO:0000172;GO:0030681	nucleus;nucleic acid binding;tRNA processing;ribonuclease P activity;RNA binding;cytoplasm;hydrolase activity;protein binding;nucleolus;rRNA processing;nucleoplasm;RNA phosphodiester bond hydrolysis, endonucleolytic;ribonuclease P RNA binding;tRNA 5'-leader removal;ribonuclease MRP complex;multimeric ribonuclease P complex;RNA phosphodiester bond hydrolysis	3D-structure;Cytoplasm;Direct protein sequencing;Hydrolase;Nucleus;RNA-binding;Reference proteome;rRNA processing;tRNA processing	R-HSA-72306;R-HSA-8953854;R-HSA-6784531	tRNA processing;Metabolism of RNA;tRNA processing in the nucleus
COQ2	positive	BANF1	ENSG00000175334	COQ2	1	COQ2	1	0.00876773465137304	WBGene00000235	WBGene00000235(1)		Nestor-Guillermo progeria syndrome;Nestor-Guillermo progeria syndrome;Nestor-Guillermo progeria syndrome	GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0003677;GO:0005694;GO:0042803;GO:0005515;GO:0042802;GO:0045071;GO:0016032;GO:0008022;GO:0047485;GO:0019899;GO:0009615;GO:0005635;GO:0007059;GO:0051169;GO:0075713;GO:0097726;GO:0007084;GO:0030261;GO:0015074;GO:0000793	DNA binding;nucleus;cytoplasm;nucleoplasm;cytosol;chromosome;protein homodimerization activity;protein binding;identical protein binding;negative regulation of viral genome replication;viral process;protein C-terminus binding;protein N-terminus binding;enzyme binding;response to virus;nuclear envelope;chromosome segregation;nuclear transport;establishment of integrated proviral latency;LEM domain binding;mitotic nuclear envelope reassembly;chromosome condensation	3D-structure;Acetylation;Chromosome;Cytoplasm;DNA-binding;Disease mutation;Host-virus interaction;Nucleus;Phosphoprotein;Reference proteome	R-HSA-1640170;R-HSA-1643685;R-HSA-162587;R-HSA-162906;R-HSA-5663205;R-HSA-162909;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-176033;R-HSA-180910;R-HSA-2980766;R-HSA-68875;R-HSA-162592;R-HSA-162594;R-HSA-164843;R-HSA-175567;R-HSA-177539;R-HSA-180689;R-HSA-2995383;R-HSA-2995410	Cell Cycle;Disease;HIV Life Cycle;HIV Infection;Infectious disease;Host Interactions of HIV factors;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Interactions of Vpr with host cellular proteins;Vpr-mediated nuclear import of PICs;Nuclear Envelope Breakdown;Mitotic Prophase;Integration of provirus;Early Phase of HIV Life Cycle;2-LTR circle formation;Integration of viral DNA into host genomic DNA;Autointegration results in viral DNA circles;APOBEC3G mediated resistance to HIV-1 infection;Initiation of Nuclear Envelope Reformation;Nuclear Envelope Reassembly
COQ2	positive	HNRNPAB	ENSG00000197451	COQ2	1	COQ2	1	0.00876773465137304					GO:0003676;GO:0003723;GO:0005634;GO:0005737;GO:0005654;GO:0005515;GO:0043565;GO:0003700;GO:1990904;GO:0090575;GO:0045893;GO:1990837;GO:0003729;GO:0001837	nucleic acid binding;RNA binding;nucleus;cytoplasm;nucleoplasm;protein binding;sequence-specific DNA binding;DNA-binding transcription factor activity;regulation of RNA metabolic process;ribonucleoprotein complex;RNA polymerase II transcription factor complex;positive regulation of transcription, DNA-templated;sequence-specific double-stranded DNA binding;mRNA binding;epithelial to mesenchymal transition	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation		
COQ2	positive	HIBCH	ENSG00000198130	COQ2	1	COQ2	1	0.00876773465137304	WBGene00017301	WBGene00017301(1)		Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency;HIBCH deficiency;3-@HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY	GO:0016787;GO:0005739;GO:0006574;GO:0009083;GO:0003860;GO:0005759	3-hydroxyisobutyryl-CoA hydrolase activity;hydrolase activity;mitochondrion;valine catabolic process;branched-chain amino acid catabolic process;mitochondrial matrix	3D-structure;Acetylation;Alternative splicing;Branched-chain amino acid catabolism;Disease mutation;Hydrolase;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-71291;R-HSA-70895	Metabolism;Metabolism of amino acids and derivatives;Branched-chain amino acid catabolism
COQ2	positive	WDR3	ENSG00000065183	COQ2	1	COQ2	1	0.00960372748243177	WBGene00017435	WBGene00017435(1)			GO:0003723;GO:0005634;GO:0005730;GO:0031965;GO:0032040;GO:0034388;GO:0005654;GO:0006364;GO:0005515	protein binding;RNA binding;nucleus;nucleoplasm;nucleolus;nuclear membrane;small-subunit processome;Pwp2p-containing subcomplex of 90S preribosome;rRNA processing;snoRNA binding;maturation of SSU-rRNA	Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation;WD repeat	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
COQ2	positive	ELAVL1	ENSG00000066044	COQ2	1	COQ2	1	0.00960372748243177	WBGene00001368				GO:0003676;GO:0003723;GO:0005634;GO:0005737;GO:0016020;GO:0005829;GO:0042803;GO:0005515;GO:0005654;GO:1990904;GO:0019901;GO:0043488;GO:2000036;GO:0051260;GO:0010494;GO:0003730;GO:0000398;GO:0003725;GO:0035925;GO:0003729;GO:0070935;GO:0035198;GO:0048255;GO:0060965;GO:0017091;GO:0045727;GO:0098794;GO:0098978	RNA binding;nucleic acid binding;ribonucleoprotein complex;nucleus;cytoplasm;membrane;cytosol;protein homodimerization activity;protein binding;nucleoplasm;protein kinase binding;regulation of mRNA stability;regulation of stem cell population maintenance;protein homooligomerization;cytoplasmic stress granule;mRNA 3'-UTR binding;mRNA splicing, via spliceosome;double-stranded RNA binding;mRNA 3'-UTR AU-rich region binding;mRNA binding;3'-UTR-mediated mRNA stabilization;miRNA binding;mRNA stabilization;negative regulation of gene silencing by miRNA;AU-rich element binding;protein import into nucleus;positive regulation of translation;endoplasmic reticulum;postsynapse;glutamatergic synapse	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation	R-HSA-8953854;R-HSA-450531;R-HSA-72203;R-HSA-450520;R-HSA-72163;R-HSA-72172	Metabolism of RNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Processing of Capped Intron-Containing Pre-mRNA;HuR (ELAVL1) binds and stabilizes mRNA;mRNA Splicing - Major Pathway;mRNA Splicing
COQ2	positive	SEH1L	ENSG00000085415	COQ2	1	COQ2	1	0.00960372748243177	WBGene00003804	WBGene00003804(1)			GO:0015031;GO:0005198;GO:1904263;GO:0005515;GO:0051028;GO:0005634;GO:0016020;GO:0005765;GO:0051301;GO:0005694;GO:0007049;GO:0005643;GO:0005764;GO:0007059;GO:0000775;GO:0000776;GO:0000777;GO:0005829;GO:0075733;GO:0043657;GO:0006110;GO:0006406;GO:0006409;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0031080;GO:0051315;GO:0007080;GO:0034198;GO:0006999;GO:0034629;GO:0032008;GO:0061700;GO:0035859;GO:0002534;GO:0050830	protein binding;structural molecule activity;positive regulation of TORC1 signaling;protein transport;cell;mRNA transport;nucleus;membrane;lysosomal membrane;cell division;chromosome;cell cycle;nuclear pore;lysosome;chromosome segregation;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cytosol;intracellular transport of virus;host cell;regulation of glycolytic process;mRNA export from nucleus;tRNA export from nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope;nuclear pore outer ring;attachment of mitotic spindle microtubules to kinetochore;mitotic metaphase plate congression;cellular response to amino acid starvation;nuclear pore organization;cellular protein-containing complex localization;positive regulation of TOR signaling;GATOR2 complex;Seh1-associated complex;cytokine production involved in inflammatory response;defense response to Gram-positive bacterium	3D-structure;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Isopeptide bond;Kinetochore;Lysosome;Membrane;Mitosis;Nuclear pore complex;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Repeat;Translocation;Transport;Ubl conjugation;WD repeat;mRNA transport		
COQ2	positive	POLE2	ENSG00000100479	COQ2	1	COQ2	1	0.00960372748243177	WBGene00017237	WBGene00017237(1)			GO:0005634;GO:0043231;GO:0016740;GO:0005654;GO:0003677;GO:0005515;GO:0016604;GO:0006260;GO:0016779;GO:0003887;GO:0008622;GO:0006261;GO:0000082;GO:0006281;GO:0042276;GO:0006270;GO:0032201	DNA binding;DNA replication;DNA-directed DNA polymerase activity;DNA-dependent DNA replication;epsilon DNA polymerase complex;nucleus;intracellular membrane-bounded organelle;nucleoplasm;protein binding;nuclear body;G1/S transition of mitotic cell cycle;DNA repair;error-prone translesion synthesis;DNA replication initiation;telomere maintenance via semi-conservative replication	3D-structure;Alternative splicing;DNA replication;DNA-binding;Nucleus;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69002;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-73886;R-HSA-453279;R-HSA-69206;R-HSA-68962;R-HSA-157579;R-HSA-180786;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174417;R-HSA-174430;R-HSA-68952;R-HSA-5696397	Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;DNA Replication Pre-Initiation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Chromosome Maintenance;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of the pre-replicative complex;Telomere Maintenance;Extension of Telomeres;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Telomere C-strand (Lagging Strand) Synthesis;Telomere C-strand synthesis initiation;DNA replication initiation;Gap-filling DNA repair synthesis and ligation in GG-NER
COQ2	positive	RBBP8	ENSG00000101773	COQ2	1	COQ2	1	0.00960372748243177		WBGene00008082(0)		JAWAD SYNDROME;Seckel syndrome;JAWAD SYNDROME;SECKEL SYNDROME 2	GO:0005634;GO:0004519;GO:0090305;GO:0000724;GO:0010792;GO:0043231;GO:0005654;GO:0016787;GO:0003677;GO:0051301;GO:0005694;GO:0006281;GO:0005515;GO:0006974;GO:0007049;GO:1903507;GO:0004518;GO:0051321;GO:0042802;GO:0003690;GO:0003697;GO:0000403;GO:1901796;GO:0006260;GO:0070317;GO:0006357;GO:0001103;GO:0003714;GO:0017053;GO:0003684;GO:0006289;GO:0035861;GO:0000729;GO:0000014;GO:0000406;GO:0070336;GO:0000082;GO:0001835;GO:0032355	nucleus;endonuclease activity;double-strand break repair via homologous recombination;DNA double-strand break processing involved in repair via single-strand annealing;nucleic acid phosphodiester bond hydrolysis;DNA repair;intracellular membrane-bounded organelle;nucleoplasm;hydrolase activity;DNA binding;cell division;chromosome;protein binding;cellular response to DNA damage stimulus;cell cycle;negative regulation of nucleic acid-templated transcription;nuclease activity;meiotic cell cycle;identical protein binding;Y-form DNA binding;double-stranded DNA binding;regulation of signal transduction by p53 class mediator;DNA replication;negative regulation of G0 to G1 transition;regulation of transcription by RNA polymerase II;RNA polymerase II repressing transcription factor binding;transcription corepressor activity;single-stranded DNA binding;transcriptional repressor complex;damaged DNA binding;site of double-strand break;DNA double-strand break processing;single-stranded DNA endodeoxyribonuclease activity;double-strand/single-strand DNA junction binding;flap-structured DNA binding;G1/S transition of mitotic cell cycle;blastocyst hatching;response to estradiol	3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Chromosome;Coiled coil;DNA damage;DNA repair;DNA-binding;Disease mutation;Dwarfism;Endonuclease;Hydrolase;Isopeptide bond;Meiosis;Mental retardation;Mitosis;Nuclease;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-69481;R-HSA-69620;R-HSA-5633007;R-HSA-6804756;R-HSA-8953750;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-5693554;R-HSA-912446;R-HSA-5685938;R-HSA-5685939	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Reproduction;Meiosis;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;G2/M Checkpoints;Cell Cycle Checkpoints;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Transcriptional Regulation by E2F6;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Meiotic recombination;HDR through Single Strand Annealing (SSA);HDR through MMEJ (alt-NHEJ)
COQ2	positive	BCCIP	ENSG00000107949	COQ2	1	COQ2	1	0.00960372748243177	WBGene00022851	WBGene00022851(0)			GO:0003723;GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0005856;GO:0005515;GO:0006281;GO:0006974;GO:0007049;GO:0000922;GO:0005813;GO:0005815;GO:0005814;GO:0015631;GO:0007052;GO:0090307;GO:0097431;GO:0000226;GO:0000079;GO:0034453;GO:0061101;GO:0000132;GO:0019207;GO:0019908	cell;RNA binding;nucleus;cytoplasm;nucleoplasm;cytosol;cytoskeleton;protein binding;DNA repair;cellular response to DNA damage stimulus;cell cycle;spindle pole;centrosome;microtubule organizing center;centriole;tubulin binding;mitotic spindle organization;mitotic spindle assembly;mitotic spindle pole;microtubule cytoskeleton organization;regulation of cyclin-dependent protein serine/threonine kinase activity;microtubule anchoring;neuroendocrine cell differentiation;establishment of mitotic spindle orientation;kinase regulator activity;nuclear cyclin-dependent protein kinase holoenzyme complex	Alternative splicing;Cell cycle;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
COQ2	positive	CISD1	ENSG00000122873	COQ2	1	COQ2	1	0.00960372748243177	WBGene00044026	WBGene00044026(0)			GO:0016020;GO:0016021;GO:0046872;GO:0005739;GO:0051537;GO:0043457;GO:0005741;GO:0032473;GO:0043231;GO:0051536;GO:0042802	2 iron, 2 sulfur cluster binding;intracellular membrane-bounded organelle;membrane;integral component of membrane;metal ion binding;mitochondrion;regulation of cellular respiration;mitochondrial outer membrane;cytoplasmic side of mitochondrial outer membrane;iron-sulfur cluster binding;identical protein binding	2Fe-2S;3D-structure;Acetylation;Iron;Iron-sulfur;Isopeptide bond;Membrane;Metal-binding;Mitochondrion;Mitochondrion outer membrane;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix;Ubl conjugation		
COQ2	positive	UQCC2	ENSG00000137288	COQ2	1	COQ2	1	0.00960372748243177		WBGene00044466(0)		Isolated complex III deficiency;MITOCHONDRIAL COMPLEX III DEFICIENCY NUCLEAR TYPE 7	GO:0005739;GO:0016604;GO:0034551;GO:0016020;GO:0005743;GO:0005759;GO:0005515;GO:0005758;GO:0070131;GO:0050796;GO:0042645;GO:1903364;GO:2001014;GO:0002082	mitochondrial respiratory chain complex III assembly;mitochondrion;nuclear body;membrane;mitochondrial inner membrane;mitochondrial matrix;protein binding;mitochondrial intermembrane space;positive regulation of mitochondrial translation;regulation of insulin secretion;mitochondrial nucleoid;positive regulation of cellular protein catabolic process;regulation of skeletal muscle cell differentiation;regulation of oxidative phosphorylation	Membrane;Mitochondrion;Mitochondrion inner membrane;Mitochondrion nucleoid;Primary mitochondrial disease;Reference proteome;Transit peptide		
COQ2	positive	NARS2	ENSG00000137513	COQ2	1	COQ2	1	0.00960372748243177	WBGene00013447;WBGene00003815	WBGene00013447(0)		Combined oxidative phosphorylation defect type 24;Combined oxidative phosphorylation deficiency 24;DEAFNESS AUTOSOMAL RECESSIVE 94	GO:0003676;GO:0006412;GO:0000166;GO:0005524;GO:0005829;GO:0005654;GO:0005739;GO:0005759;GO:0016874;GO:0004812;GO:0006418;GO:0004816;GO:0006421	ATP binding;nucleic acid binding;aminoacyl-tRNA ligase activity;tRNA aminoacylation for protein translation;nucleotide binding;asparagine-tRNA ligase activity;asparaginyl-tRNA aminoacylation;translation;nucleoplasm;cytosol;mitochondrion;mitochondrial matrix;ligase activity	ATP-binding;Acetylation;Alternative splicing;Aminoacyl-tRNA synthetase;Deafness;Disease mutation;Leigh syndrome;Ligase;Mitochondrion;Non-syndromic deafness;Nucleotide-binding;Polymorphism;Primary mitochondrial disease;Protein biosynthesis;Reference proteome;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-379724;R-HSA-379726	Metabolism of proteins;Translation;tRNA Aminoacylation;Mitochondrial tRNA aminoacylation
COQ2	positive	SAE1	ENSG00000142230	COQ2	1	COQ2	1	0.00960372748243177	WBGene00000142	WBGene00000142(1)			GO:0008641;GO:0005634;GO:0016567;GO:0006464;GO:0043085;GO:0016874;GO:0005515;GO:0005737;GO:0005654;GO:0004839;GO:0032446;GO:0016925;GO:0008022;GO:0046982;GO:1903955;GO:0008047;GO:0044388;GO:0019948;GO:0043008;GO:0031510	ubiquitin-like modifier activating enzyme activity;cellular protein modification process;nucleus;protein ubiquitination;positive regulation of catalytic activity;ligase activity;protein binding;cytoplasm;nucleoplasm;ubiquitin activating enzyme activity;protein modification by small protein conjugation;protein sumoylation;protein C-terminus binding;protein heterodimerization activity;positive regulation of protein targeting to mitochondrion;enzyme activator activity;positive regulation of protein sumoylation;small protein activating enzyme binding;SUMO activating enzyme activity;ATP-dependent protein binding;SUMO activating enzyme complex	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Ligase;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-2990846;R-HSA-3065676;R-HSA-3065678;R-HSA-3215018	Metabolism of proteins;Post-translational protein modification;SUMOylation;SUMO is conjugated to E1 (UBA2:SAE1);SUMO is transferred from E1 to E2 (UBE2I, UBC9);Processing and activation of SUMO
COQ2	positive	SHQ1	ENSG00000144736	COQ2	1	COQ2	1	0.00960372748243177	WBGene00021655	WBGene00021655(0)			GO:0000493;GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0005515;GO:0051082;GO:1904874;GO:0043065;GO:0022618;GO:2000233	box H/ACA snoRNP assembly;nucleus;cytoplasm;nucleoplasm;cytosol;protein binding;unfolded protein binding;positive regulation of telomerase RNA localization to Cajal body;positive regulation of apoptotic process;ribonucleoprotein complex assembly;negative regulation of rRNA processing	3D-structure;Alternative splicing;Cytoplasm;Nucleus;Polymorphism;Reference proteome		
COQ2	positive	GUF1	ENSG00000151806	COQ2	1	COQ2	1	0.00960372748243177	WBGene00022862	WBGene00022862(1)		West syndrome;Epileptic encephalopathy early infantile 40	GO:0016020;GO:0006412;GO:0000166;GO:0016787;GO:0005743;GO:0003924;GO:0005525;GO:0005739;GO:0005759;GO:0043022;GO:0045727	GTP binding;GTPase activity;membrane;translation;nucleotide binding;hydrolase activity;mitochondrial inner membrane;mitochondrion;mitochondrial matrix;ribosome binding;positive regulation of translation	Disease mutation;Epilepsy;GTP-binding;Hydrolase;Membrane;Mitochondrion;Mitochondrion inner membrane;Nucleotide-binding;Polymorphism;Protein biosynthesis;Reference proteome;Transit peptide		
COQ2	positive	MTERF3	ENSG00000156469	COQ2	1	COQ2	1	0.00960372748243177	WBGene00008236	WBGene00008236(0)			GO:0005654;GO:0006355;GO:0005739;GO:0003690;GO:0003677;GO:0005515;GO:0042254;GO:0044212;GO:0045892;GO:0006390;GO:0005741;GO:0016236;GO:0032543;GO:0061668	regulation of transcription, DNA-templated;double-stranded DNA binding;nucleoplasm;mitochondrion;DNA binding;protein binding;ribosome biogenesis;transcription regulatory region DNA binding;negative regulation of transcription, DNA-templated;mitochondrial transcription;mitochondrial outer membrane;macroautophagy;mitochondrial ribosome assembly	3D-structure;Alternative splicing;DNA-binding;Direct protein sequencing;Mitochondrion;Polymorphism;Reference proteome;Ribosome biogenesis;Transcription;Transcription regulation;Transit peptide	R-HSA-9612973;R-HSA-8953897;R-HSA-1632852;R-HSA-5205647;R-HSA-5205685	Autophagy;Cellular responses to external stimuli;Macroautophagy;Mitophagy;Pink/Parkin Mediated Mitophagy
COQ2	positive	SRSF2	ENSG00000161547	COQ2	1	COQ2	1	0.00960372748243177	WBGene00004701	WBGene00004701(0)			GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0016607;GO:0005829;GO:0005515;GO:0000381;GO:1903507;GO:0005654;GO:0003714;GO:0006406;GO:0006405;GO:0031124;GO:0000398;GO:0045292;GO:0043484	RNA binding;nucleic acid binding;regulation of alternative mRNA splicing, via spliceosome;mRNA processing;RNA splicing;nucleus;nuclear speck;nucleoplasm;cytosol;protein binding;negative regulation of nucleic acid-templated transcription;cytoplasm;transcription corepressor activity;mRNA export from nucleus;RNA export from nucleus;mRNA 3'-end processing;mRNA splicing, via spliceosome;mRNA cis splicing, via spliceosome;protein kinase C binding;pre-mRNA binding;mitotic cell cycle;response to vitamin E;spliceosomal complex;interchromatin granule	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing;mRNA splicing	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-159236;R-HSA-72202;R-HSA-72203;R-HSA-72187;R-HSA-73856;R-HSA-72163;R-HSA-72172;R-HSA-72165	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA Splicing - Minor Pathway
COQ2	positive	TOPBP1	ENSG00000163781	COQ2	1	COQ2	1	0.00960372748243177	WBGene00009507				GO:0005634;GO:0005737;GO:0003677;GO:0005694;GO:0015629;GO:0005856;GO:0005515;GO:0006281;GO:0006974;GO:0016604;GO:0000922;GO:0005815;GO:0042802;GO:0005654;GO:0016605;GO:0006259;GO:1901796;GO:0006260;GO:0033314;GO:0008022;GO:0010212;GO:0000794;GO:0001673	nucleus;cytoplasm;intracellular membrane-bounded organelle;nucleoplasm;plasma membrane;DNA binding;cytoskeleton;chromosome;actin cytoskeleton;protein binding;DNA repair;cellular response to DNA damage stimulus;nuclear body;spindle pole;microtubule organizing center;identical protein binding;PML body;DNA metabolic process;regulation of signal transduction by p53 class mediator;DNA replication;DNA replication initiation;mitotic DNA replication checkpoint;mitotic G2 DNA damage checkpoint;protein C-terminus binding;response to ionizing radiation;condensed nuclear chromosome;male germ cell nucleus	3D-structure;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69481;R-HSA-69620;R-HSA-5633007;R-HSA-6804756;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-5685938	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;G2/M Checkpoints;Cell Cycle Checkpoints;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;HDR through Single Strand Annealing (SSA)
COQ2	positive	ABCE1	ENSG00000164163	COQ2	1	COQ2	1	0.00960372748243177	WBGene00012714	WBGene00012714(1)			GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0005829;GO:0005739;GO:0005515;GO:0016887;GO:0000054;GO:0005759;GO:0016032;GO:0006413;GO:0005506;GO:0043024;GO:0006415;GO:0051607;GO:0060338;GO:0060698;GO:0060702	ATP binding;ATPase activity;cytoplasm;membrane;nucleotide binding;cytosol;mitochondrion;protein binding;ribosomal subunit export from nucleus;mitochondrial matrix;viral process;translational initiation;iron ion binding;ribosomal small subunit binding;translational termination;defense response to virus;regulation of type I interferon-mediated signaling pathway;endoribonuclease inhibitor activity;negative regulation of endoribonuclease activity	ATP-binding;Chaperone;Cytoplasm;Host-virus interaction;Mitochondrion;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat	R-HSA-168256;R-HSA-1280215;R-HSA-1169410;R-HSA-913531;R-HSA-909733;R-HSA-8983711	Immune System;Cytokine Signaling in Immune system;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling;Interferon alpha/beta signaling;OAS antiviral response
COQ2	positive	FXN	ENSG00000165060	COQ2	1	COQ2	1	0.00960372748243177	WBGene00001486	WBGene00001486(1)		FRIEDREICH ATAXIA;FRIEDREICH ATAXIA 1	GO:0008199;GO:0016226;GO:0008284;GO:0005737;GO:0046872;GO:0043066;GO:0016491;GO:0055114;GO:0005739;GO:0005829;GO:0006811;GO:0006879;GO:0005515;GO:0004322;GO:0006119;GO:0007005;GO:0007628;GO:0009060;GO:0009792;GO:0019230;GO:0040015;GO:0046621;GO:0005759;GO:0006783;GO:0030307;GO:0070301;GO:0090201;GO:0016540;GO:0043085;GO:0008198;GO:0034986;GO:0055072;GO:0044281;GO:0010039;GO:0051537;GO:0010722;GO:0018283;GO:0051349;GO:1904231;GO:1904234;GO:1990221	ferric iron binding;iron-sulfur cluster assembly;oxidation-reduction process;mitochondrion;ferroxidase activity;positive regulation of cell population proliferation;cell;cytoplasm;metal ion binding;negative regulation of apoptotic process;oxidoreductase activity;cytosol;ion transport;cellular iron ion homeostasis;protein binding;oxidative phosphorylation;mitochondrion organization;adult walking behavior;aerobic respiration;embryo development ending in birth or egg hatching;proprioception;negative regulation of multicellular organism growth;negative regulation of organ growth;heme biosynthetic process;mitochondrial matrix;positive regulation of cell growth;cellular response to hydrogen peroxide;negative regulation of release of cytochrome c from mitochondria;protein autoprocessing;positive regulation of catalytic activity;ferrous iron binding;iron chaperone activity;iron ion homeostasis;small molecule metabolic process;response to iron ion;2 iron, 2 sulfur cluster binding;regulation of ferrochelatase activity;iron incorporation into metallo-sulfur cluster;positive regulation of lyase activity;positive regulation of succinate dehydrogenase activity;positive regulation of aconitate hydratase activity;L-cysteine desulfurase complex	3D-structure;Alternative splicing;Cytoplasm;Direct protein sequencing;Disease mutation;Heme biosynthesis;Ion transport;Iron;Iron storage;Iron transport;Metal-binding;Mitochondrion;Oxidoreductase;Polymorphism;Reference proteome;Transit peptide;Transport;Triplet repeat expansion	R-HSA-1430728;R-HSA-9609507;R-HSA-1268020;R-HSA-1362409	Metabolism;Protein localization;Mitochondrial protein import;Mitochondrial iron-sulfur cluster biogenesis
COQ2	positive	TOR3A	ENSG00000186283	COQ2	1	COQ2	1	0.00960372748243177	WBGene00003870;WBGene00006597;WBGene00006598	WBGene00006598(0);WBGene00003870(1);WBGene00006597(0)			GO:0005737;GO:0000166;GO:0005524;GO:0005783;GO:0005788;GO:0016887;GO:0070062;GO:0005635	ATP binding;cytoplasm;nucleotide binding;endoplasmic reticulum;ATPase activity;endoplasmic reticulum lumen;extracellular exosome;nuclear envelope	ATP-binding;Alternative splicing;Cytoplasm;Endoplasmic reticulum;Glycoprotein;Nucleotide-binding;Polymorphism;Reference proteome;Signal		
COQ2	positive	BLM	ENSG00000197299	COQ2	1	COQ2	1	0.00960372748243177	WBGene00001865;WBGene00004322;WBGene00006944;WBGene00019334	WBGene00001865(0)		Bloom syndrome;Bloom syndrome;Bloom syndrome	GO:0005634;GO:0003676;GO:0046872;GO:0000166;GO:0005524;GO:0005829;GO:0016787;GO:0008270;GO:0003677;GO:0003824;GO:0042803;GO:0006281;GO:0005515;GO:0006310;GO:0006974;GO:0004386;GO:0006260;GO:0003678;GO:0045893;GO:0005730;GO:0044237;GO:0005737;GO:0016818;GO:0000781;GO:0043138;GO:0005654;GO:0016887;GO:0051260;GO:0031297;GO:0000800;GO:0000733;GO:0016605;GO:0032508;GO:0000400;GO:0016363;GO:1901796;GO:0051259;GO:0007095;GO:0000724;GO:0002039;GO:0003697;GO:0008094;GO:0000228;GO:0071479;GO:0090656;GO:0000723;GO:0051782;GO:0000405;GO:0009378;GO:0036310;GO:0061821;GO:0006268;GO:0061820;GO:0005694;GO:0051880;GO:0044806;GO:0000079;GO:0072711;GO:0010165;GO:0000729;GO:0000403;GO:0061749;GO:0061849;GO:1905773;GO:0045910;GO:0048478;GO:0072757;GO:0090329;GO:0005657;GO:0005622	DNA binding;nucleus;ATP binding;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;catalytic activity;DNA repair;nucleic acid binding;cellular metabolic process;DNA replication;nucleotide binding;DNA recombination;helicase activity;3'-5' DNA helicase activity;metal ion binding;nucleoplasm;cytosol;hydrolase activity;zinc ion binding;protein homodimerization activity;protein binding;cellular response to DNA damage stimulus;identical protein binding;ATPase activity;DNA helicase activity;positive regulation of transcription, DNA-templated;nucleolus;cytoplasm;chromosome, telomeric region;PML body;protein-containing complex;protein homooligomerization;replication fork processing;lateral element;DNA strand renaturation;single-stranded DNA binding;replication fork protection;four-way junction DNA binding;nuclear matrix;regulation of signal transduction by p53 class mediator;mitotic G2 DNA damage checkpoint;protein complex oligomerization;double-strand break repair via homologous recombination;p53 binding;DNA-dependent ATPase activity;nuclear chromosome;cellular response to ionizing radiation;t-circle formation;telomere maintenance;DNA duplex unwinding;negative regulation of cell division;bubble DNA binding;four-way junction helicase activity;annealing helicase activity;telomeric D-loop binding;DNA unwinding involved in DNA replication;telomeric D-loop disassembly;chromosome;G-quadruplex DNA binding;G-quadruplex DNA unwinding;regulation of cyclin-dependent protein serine/threonine kinase activity;cellular response to hydroxyurea;response to X-ray;DNA double-strand break processing;Y-form DNA binding;forked DNA-dependent helicase activity;telomeric G-quadruplex DNA binding;8-hydroxy-2'-deoxyguanosine DNA binding;negative regulation of DNA recombination;cellular response to camptothecin;regulation of DNA-dependent DNA replication;replication fork	3D-structure;ATP-binding;Acetylation;DNA damage;DNA repair;DNA replication;DNA-binding;Disease mutation;Dwarfism;Helicase;Hydrolase;Isopeptide bond;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Zinc	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-69481;R-HSA-69620;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-5633007;R-HSA-6804756;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-5693554;R-HSA-912446;R-HSA-5685938	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Reproduction;Meiosis;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;G2/M Checkpoints;Cell Cycle Checkpoints;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Meiotic recombination;HDR through Single Strand Annealing (SSA)
COQ2	negative	DNAJB9	ENSG00000128590	COQ2	1	COQ2	1	8.04999550153562e-05	WBGene00001036;WBGene00001031;WBGene00001034				GO:0005737;GO:0005783;GO:0005730;GO:0005788;GO:0005515;GO:0006986;GO:0005789;GO:0070062;GO:0030433;GO:0034976;GO:0051087;GO:0036498;GO:0030183;GO:0051787;GO:1903895;GO:0030544;GO:0002377	cytoplasm;endoplasmic reticulum;nucleolus;protein binding;endoplasmic reticulum lumen;response to unfolded protein;endoplasmic reticulum membrane;extracellular exosome;ubiquitin-dependent ERAD pathway;response to endoplasmic reticulum stress;chaperone binding;IRE1-mediated unfolded protein response;B cell differentiation;misfolded protein binding;negative regulation of IRE1-mediated unfolded protein response;Hsp70 protein binding;immunoglobulin production	3D-structure;Chaperone;Endoplasmic reticulum;Phosphoprotein;Polymorphism;Reference proteome;Signal;Unfolded protein response	R-HSA-392499;R-HSA-381038;R-HSA-381070;R-HSA-381119	Metabolism of proteins;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR)
COQ2	negative	BTG1	ENSG00000133639	COQ2	1	COQ2	1	0.000394766982552475					GO:0005634;GO:0005737;GO:0005515;GO:0008285;GO:0005654;GO:0016477;GO:0019899;GO:0006355;GO:0030308;GO:0003712;GO:0045766;GO:0019900;GO:2000271;GO:0045930;GO:0045663;GO:0006979;GO:0007283;GO:0043434;GO:0045603	negative regulation of cell population proliferation;nucleus;cytoplasm;protein binding;nucleoplasm;cell migration;regulation of transcription, DNA-templated;enzyme binding;negative regulation of cell growth;transcription coregulator activity;positive regulation of angiogenesis;kinase binding;positive regulation of fibroblast apoptotic process;negative regulation of mitotic cell cycle;positive regulation of myoblast differentiation;positive regulation of endothelial cell differentiation	Chromosomal rearrangement;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9614085;R-HSA-9617828	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of cell cycle genes
COQ2	negative	CREBRF	ENSG00000164463	COQ2	1	COQ2	1	0.000466309116790464					GO:0005634;GO:0006355;GO:0003700;GO:0005515;GO:0006986;GO:0000981;GO:0005654;GO:0001228;GO:0045944;GO:0000977;GO:0030968;GO:0042711;GO:1900170;GO:1902213;GO:0016604	response to unfolded protein;nucleus;nucleoplasm;regulation of transcription, DNA-templated;DNA-binding transcription factor activity;protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;positive regulation of transcription by RNA polymerase II;RNA polymerase II regulatory region sequence-specific DNA binding;endoplasmic reticulum unfolded protein response;maternal behavior;negative regulation of glucocorticoid mediated signaling pathway;positive regulation of prolactin signaling pathway;nuclear body	Alternative splicing;Nucleus;Polymorphism;Reference proteome;Repressor;Stress response;Transcription;Transcription regulation;Transport;Unfolded protein response	R-HSA-392499;R-HSA-381119;R-HSA-8874211	Metabolism of proteins;Unfolded Protein Response (UPR);CREB3 factors activate genes
COQ2	negative	TSC22D3	ENSG00000157514	COQ2	1	COQ2	1	0.000646720155057623	WBGene00011824;WBGene00012994;WBGene00016269	WBGene00011824(0);WBGene00012994(0)	CCND1		GO:0006355;GO:0003700;GO:0005634;GO:0005737;GO:0006357;GO:0000981;GO:0005829;GO:0034220;GO:0006970;GO:0070236	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleus;cytoplasm;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;cytosol;ion transmembrane transport;response to osmotic stress;negative regulation of activation-induced cell death of T cells	Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome	R-HSA-382551;R-HSA-2672351;R-HSA-983712	Transport of small molecules;Stimuli-sensing channels;Ion channel transport
COQ2	negative	BSDC1	ENSG00000160058	COQ2	1	COQ2	1	0.00075932574989046	WBGene00022401	WBGene00022401(0)			GO:0005515	protein binding	Alternative splicing;Phosphoprotein;Reference proteome		
COQ2	negative	MYLIP	ENSG00000007944	COQ2	1	COQ2	1	0.000889750939452982	WBGene00001491;WBGene00009932				GO:0005737;GO:0016020;GO:0046872;GO:0016740;GO:0016567;GO:0005886;GO:0005856;GO:0005515;GO:0008092;GO:0004842;GO:0007399;GO:0006511;GO:0005829;GO:0000209;GO:0010977;GO:0061630;GO:0032802;GO:0010989;GO:0031648;GO:0032803;GO:0042632;GO:0045732	cytoskeleton;cytoskeletal protein binding;cytoplasm;membrane;metal ion binding;transferase activity;protein ubiquitination;plasma membrane;protein binding;ubiquitin-protein transferase activity;nervous system development;ubiquitin-dependent protein catabolic process;cytosol;protein polyubiquitination;negative regulation of neuron projection development;ubiquitin protein ligase activity;low-density lipoprotein particle receptor catabolic process;negative regulation of low-density lipoprotein particle clearance;protein destabilization;regulation of low-density lipoprotein particle receptor catabolic process;cholesterol homeostasis;positive regulation of protein catabolic process	3D-structure;Alternative splicing;Cell membrane;Cytoplasm;Iron;Membrane;Metal-binding;Polymorphism;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169;R-HSA-382551;R-HSA-174824;R-HSA-8964043;R-HSA-8866427	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Transport of small molecules;Plasma lipoprotein assembly, remodeling, and clearance;Plasma lipoprotein clearance;VLDLR internalisation and degradation
COQ2	negative	HLA-E	ENSG00000204592	COQ2	1	COQ2	1	0.000889750939452982					GO:0016020;GO:0016021;GO:0005794;GO:0005886;GO:0005515;GO:0005576;GO:0006955;GO:0000139;GO:0009986;GO:0002376;GO:0045087;GO:0005615;GO:0002250;GO:0009897;GO:0050776;GO:0042605;GO:0019882;GO:0002474;GO:0042612;GO:0070062;GO:0002479;GO:0019731;GO:0050830;GO:0005102;GO:0030670;GO:0002519;GO:0032753;GO:0045953;GO:0060333;GO:0012507;GO:0002717;GO:0060337;GO:0001916;GO:0042288;GO:0071556;GO:0045954;GO:0031901;GO:0032760;GO:0002729;GO:0002480;GO:0042270;GO:0055038;GO:0030881;GO:0002476;GO:0002486;GO:0042608;GO:0036037;GO:2000566;GO:0032736;GO:0046703;GO:0001815;GO:0002477;GO:0002715;GO:0032759;GO:0032819;GO:0051024;GO:2001187;GO:0032398	immune response;antigen processing and presentation;membrane;integral component of membrane;Golgi apparatus;plasma membrane;protein binding;extracellular region;Golgi membrane;cell surface;immune system process;innate immune response;adaptive immune response;extracellular space;external side of plasma membrane;regulation of immune response;defense response to Gram-positive bacterium;peptide antigen binding;extracellular exosome;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;viral process;antibacterial humoral response;antigen processing and presentation of peptide antigen via MHC class I;MHC class I protein complex;signaling receptor binding;phagocytic vesicle membrane;natural killer cell tolerance induction;positive regulation of interleukin-4 production;negative regulation of natural killer cell mediated cytotoxicity;interferon-gamma-mediated signaling pathway;ER to Golgi transport vesicle membrane;positive regulation of natural killer cell mediated immunity;type I interferon signaling pathway;positive regulation of T cell mediated cytotoxicity;MHC class I protein binding;integral component of lumenal side of endoplasmic reticulum membrane;positive regulation of natural killer cell mediated cytotoxicity;early endosome membrane;positive regulation of tumor necrosis factor production;positive regulation of natural killer cell cytokine production;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;protection from natural killer cell mediated cytotoxicity;recycling endosome membrane;beta-2-microglobulin binding;T cell receptor binding;CD8-positive, alpha-beta T cell activation;positive regulation of CD8-positive, alpha-beta T cell proliferation;positive regulation of interleukin-13 production;natural killer cell lectin-like receptor binding;positive regulation of antibody-dependent cellular cytotoxicity;antigen processing and presentation of endogenous peptide antigen via MHC class Ib;antigen processing and presentation of exogenous peptide antigen via MHC class Ib;regulation of natural killer cell mediated immunity;positive regulation of TRAIL production;positive regulation of natural killer cell proliferation;positive regulation of immunoglobulin secretion;positive regulation of CD8-positive, alpha-beta T cell activation;MHC class Ib protein complex	3D-structure;Adaptive immunity;Cell membrane;Disulfide bond;Glycoprotein;Golgi apparatus;Host-virus interaction;Immunity;Innate immunity;MHC I;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Secreted;Signal;Transmembrane;Transmembrane helix	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-198933;R-HSA-983169;R-HSA-1236974;R-HSA-1236975;R-HSA-1280215;R-HSA-2172127;R-HSA-913531;R-HSA-2424491;R-HSA-877300;R-HSA-909733;R-HSA-983170;R-HSA-1236977	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Class I MHC mediated antigen processing & presentation;ER-Phagosome pathway;Antigen processing-Cross presentation;Cytokine Signaling in Immune system;DAP12 interactions;Interferon Signaling;DAP12 signaling;Interferon gamma signaling;Interferon alpha/beta signaling;Antigen Presentation: Folding, assembly and peptide loading of class I MHC;Endosomal/Vacuolar pathway
COQ2	negative	EZH1	ENSG00000108799	COQ2	1	COQ2	1	0.00104049170795806	WBGene00003220	WBGene00019883(0);WBGene00019584(0);WBGene00011729(0);WBGene00018023(0);WBGene00008527(0);WBGene00019690(0);WBGene00020919(0);WBGene00016603(0);WBGene00021282(0);WBGene00022431(0);WBGene00008062(0);WBGene00008206(0);WBGene00020006(0)			GO:0005634;GO:0016740;GO:0005654;GO:0008168;GO:0032259;GO:0006325;GO:0018024;GO:0070734;GO:0000981;GO:0035098;GO:0000122;GO:0009653;GO:0003682;GO:0006348;GO:0000781;GO:0003714;GO:0031493;GO:0006338;GO:0006343;GO:0021766;GO:0045944;GO:0005515	protein binding;histone-lysine N-methyltransferase activity;histone H3-K27 methylation;nucleus;transferase activity;nucleoplasm;methyltransferase activity;methylation;chromatin organization;DNA-binding transcription factor activity, RNA polymerase II-specific;ESC/E(Z) complex;negative regulation of transcription by RNA polymerase II;anatomical structure morphogenesis;chromatin binding;chromatin silencing at telomere;chromosome, telomeric region;transcription corepressor activity;nucleosomal histone binding;chromatin remodeling;establishment of chromatin silencing;hippocampus development;positive regulation of transcription by RNA polymerase II	Alternative splicing;Chromatin regulator;Isopeptide bond;Methyltransferase;Nucleus;Reference proteome;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation		
COQ2	negative	PNRC1	ENSG00000146278	COQ2	1	COQ2	1	0.00104049170795806					GO:0005634;GO:0005515	nucleus;protein binding	Activator;Alternative splicing;Nucleus;Polymorphism;Reference proteome;Transcription;Transcription regulation		
COQ2	negative	TSPYL2	ENSG00000184205	COQ2	1	COQ2	1	0.00104049170795806	WBGene00005007	WBGene00005007(0)			GO:0005634;GO:0005737;GO:0006325;GO:0006334;GO:0005515;GO:0007049;GO:0005730;GO:0005654;GO:0030308;GO:0045786;GO:0009966;GO:0036498;GO:0045859;GO:0000182;GO:0008156	nucleus;nucleosome assembly;cytoplasm;chromatin organization;protein binding;cell cycle;nucleolus;nucleoplasm;negative regulation of cell growth;negative regulation of cell cycle;regulation of signal transduction;IRE1-mediated unfolded protein response;regulation of protein kinase activity;rDNA binding;negative regulation of DNA replication	Cell cycle;Chromatin regulator;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-392499;R-HSA-381038;R-HSA-381070;R-HSA-381119	Metabolism of proteins;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR)
COQ2	negative	HIVEP2	ENSG00000010818	COQ2	1	COQ2	1	0.00121433891361644	WBGene00004862			Autosomal dominant non-syndromic intellectual disability;HIVEP2 associated syndromic developmental delay with intellectual disability;MENTAL RETARDATION AUTOSOMAL DOMINANT 43	GO:0003676;GO:0005634;GO:0046872;GO:0005654;GO:0003677;GO:0006357;GO:0000981	nucleic acid binding;nucleus;metal ion binding;nucleoplasm;DNA binding	DNA-binding;Mental retardation;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ2	negative	PHF1	ENSG00000112511	COQ2	1	COQ2	1	0.00141440452458363					GO:0046872;GO:0006974;GO:0035064;GO:0031060;GO:0005634;GO:0005737;GO:0005654;GO:0006325;GO:0005856;GO:0005515;GO:0005813;GO:0005815;GO:0003700;GO:0043565;GO:0045893;GO:0035098;GO:0035861;GO:0061087;GO:0031491;GO:0045814;GO:0061086;GO:0003682	cellular response to DNA damage stimulus;methylated histone binding;regulation of histone methylation;metal ion binding;nucleus;cytoplasm;nucleoplasm;cytoskeleton;chromatin organization;protein binding;centrosome;microtubule organizing center;regulation of transcription, DNA-templated;DNA binding;ESC/E(Z) complex;site of double-strand break;chromatin binding;DNA-binding transcription factor activity;positive regulation of histone H3-K27 methylation;negative regulation of gene expression, epigenetic;negative regulation of histone H3-K27 methylation	3D-structure;Alternative splicing;Chromatin regulator;Chromosomal rearrangement;Cytoplasm;Cytoskeleton;DNA damage;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-74160;R-HSA-212165;R-HSA-212300	Gene expression (Transcription);Epigenetic regulation of gene expression;PRC2 methylates histones and DNA
COQ2	negative	YPEL5	ENSG00000119801	COQ2	1	COQ2	1	0.00141440452458363	WBGene00015250;WBGene00015251;WBGene00009503	WBGene00015250(0);WBGene00015251(1)			GO:0005634;GO:0005737;GO:0046872;GO:0005856;GO:0000922;GO:0005813;GO:0005815;GO:0030496;GO:0005576;GO:0005515;GO:0000151;GO:0008283;GO:0043312;GO:1904813;GO:1904724;GO:0097431	nucleus;cytoplasm;metal ion binding;cytoskeleton;spindle pole;centrosome;microtubule organizing center;midbody;extracellular region;protein binding;ubiquitin ligase complex;neutrophil degranulation;ficolin-1-rich granule lumen;tertiary granule lumen;mitotic spindle pole;cell population proliferation	Cytoplasm;Cytoskeleton;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Zinc	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
COQ2	negative	FAM117A	ENSG00000121104	COQ2	1	COQ2	1	0.00141440452458363							Alternative splicing;Coiled coil;Phosphoprotein;Reference proteome		
COQ2	negative	MAPK8IP3	ENSG00000138834	COQ2	1	COQ2	1	0.00141440452458363	WBGene00006755;WBGene00019832	WBGene00006755(1)		Intellectual Disability with Variable Brain Anomalies;NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAINABNORMALITIES	GO:0005737;GO:0005794;GO:1904115;GO:0042995;GO:0005515;GO:0000139;GO:0048471;GO:0031410;GO:0030425;GO:0016192;GO:0005078;GO:0030424;GO:0030426;GO:0099641;GO:0044297;GO:0019894;GO:0007257;GO:0008432;GO:0030159;GO:0046328;GO:0061564;GO:0031103;GO:0043410;GO:0031434;GO:0031435;GO:0001701;GO:0007254;GO:0007411;GO:0007585;GO:0008104;GO:0009791;GO:0010468;GO:0030900;GO:0031175;GO:0043507;GO:0045666;GO:0048286;GO:0060425;GO:2001224;GO:0005790;GO:0005886;GO:0030673;GO:0043005	protein binding;MAP-kinase scaffold activity;cytoplasm;Golgi apparatus;axon cytoplasm;cell projection;perinuclear region of cytoplasm;cytoplasmic vesicle;Golgi membrane;vesicle-mediated transport;dendrite;axon;growth cone;anterograde axonal protein transport;cell body;kinesin binding;activation of JUN kinase activity;JUN kinase binding;receptor signaling complex adaptor activity;regulation of JNK cascade;axon development;axon regeneration;positive regulation of MAPK cascade;mitogen-activated protein kinase kinase binding;mitogen-activated protein kinase kinase kinase binding;in utero embryonic development;JNK cascade;axon guidance;respiratory gaseous exchange by respiratory system;protein localization;post-embryonic development;regulation of gene expression;forebrain development;neuron projection development;positive regulation of JUN kinase activity;positive regulation of neuron differentiation;lung alveolus development;lung morphogenesis;positive regulation of neuron migration;smooth endoplasmic reticulum;plasma membrane;axolemma;neuron projection	3D-structure;Alternative splicing;Cell projection;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Disease mutation;Golgi apparatus;Mental retardation;Phosphoprotein;Polymorphism;Reference proteome		
COQ2	negative	PBXIP1	ENSG00000163346	COQ2	1	COQ2	1	0.00141440452458363					GO:0005634;GO:0005737;GO:0005829;GO:0003714;GO:0005856;GO:0005515;GO:0030154;GO:0045892;GO:0007275;GO:0005874;GO:0016020;GO:2001106	transcription corepressor activity;negative regulation of transcription, DNA-templated;cell differentiation;nucleus;cytoplasm;cytoskeleton;cytosol;protein binding;multicellular organism development;microtubule;membrane;regulation of Rho guanyl-nucleotide exchange factor activity	Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Microtubule;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
COQ2	negative	AKAP13	ENSG00000170776	COQ2	1	COQ2	1	0.00141440452458363	WBGene00013682				GO:0006468;GO:0035023;GO:0004691;GO:0005634;GO:0005737;GO:0016020;GO:0046872;GO:0005829;GO:0035556;GO:0005089;GO:0005515;GO:0007186;GO:0060348;GO:0005085;GO:0051056;GO:0007507;GO:0005938;GO:0017048;GO:0043123;GO:0030864;GO:0043065;GO:0060090;GO:0051018;GO:0035025;GO:0055007;GO:0005078;GO:0060297;GO:0071875;GO:0086023;GO:0043406;GO:0051168;GO:0061049;GO:1900169;GO:0005884;GO:0015629;GO:0048471	regulation of Rho protein signal transduction;cAMP-dependent protein kinase activity;protein phosphorylation;nucleus;cytoplasm;membrane;metal ion binding;cytosol;intracellular signal transduction;guanyl-nucleotide exchange factor activity;protein binding;G protein-coupled receptor signaling pathway;bone development;regulation of small GTPase mediated signal transduction;heart development;cell cortex;positive regulation of I-kappaB kinase/NF-kappaB signaling;cortical actin cytoskeleton;positive regulation of apoptotic process;Rho guanyl-nucleotide exchange factor activity;Rho GTPase binding;molecular adaptor activity;protein kinase A binding;positive regulation of Rho protein signal transduction;MAP-kinase scaffold activity;cardiac muscle cell differentiation;regulation of sarcomere organization;adrenergic receptor signaling pathway;adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process;positive regulation of MAP kinase activity;nuclear export;cell growth involved in cardiac muscle cell development;regulation of glucocorticoid mediated signaling pathway;actin filament;actin cytoskeleton;perinuclear region of cytoplasm	3D-structure;Alternative splicing;Coiled coil;Cytoplasm;Guanine-nucleotide releasing factor;Membrane;Metal-binding;Methylation;Nucleus;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;Zinc;Zinc-finger	R-HSA-162582;R-HSA-194315;R-HSA-194840;R-HSA-193648;R-HSA-193704;R-HSA-204998;R-HSA-372790;R-HSA-388396;R-HSA-416482;R-HSA-73887	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
COQ2	negative	GOLGA8A	ENSG00000175265	COQ2	1	COQ2	1	0.00141440452458363		WBGene00018017(0)			GO:0016020;GO:0005794;GO:0005829;GO:0007030;GO:0000137;GO:0005801;GO:0032580	Golgi apparatus;membrane;cytosol;Golgi organization;Golgi cis cisterna;cis-Golgi network;Golgi cisterna membrane	Alternative splicing;Coiled coil;Golgi apparatus;Membrane;Polymorphism;Reference proteome		
COQ2	negative	KDM7A	ENSG00000006459	COQ2	1	COQ2	1	0.00190740906706166	WBGene00005013;WBGene00017920;WBGene00020821	WBGene00017920(0);WBGene00005013(0)			GO:0005634;GO:0046872;GO:0005730;GO:0005654;GO:0016491;GO:0055114;GO:0008270;GO:0006325;GO:0051213;GO:0005506;GO:0007399;GO:0016706;GO:0032454;GO:0033169;GO:0035064;GO:0071558;GO:0071557;GO:0051864;GO:0070544;GO:0030901;GO:0035575;GO:0035574;GO:0045893	nucleus;metal ion binding;nucleoplasm;nucleolus;oxidoreductase activity;oxidation-reduction process;zinc ion binding;chromatin organization;dioxygenase activity;iron ion binding;nervous system development;2-oxoglutarate-dependent dioxygenase activity;histone demethylase activity (H3-K9 specific);histone H3-K9 demethylation;methylated histone binding;histone demethylase activity (H3-K27 specific);histone H3-K27 demethylation;histone demethylase activity (H3-K36 specific);histone H3-K36 demethylation;midbrain development;histone demethylase activity (H4-K20 specific);histone H4-K20 demethylation;positive regulation of transcription, DNA-templated	3D-structure;Alternative splicing;Chromatin regulator;Dioxygenase;Iron;Metal-binding;Neurogenesis;Nucleus;Oxidoreductase;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-1643685;R-HSA-5663202;R-HSA-6802952;R-HSA-6802957;R-HSA-3247509;R-HSA-4839726;R-HSA-3214842	Disease;Diseases of signal transduction;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Chromatin modifying enzymes;Chromatin organization;HDMs demethylate histones
COQ2	negative	CCDC130	ENSG00000104957	COQ2	1	COQ2	1	0.00190740906706166	WBGene00014250	WBGene00014250(1)			GO:0005515;GO:0005575;GO:0009615	protein binding;cellular_component;response to virus	Coiled coil;Phosphoprotein;Polymorphism;Reference proteome		
COQ2	negative	SERINC1	ENSG00000111897	COQ2	1	COQ2	1	0.00190740906706166	WBGene00021956;WBGene00011250	WBGene00011250(1);WBGene00021956(1)			GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0006629;GO:0006665;GO:0005515;GO:0008654;GO:0006658;GO:0005886;GO:0030674;GO:1904219;GO:1904222;GO:0019899;GO:0044091	membrane;sphingolipid metabolic process;phosphatidylserine metabolic process;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;lipid metabolic process;protein binding;phospholipid biosynthetic process;plasma membrane;protein binding, bridging;positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity;positive regulation of serine C-palmitoyltransferase activity;enzyme binding;membrane biogenesis	Endoplasmic reticulum;Glycoprotein;Lipid biosynthesis;Lipid metabolism;Lipoprotein;Membrane;Myristate;Phospholipid biosynthesis;Phospholipid metabolism;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-71291;R-HSA-977347	Metabolism;Metabolism of amino acids and derivatives;Serine biosynthesis
COQ2	negative	SPSB3	ENSG00000162032	COQ2	1	COQ2	1	0.00190740906706166					GO:0016567;GO:0005515;GO:0006511;GO:0005829;GO:0043161;GO:0043687;GO:0019005	protein binding;protein ubiquitination;ubiquitin-dependent protein catabolic process;cytosol;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification;SCF ubiquitin ligase complex	Polymorphism;Reference proteome	R-HSA-392499;R-HSA-597592;R-HSA-8951664	Metabolism of proteins;Post-translational protein modification;Neddylation
COQ2	negative	MOAP1	ENSG00000165943	COQ2	1	COQ2	1	0.00190740906706166					GO:0005515;GO:0006915;GO:0005737;GO:0043065;GO:0005829;GO:0090200;GO:0031625;GO:0005739;GO:0008625;GO:0097192;GO:0097190;GO:0008630;GO:0005741;GO:0001844	protein binding;apoptotic process;cytoplasm;regulation of apoptotic process;positive regulation of apoptotic process;cytosol;positive regulation of release of cytochrome c from mitochondria;ubiquitin protein ligase binding;mitochondrion;extrinsic apoptotic signaling pathway via death domain receptors;extrinsic apoptotic signaling pathway in absence of ligand;apoptotic signaling pathway;intrinsic apoptotic signaling pathway in response to DNA damage;mitochondrial outer membrane;protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	Apoptosis;Reference proteome;Ubl conjugation		
COQ2	negative	OPTN	ENSG00000123240	COQ2	1	COQ2	1	0.00220842749346983				Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS 12;GLAUCOMA NORMAL TENSION SUSCEPTIBILITY TO;GLAUCOMA PRIMARY OPEN ANGLE	GO:0005737;GO:0016192;GO:0046872;GO:0006914;GO:0005829;GO:0005794;GO:0005515;GO:0048471;GO:0031410;GO:0070530;GO:0002376;GO:0045087;GO:0005634;GO:0042802;GO:0005768;GO:0005776;GO:0005654;GO:0050829;GO:0005802;GO:0055037;GO:0000086;GO:0008022;GO:0034067;GO:0007165;GO:0000139;GO:0090161;GO:0007030;GO:0010508;GO:0017137;GO:0061734;GO:0055038;GO:0008219;GO:0030674;GO:0031593;GO:0043001;GO:0034620;GO:0001920;GO:1904417;GO:0034613;GO:0043124	Golgi apparatus;vesicle-mediated transport;autophagy;cytoplasmic vesicle;K63-linked polyubiquitin modification-dependent protein binding;cytoplasm;metal ion binding;cytosol;endosome;protein binding;perinuclear region of cytoplasm;immune system process;innate immune response;nucleus;identical protein binding;autophagosome;nucleoplasm;defense response to Gram-negative bacterium;trans-Golgi network;viral process;recycling endosome;G2/M transition of mitotic cell cycle;protein C-terminus binding;protein localization to Golgi apparatus;signal transduction;Golgi membrane;regulation of I-kappaB kinase/NF-kappaB signaling;Golgi ribbon formation;Golgi organization;positive regulation of autophagy;Rab GTPase binding;parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization;recycling endosome membrane;cell death;protein binding, bridging;polyubiquitin modification-dependent protein binding;Golgi to plasma membrane protein transport;cellular response to unfolded protein;negative regulation of receptor recycling;positive regulation of xenophagy;cellular protein localization;negative regulation of I-kappaB kinase/NF-kappaB signaling	3D-structure;Alternative splicing;Amyotrophic lateral sclerosis;Autophagy;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Disease mutation;Endosome;Glaucoma;Golgi apparatus;Host-virus interaction;Immunity;Innate immunity;Metal-binding;Neurodegeneration;Phosphoprotein;Polymorphism;Reference proteome;Zinc;Zinc-finger	R-HSA-5653656;R-HSA-1640170;R-HSA-199991;R-HSA-9007101;R-HSA-453274;R-HSA-69275;R-HSA-69278;R-HSA-2565942;R-HSA-8854214	Vesicle-mediated transport;Cell Cycle;Membrane Trafficking;Rab regulation of trafficking;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic;Regulation of PLK1 Activity at G2/M Transition;TBC/RABGAPs
COQ2	negative	CCDC186	ENSG00000165813	COQ2	1	COQ2	1	0.00220842749346983	WBGene00013042;WBGene00013043	WBGene00013042(0)			GO:0009617	cell;response to bacterium;insulin secretion involved in cellular response to glucose stimulus;glucose homeostasis;vesicle cytoskeletal trafficking;Golgi apparatus	Acetylation;Coiled coil;Phosphoprotein;Polymorphism;Reference proteome		
COQ2	negative	SERTAD2	ENSG00000179833	COQ2	1	COQ2	1	0.00220842749346983					GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0030308;GO:0003713;GO:0045893	nucleus;cytoplasm;nucleoplasm;cytosol;negative regulation of cell growth;transcription coactivator activity;positive regulation of transcription, DNA-templated	Cytoplasm;Nucleus;Reference proteome;Transcription;Transcription regulation;Ubl conjugation		
COQ2	negative	GSDMB	ENSG00000073605	COQ2	1	COQ2	1	0.0025518816488046					GO:0005737;GO:0016020;GO:0005829;GO:0005886;GO:0005546;GO:0003674;GO:0008150;GO:0005575;GO:0070273;GO:0012501;GO:0001786;GO:0070269	cytoplasm;membrane;cytosol;plasma membrane;defense response to bacterium;phosphatidylinositol-4,5-bisphosphate binding;molecular_function;biological_process;cellular_component;phosphatidylinositol-4-phosphate binding;programmed cell death;phosphatidylserine binding;pyroptosis	3D-structure;Alternative splicing;Cell membrane;Coiled coil;Cytoplasm;Disulfide bond;Membrane;Necrosis;Polymorphism;Reference proteome		
COQ2	negative	IL3RA	ENSG00000185291	COQ2	1	COQ2	1	0.0025518816488046					GO:0016020;GO:0016021;GO:0004896;GO:0009897;GO:0005886;GO:0043235;GO:0000165;GO:0019221;GO:0019955;GO:0004912;GO:0036016;GO:0038156;GO:0005515	protein binding;membrane;cytokine receptor activity;integral component of membrane;external side of plasma membrane;plasma membrane;receptor complex;MAPK cascade;cytokine-mediated signaling pathway;cytokine binding;interleukin-3 receptor activity;cellular response to interleukin-3;interleukin-3-mediated signaling pathway	3D-structure;Alternative splicing;Glycoprotein;Membrane;Polymorphism;Receptor;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-168256;R-HSA-162582;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-451927;R-HSA-512988;R-HSA-912526	Immune System;Signal Transduction;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Interleukin receptor SHC signaling
COQ2	negative	MKNK2	ENSG00000099875	COQ2	1	COQ2	1	0.00294291356853738	WBGene00011304	WBGene00011304(1)			GO:0004672;GO:0005524;GO:0016301;GO:0006468;GO:0016310;GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0004674;GO:0016740;GO:0005654;GO:0005515;GO:0016604;GO:0006915;GO:0035556;GO:0006417;GO:0005516;GO:0016605;GO:0018105;GO:0007166;GO:0030097;GO:0071243;GO:0046777;GO:0004683;GO:0009931;GO:0097192	ATP binding;protein phosphorylation;protein kinase activity;kinase activity;phosphorylation;nucleus;cytoplasm;metal ion binding;nucleotide binding;protein serine/threonine kinase activity;transferase activity;nucleoplasm;protein binding;nuclear body;apoptotic process;intracellular signal transduction;PML body;regulation of translation;calmodulin binding;peptidyl-serine phosphorylation;cell surface receptor signaling pathway;hemopoiesis;cellular response to arsenic-containing substance;protein autophosphorylation;calcium-dependent protein serine/threonine kinase activity;extrinsic apoptotic signaling pathway in absence of ligand	3D-structure;ATP-binding;Alternative splicing;Apoptosis;Cytoplasm;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Translation regulation;Zinc		
COQ2	negative	ANKRD12	ENSG00000101745	COQ2	1	COQ2	1	0.00294291356853738					GO:0005634;GO:0005829;GO:0005654;GO:0005515	protein binding;nucleus;nucleoplasm;cytosol	ANK repeat;Alternative splicing;Disease mutation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat		
COQ2	negative	TRIM23	ENSG00000113595	COQ2	1	COQ2	1	0.00294291356853738	WBGene00000180;WBGene00000182;WBGene00000183	WBGene00000180(1)			GO:0003676;GO:0005737;GO:0016020;GO:0008270;GO:0046872;GO:0000166;GO:0016740;GO:0016567;GO:0005525;GO:0005794;GO:0005765;GO:0043085;GO:0005515;GO:0000139;GO:0002376;GO:0045087;GO:0005764;GO:0042802;GO:0006886;GO:0005886;GO:0016192;GO:0012505;GO:0016032;GO:0003924;GO:0008047;GO:0004842;GO:0019003;GO:0005634;GO:0005622	zinc ion binding;GTP binding;nucleic acid binding;cytoplasm;membrane;metal ion binding;nucleotide binding;transferase activity;protein ubiquitination;Golgi apparatus;lysosomal membrane;positive regulation of catalytic activity;protein binding;Golgi membrane;immune system process;innate immune response;lysosome;plasma membrane;identical protein binding;intracellular protein transport;vesicle-mediated transport;endomembrane system;viral process;GTPase activity;enzyme activator activity;ubiquitin-protein transferase activity;GDP binding;nucleus	3D-structure;Alternative splicing;Coiled coil;Cytoplasm;GTP-binding;Golgi apparatus;Host-virus interaction;Immunity;Innate immunity;Lysosome;Membrane;Metal-binding;Nucleotide-binding;Polymorphism;Reference proteome;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger		
COQ2	negative	NR1D1	ENSG00000126368	COQ2	1	COQ2	1	0.00294291356853738	WBGene00003675	WBGene00044353(0);WBGene00013512(0);WBGene00011565(0);WBGene00011566(0);WBGene00008901(0);WBGene00011568(0);WBGene00022639(0);WBGene00022640(0);WBGene00022637(0);WBGene00008208(0);WBGene00012050(0);WBGene00010017(0);WBGene00006471(0);WBGene00014068(0);WBGene00010186(0);WBGene00012056(0);WBGene00003641(0);WBGene00008884(0);WBGene00010601(0);WBGene00010602(0);WBGene00010600(0);WBGene00003642(0);WBGene00010603(0);WBGene00018404(0);WBGene00016927(0);WBGene00016926(0);WBGene00010180(0);WBGene00018541(0);WBGene00003614(0);WBGene00018545(0);WBGene00018544(0);WBGene00003608(0);WBGene00003702(0);WBGene00011396(0);WBGene00007367(0);WBGene00003653(0);WBGene00003640(0);WBGene00016367(0);WBGene00016366(0);WBGene00016365(0);WBGene00016368(0);WBGene00020750(0);WBGene00018542(0);WBGene00003638(0);WBGene00015897(0);WBGene00003648(0);WBGene00020852(0);WBGene00003715(0);WBGene00020850(0);WBGene00020849(0);WBGene00003705(0);WBGene00020851(0);WBGene00020015(0);WBGene00017961(0);WBGene00003685(0);WBGene00003696(0);WBGene00003708(0);WBGene00003728(0);WBGene00022805(0);WBGene00003669(0);WBGene00021610(0);WBGene00003632(0);WBGene00003698(0);WBGene00008830(0);WBGene00021611(0);WBGene00018265(0);WBGene00018266(0);WBGene00003646(0);WBGene00003725(0);WBGene00044699(0);WBGene00003620(0);WBGene00021617(0);WBGene00003651(0);WBGene00003618(0);WBGene00015497(0);WBGene00016517(0);WBGene00008619(0);WBGene00008630(0);WBGene00003723(0);WBGene00018415(0);WBGene00018622(0);WBGene00012446(0);WBGene00003655(0);WBGene00013584(0);WBGene00015901(0);WBGene00015900(0);WBGene00015902(0);WBGene00018539(0);WBGene00003680(0);WBGene00010215(0);WBGene00003722(0);WBGene00006790(0);WBGene00021522(0);WBGene00020062(0);WBGene00003693(0);WBGene00003617(0);WBGene00003716(0);WBGene00003718(0);WBGene00003724(0);WBGene00003686(0);WBGene00003712(0);WBGene00003677(0);WBGene00003694(0);WBGene00011520(0);WBGene00003692(0);WBGene00011750(0);WBGene00020385(0);WBGene00014189(0);WBGene00003663(0);WBGene00003671(0);WBGene00003672(0);WBGene00010410(0);WBGene00008778(0);WBGene00003662(0);WBGene00003667(0);WBGene00008474(0);WBGene00008289(0);WBGene00008056(0);WBGene00011651(0);WBGene00009608(0);WBGene00008158(0);WBGene00016233(0);WBGene00022756(0);WBGene00015758(0);WBGene00001062(0);WBGene00022726(0);WBGene00012596(0);WBGene00003714(0);WBGene00016772(0);WBGene00003658(0);WBGene00003704(0);WBGene00012703(0);WBGene00018412(0);WBGene00019742(0);WBGene00019741(0);WBGene00019743(0);WBGene00003688(0);WBGene00003713(0);WBGene00003689(0);WBGene00003645(0);WBGene00003720(0);WBGene00020153(0);WBGene00020152(0);WBGene00021163(0);WBGene00003649(0);WBGene00003721(0);WBGene00019115(0);WBGene00020555(0);WBGene00003634(0);WBGene00019116(0);WBGene00003707(0);WBGene00017503(0);WBGene00017512(0);WBGene00003700(0);WBGene00016364(0);WBGene00003684(0);WBGene00016091(0);WBGene00003717(0);WBGene00008309(0);WBGene00012449(0);WBGene00013067(0);WBGene00003644(0);WBGene00020460(0);WBGene00003615(0);WBGene00003699(0);WBGene00003676(0);WBGene00003601(0);WBGene00003611(0);WBGene00011002(0);WBGene00003622(0);WBGene00010604(0);WBGene00003643(0);WBGene00004786(0);WBGene00003624(0);WBGene00003682(0);WBGene00003660(0);WBGene00014193(0);WBGene00045515(0);WBGene00011150(0);WBGene00013940(0);WBGene00022097(0);WBGene00018189(0);WBGene00013483(0)			GO:0071222;GO:0044212;GO:0005634;GO:0005737;GO:0008270;GO:0046872;GO:0006355;GO:0003677;GO:0003700;GO:0019216;GO:0043565;GO:0042995;GO:0005515;GO:0003707;GO:0030522;GO:0043401;GO:0016604;GO:0048511;GO:0032922;GO:0030154;GO:0045893;GO:0030425;GO:0020037;GO:0000981;GO:0000977;GO:0045944;GO:0000122;GO:0000790;GO:0008134;GO:0000978;GO:0001227;GO:0005654;GO:0090575;GO:0031648;GO:0038023;GO:0050728;GO:0071347;GO:0071356;GO:0009755;GO:0043197;GO:0000976;GO:0070888;GO:0005978;GO:0007623;GO:0010498;GO:0042632;GO:0042749;GO:0042752;GO:0043124;GO:0044321;GO:0045598;GO:0045892;GO:0060086;GO:0061178;GO:0061469;GO:0061889;GO:0070859;GO:0120163;GO:0150079;GO:1903979;GO:0007275;GO:0003714;GO:0006367;GO:0030374;GO:0001222;GO:0004879;GO:0033993;GO:0010871;GO:0034144;GO:0035947	DNA binding;steroid hormone receptor activity;zinc ion binding;regulation of transcription, DNA-templated;nucleus;DNA-binding transcription factor activity;sequence-specific DNA binding;cell;cellular response to lipopolysaccharide;transcription regulatory region DNA binding;cytoplasm;metal ion binding;regulation of lipid metabolic process;cell projection;protein binding;intracellular receptor signaling pathway;steroid hormone mediated signaling pathway;nuclear body;rhythmic process;cell junction;circadian regulation of gene expression;cell differentiation;positive regulation of transcription, DNA-templated;synapse;dendrite;heme binding;DNA-binding transcription factor activity, RNA polymerase II-specific;multicellular organism development;positive regulation of transcription by RNA polymerase II;negative regulation of transcription by RNA polymerase II;RNA polymerase II regulatory region sequence-specific DNA binding;nuclear chromatin;transcription factor binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;nucleoplasm;RNA polymerase II transcription factor complex;protein destabilization;signaling receptor activity;negative regulation of inflammatory response;cellular response to interleukin-1;cellular response to tumor necrosis factor;hormone-mediated signaling pathway;dendritic spine;transcription regulatory region sequence-specific DNA binding;E-box binding;glycogen biosynthetic process;circadian rhythm;proteasomal protein catabolic process;cholesterol homeostasis;regulation of circadian sleep/wake cycle;regulation of circadian rhythm;negative regulation of I-kappaB kinase/NF-kappaB signaling;response to leptin;regulation of fat cell differentiation;negative regulation of transcription, DNA-templated;circadian temperature homeostasis;regulation of insulin secretion involved in cellular response to glucose stimulus;regulation of type B pancreatic cell proliferation;negative regulation of astrocyte activation;positive regulation of bile acid biosynthetic process;negative regulation of cold-induced thermogenesis;negative regulation of neuroinflammatory response;negative regulation of microglial cell activation;transcription corepressor activity;transcription initiation from RNA polymerase II promoter;cellular glucose homeostasis;nuclear receptor transcription coactivator activity;ligand-activated transcription factor activity;response to lipid;transcription corepressor binding;nuclear receptor activity;negative regulation of receptor biosynthetic process;negative regulation of toll-like receptor 4 signaling pathway	3D-structure;Acetylation;Activator;Biological rhythms;Cell junction;Cell projection;Cytoplasm;DNA-binding;Differentiation;Heme;Iron;Metal-binding;Nucleus;Phosphoprotein;Receptor;Reference proteome;Repressor;Synapse;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-1852241;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-400206;R-HSA-400253;R-HSA-1592230;R-HSA-2151201;R-HSA-1368071;R-HSA-383280	Organelle biogenesis and maintenance;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;Metabolism of lipids;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Mitochondrial biogenesis;Transcriptional activation of mitochondrial biogenesis;NR1D1 (REV-ERBA) represses gene expression;Nuclear Receptor transcription pathway
COQ2	negative	ZSWIM8	ENSG00000214655	COQ2	1	COQ2	1	0.00294291356853738	WBGene00004140	WBGene00004140(0)			GO:0008270;GO:0046872;GO:1902667;GO:0031462	zinc ion binding;metal ion binding;regulation of axon guidance;Cul2-RING ubiquitin ligase complex	Alternative splicing;Metal-binding;Phosphoprotein;Reference proteome;Zinc;Zinc-finger	R-HSA-1266738;R-HSA-422475;R-HSA-376176;R-HSA-9010553	Developmental Biology;Axon guidance;Signaling by ROBO receptors;Regulation of expression of SLITs and ROBOs
COQ2	negative	CACNA2D2	ENSG00000007402	COQ2	1	COQ2	1	0.00338715942520329	WBGene00006772;WBGene00007041	WBGene00006772(0)			GO:0016020;GO:0016021;GO:0046872;GO:0005244;GO:0006811;GO:0034765;GO:0006816;GO:0005262;GO:0070588;GO:0005886;GO:0061337;GO:0005891;GO:0005245;GO:0050796;GO:0007528;GO:0040014;GO:0046622;GO:0048747;GO:0060024	membrane;integral component of membrane;metal ion binding;voltage-gated ion channel activity;ion transport;regulation of ion transmembrane transport;calcium ion transport;calcium channel activity;calcium ion transmembrane transport;plasma membrane;cardiac conduction;voltage-gated calcium channel complex;voltage-gated calcium channel activity;regulation of insulin secretion;neuromuscular junction development;regulation of multicellular organism growth;positive regulation of organ growth;muscle fiber development;rhythmic synaptic transmission	Alternative splicing;Calcium;Calcium channel;Calcium transport;Disease mutation;Disulfide bond;Epilepsy;Glycoprotein;Ion channel;Ion transport;Membrane;Metal-binding;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix;Transport;Voltage-gated channel	R-HSA-1430728;R-HSA-112315;R-HSA-112316;R-HSA-397014;R-HSA-5576891;R-HSA-112308;R-HSA-5576892;R-HSA-5576893;R-HSA-163685;R-HSA-422356;R-HSA-400042	Metabolism;Transmission across Chemical Synapses;Neuronal System;Muscle contraction;Cardiac conduction;Presynaptic depolarization and calcium channel opening;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;Integration of energy metabolism;Regulation of insulin secretion;Adrenaline,noradrenaline inhibits insulin secretion
COQ2	negative	PPP1R15A	ENSG00000087074	COQ2	1	COQ2	1	0.00338715942520329					GO:0016020;GO:0005783;GO:0005789;GO:0005739;GO:0005515;GO:0006915;GO:0005741;GO:0005737;GO:0005829;GO:0019901;GO:0006417;GO:0070059;GO:0005794;GO:0007050;GO:0034976;GO:0006974;GO:0000164;GO:0008157;GO:0019888;GO:0072542;GO:0032058;GO:0032515;GO:0032516;GO:0035308;GO:0036496;GO:0070972;GO:1902310;GO:1903898;GO:1903917	membrane;endoplasmic reticulum;endoplasmic reticulum membrane;mitochondrion;protein binding;apoptotic process;mitochondrial outer membrane;cytoplasm;cytosol;protein kinase binding;regulation of translation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;Golgi apparatus;cell cycle arrest;response to endoplasmic reticulum stress;cellular response to DNA damage stimulus;protein phosphatase regulator activity;protein phosphatase 1 binding;protein phosphatase activator activity;positive regulation of translational initiation in response to stress;negative regulation of phosphoprotein phosphatase activity;positive regulation of phosphoprotein phosphatase activity;negative regulation of protein dephosphorylation;regulation of translational initiation by eIF2 alpha dephosphorylation;protein localization to endoplasmic reticulum;positive regulation of peptidyl-serine dephosphorylation;negative regulation of PERK-mediated unfolded protein response;positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation;protein phosphatase type 1 complex	3D-structure;Alternative splicing;Apoptosis;Endoplasmic reticulum;Membrane;Mitochondrion;Mitochondrion outer membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Stress response;Translation regulation;Ubl conjugation	R-HSA-162582;R-HSA-9006936;R-HSA-170834;R-HSA-2173788;R-HSA-2173789	Signal Transduction;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs
COQ2	negative	CYP3A5	ENSG00000106258	COQ2	1	COQ2	1	0.00338715942520329	WBGene00000372;WBGene00008809;WBGene00008810;WBGene00011671;WBGene00011672;WBGene00011674;WBGene00011675;WBGene00011677;WBGene00014254;WBGene00007963;WBGene00007964;WBGene00007967;WBGene00008519;WBGene00010606;WBGene00011673;WBGene00011676;WBGene00014697;WBGene00019438;WBGene00017108;WBGene00007140;WBGene00009226;WBGene00010354;WBGene00011830;WBGene00013585;WBGene00016147;WBGene00021167;WBGene00021200;WBGene00021412			Tacrolimus dose selection;HYPERTENSION ESSENTIAL	GO:0016020;GO:0046872;GO:0004497;GO:0016491;GO:0055114;GO:0005783;GO:0005789;GO:0031090;GO:0043231;GO:0006629;GO:0008202;GO:0005506;GO:0016705;GO:0020037;GO:0008395;GO:0016712;GO:0050649;GO:0101020;GO:0070989;GO:0070330;GO:0006805;GO:0008401;GO:0019825;GO:0042573;GO:0042572;GO:0008210;GO:0002933;GO:0042737;GO:0009822;GO:0016021	oxidation-reduction process;monooxygenase activity;heme binding;iron ion binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;membrane;metal ion binding;oxidoreductase activity;endoplasmic reticulum;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle;lipid metabolic process;steroid metabolic process;steroid hydroxylase activity;testosterone 6-beta-hydroxylase activity;estrogen 16-alpha-hydroxylase activity;oxidative demethylation;aromatase activity;xenobiotic metabolic process;retinoic acid 4-hydroxylase activity;oxygen binding;retinoic acid metabolic process;retinol metabolic process;estrogen metabolic process;lipid hydroxylation;drug catabolic process;alkaloid catabolic process;integral component of membrane	3D-structure;Alternative splicing;Endoplasmic reticulum;Heme;Iron;Lipid metabolism;Membrane;Metal-binding;Microsome;Monooxygenase;Oxidoreductase;Polymorphism;Reference proteome;Steroid metabolism	R-HSA-1430728;R-HSA-211859;R-HSA-5423646;R-HSA-211897;R-HSA-211945;R-HSA-211981	Metabolism;Biological oxidations;Aflatoxin activation and detoxification;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Xenobiotics
COQ2	negative	KLF9	ENSG00000119138	COQ2	1	COQ2	1	0.00338715942520329	WBGene00012735;WBGene00009998		PDCD5		GO:0003676;GO:0005634;GO:0046872;GO:0005829;GO:0005654;GO:0003677;GO:0005886;GO:0007623;GO:0048511;GO:0000981;GO:0006357;GO:0000790;GO:0003700;GO:0097067;GO:0010839;GO:0071387	nucleic acid binding;nucleus;metal ion binding;nucleoplasm;cytosol;plasma membrane;DNA binding;circadian rhythm;rhythmic process;DNA-binding transcription factor activity, RNA polymerase II-specific;regulation of transcription by RNA polymerase II;nuclear chromatin;DNA-binding transcription factor activity;cellular response to thyroid hormone stimulus;negative regulation of keratinocyte proliferation;cellular response to cortisol stimulus	Biological rhythms;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ2	negative	ARID4A	ENSG00000032219	COQ2	1	COQ2	1	0.00389077865305032	WBGene00044689	WBGene00044689(0)			GO:0005634;GO:0005829;GO:0005654;GO:0003677;GO:0005886;GO:0006325;GO:0006349;GO:0007283;GO:0034773;GO:0036124;GO:0045944;GO:0048821;GO:0080182;GO:0097368;GO:0030154;GO:0006357;GO:0044212;GO:0045892;GO:0017053	DNA binding;nucleus;nucleoplasm;cytosol;plasma membrane;chromatin organization;regulation of gene expression by genetic imprinting;spermatogenesis;histone H4-K20 trimethylation;histone H3-K9 trimethylation;positive regulation of transcription by RNA polymerase II;erythrocyte development;histone H3-K4 trimethylation;establishment of Sertoli cell barrier;cell differentiation;regulation of transcription by RNA polymerase II;transcription regulatory region DNA binding;negative regulation of transcription, DNA-templated;transcriptional repressor complex	3D-structure;Alternative splicing;Chromatin regulator;DNA-binding;Differentiation;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Spermatogenesis;Transcription;Transcription regulation;Ubl conjugation	R-HSA-3214815;R-HSA-3247509;R-HSA-4839726	HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization
COQ2	negative	WBP2	ENSG00000132471	COQ2	1	COQ2	1	0.00389077865305032	WBGene00015955;WBGene00008404	WBGene00015955(1);WBGene00008404(1)		Autosomal recessive non-syndromic sensorineural deafness type DFNB;DEAFNESS AUTOSOMAL RECESSIVE 107	GO:0003713;GO:1903508;GO:0045815;GO:0071391;GO:0000790;GO:0005634;GO:0005737;GO:0031490;GO:0005515;GO:0045944;GO:0030331;GO:0000978;GO:0033148;GO:0043627;GO:0045184;GO:0032570;GO:0050847;GO:0071442	transcription coactivator activity;positive regulation of gene expression, epigenetic;cellular response to estrogen stimulus;nuclear chromatin;positive regulation of nucleic acid-templated transcription;nucleus;cytoplasm;chromatin DNA binding;protein binding;positive regulation of transcription by RNA polymerase II;positive regulation of transcription, DNA-templated;estrogen receptor binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;positive regulation of intracellular estrogen receptor signaling pathway;response to estrogen;establishment of protein localization;response to progesterone;progesterone receptor signaling pathway;positive regulation of histone H3-K14 acetylation	Alternative splicing;Cytoplasm;Deafness;Disease mutation;Non-syndromic deafness;Nucleus;Phosphoprotein;Reference proteome;Repeat		
COQ2	negative	SECISBP2L	ENSG00000138593	COQ2	1	COQ2	1	0.00389077865305032					GO:0035368;GO:0003723;GO:0005515;GO:1990904;GO:0003730;GO:0043021;GO:0001514	selenocysteine insertion sequence binding;RNA binding;protein binding;ribonucleoprotein complex;mRNA 3'-UTR binding;ribonucleoprotein complex binding;selenocysteine incorporation	Alternative splicing;Phosphoprotein;Reference proteome		
COQ2	negative	DUSP10	ENSG00000143507	COQ2	1	COQ2	1	0.00389077865305032					GO:0070373;GO:0005737;GO:0030336;GO:0050680;GO:0005634;GO:0043508;GO:0046329;GO:1903753;GO:0016607;GO:0005794;GO:0005829;GO:0005654;GO:0016787;GO:0004721;GO:0006470;GO:0005515;GO:0004725;GO:0016311;GO:0016791;GO:0008138;GO:0017017;GO:0045591;GO:0048273;GO:0008432;GO:1990264;GO:0000188;GO:0033549;GO:0010633;GO:0008330;GO:0002819;GO:0010033;GO:0032496;GO:0032873;GO:0035970;GO:0044387;GO:0045088;GO:0048709;GO:0048715;GO:0060266;GO:0090335;GO:1905042	phosphatase activity;protein tyrosine phosphatase activity;protein dephosphorylation;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;MAP kinase tyrosine/serine/threonine phosphatase activity;negative regulation of ERK1 and ERK2 cascade;negative regulation of cell migration;cytoplasm;negative regulation of epithelial cell proliferation;nucleus;negative regulation of JUN kinase activity;negative regulation of JNK cascade;negative regulation of p38MAPK cascade;nuclear speck;Golgi apparatus;nucleoplasm;cytosol;hydrolase activity;phosphoprotein phosphatase activity;protein binding;positive regulation of regulatory T cell differentiation;mitogen-activated protein kinase p38 binding;JUN kinase binding;peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity;inactivation of MAPK activity;MAP kinase phosphatase activity;negative regulation of epithelial cell migration;protein tyrosine/threonine phosphatase activity;regulation of adaptive immune response;response to organic substance;response to lipopolysaccharide;negative regulation of stress-activated MAPK cascade;peptidyl-threonine dephosphorylation;negative regulation of protein kinase activity by regulation of protein phosphorylation;regulation of innate immune response;oligodendrocyte differentiation;negative regulation of oligodendrocyte differentiation;negative regulation of respiratory burst involved in inflammatory response;regulation of brown fat cell differentiation;negative regulation of epithelium regeneration	3D-structure;Alternative splicing;Cytoplasm;Hydrolase;Nucleus;Protein phosphatase;Reference proteome	R-HSA-168256;R-HSA-162582;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-112409;R-HSA-5675221	Immune System;Signal Transduction;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;RAF-independent MAPK1/3 activation;Negative regulation of MAPK pathway
COQ2	negative	SELENOM	ENSG00000198832	COQ2	1	COQ2	1	0.00389077865305032		WBGene00022297(0)			GO:0005737;GO:0005783;GO:0005794;GO:0005515;GO:0048471;GO:0010269;GO:0035264;GO:0035934;GO:0042445;GO:0060612	cytoplasm;endoplasmic reticulum;Golgi apparatus;oxidation-reduction process;protein binding;perinuclear region of cytoplasm;oxidoreductase activity;endoplasmic reticulum lumen;response to selenium ion;multicellular organism growth;corticosterone secretion;hormone metabolic process;adipose tissue development	Cytoplasm;Endoplasmic reticulum;Golgi apparatus;Reference proteome;Selenocysteine;Signal		
COQ2	negative	CHMP1B	ENSG00000255112	COQ2	1	COQ2	1	0.00389077865305032	WBGene00017735	WBGene00017735(1)			GO:0005737;GO:0016020;GO:0015031;GO:0005634;GO:0051301;GO:0005829;GO:0005515;GO:0007049;GO:0030496;GO:0007034;GO:0042802;GO:0005768;GO:0031902;GO:0070062;GO:0036258;GO:0039702;GO:0045324;GO:0019904;GO:0007080;GO:0010824;GO:0006997;GO:0032509;GO:0045184;GO:0061952;GO:1901673;GO:1904903;GO:0000815;GO:0005771;GO:0030117;GO:0010008	vacuolar transport;cell;cytoplasm;membrane;protein transport;nucleoplasm;endosome;cell division;cytosol;protein binding;cell cycle;midbody;identical protein binding;late endosome membrane;extracellular exosome;multivesicular body assembly;viral budding via host ESCRT complex;late endosome to vacuole transport;protein domain specific binding;mitotic metaphase plate congression;regulation of centrosome duplication;nucleus organization;endosome transport via multivesicular body sorting pathway;establishment of protein localization;midbody abscission;regulation of mitotic spindle assembly;ESCRT III complex disassembly;ESCRT III complex;multivesicular body;membrane coat;endosome membrane	3D-structure;Cell cycle;Cell division;Coiled coil;Cytoplasm;Endosome;Membrane;Protein transport;Reference proteome;Transport		
COQ2	negative	AKAP8L	ENSG00000011243	COQ2	1	COQ2	1	0.00446048224889206					GO:0005634;GO:0003723;GO:0006397;GO:0008380;GO:0005737;GO:0016607;GO:0046872;GO:0003677;GO:0005515;GO:0045944;GO:1990904;GO:0016605;GO:0000785;GO:0016363;GO:0031065;GO:0042826;GO:0034237;GO:0033127;GO:0044839;GO:0005521;GO:0007076;GO:0051081;GO:0010793;GO:0017151;GO:0016301;GO:0016310	DNA binding;nucleus;RNA binding;mRNA processing;RNA splicing;cytoplasm;nuclear speck;metal ion binding;protein binding;PML body;positive regulation of transcription by RNA polymerase II;viral process;ribonucleoprotein complex;chromatin;nuclear matrix;positive regulation of histone deacetylation;histone deacetylase binding;protein kinase A regulatory subunit binding;regulation of histone phosphorylation;cell cycle G2/M phase transition;lamin binding;mitotic chromosome condensation;nuclear envelope disassembly;regulation of mRNA export from nucleus;DEAD/H-box RNA helicase binding;kinase activity;phosphorylation	Acetylation;Alternative splicing;Cytoplasm;Host-virus interaction;Metal-binding;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger;mRNA processing;mRNA splicing		
COQ2	negative	PHF21A	ENSG00000135365	COQ2	1	COQ2	1	0.00446048224889206				Potocki-Shaffer syndrome;Potocki-Shaffer syndrome	GO:0005634;GO:0046872;GO:0003677;GO:0006325;GO:0005515;GO:0000122;GO:0005654;GO:0003682;GO:0007596;GO:0000118;GO:1990391	nucleus;metal ion binding;DNA binding;chromatin organization;protein binding;negative regulation of transcription by RNA polymerase II;nucleoplasm;chromatin binding;blood coagulation;histone deacetylase complex;DNA repair complex	3D-structure;Alternative splicing;Chromatin regulator;Coiled coil;DNA-binding;Disease mutation;Epilepsy;Isopeptide bond;Mental retardation;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-109582;R-HSA-983231;R-HSA-3214815;R-HSA-3247509;R-HSA-4839726	Hemostasis;Factors involved in megakaryocyte development and platelet production;HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization
COQ2	negative	DEPP1	ENSG00000165507	COQ2	1	COQ2	1	0.00446048224889206					GO:0005737;GO:0005739;GO:0006914;GO:0005777;GO:0010506	cytoplasm;intracellular membrane-bounded organelle;mitochondrion;autophagy;peroxisome;regulation of autophagy	Autophagy;Cytoplasm;Mitochondrion;Peroxisome;Polymorphism;Reference proteome		
COQ2	negative	LCOR	ENSG00000196233	COQ2	1	COQ2	1	0.00446048224889206	WBGene00011315				GO:0005634;GO:0005654;GO:0003677;GO:0005515;GO:0006357;GO:0000981	DNA binding;nucleus;nucleoplasm;protein binding;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific	3D-structure;Activator;Alternative splicing;DNA-binding;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation		
COQ2	negative	ZBTB10	ENSG00000205189	COQ2	1	COQ2	1	0.00446048224889206					GO:0003676;GO:0005634;GO:0046872;GO:0005654;GO:0003677;GO:0005515	protein binding;nucleic acid binding;nucleus;metal ion binding;nucleoplasm;DNA binding	Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ2	negative	PLD3	ENSG00000105223	COQ2	1	COQ2	1	0.00510355981501365	WBGene00017316;WBGene00013080;WBGene00017124;WBGene00020256	WBGene00020256(1);WBGene00017316(1);WBGene00017124(0);WBGene00013080(1)		SPINOCEREBELLAR ATAXIA 46	GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0016787;GO:0003824;GO:0006629;GO:0016042;GO:0005515;GO:0070062;GO:0004630;GO:0070290	membrane;integral component of membrane;catalytic activity;endoplasmic reticulum;endoplasmic reticulum membrane;hydrolase activity;endosome;Golgi apparatus;DNA metabolic process;nucleic acid phosphodiester bond hydrolysis;protein binding;exonuclease activity;nuclease activity;inflammatory response;Golgi membrane;immune system process;lysosome;late endosome membrane;extracellular exosome;early endosome membrane;endosome membrane;lysosomal lumen;phospholipase D activity;regulation of cytokine production involved in inflammatory response;myotube differentiation;single-stranded DNA 5'-3' exodeoxyribonuclease activity;lysosomal membrane	Disease mutation;Endoplasmic reticulum;Endosome;Exonuclease;Glycoprotein;Golgi apparatus;Hydrolase;Immunity;Inflammatory response;Lysosome;Membrane;Neurodegeneration;Nuclease;Polymorphism;Reference proteome;Repeat;Signal-anchor;Spinocerebellar ataxia;Transmembrane;Transmembrane helix;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-2029480;R-HSA-2029485;R-HSA-1430728;R-HSA-556833;R-HSA-1483257;R-HSA-1483206;R-HSA-1483148	Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Metabolism;Metabolism of lipids;Phospholipid metabolism;Glycerophospholipid biosynthesis;Synthesis of PG
COQ2	negative	ANKRA2	ENSG00000164331	COQ2	1	COQ2	1	0.00510355981501365					GO:0005737;GO:0016020;GO:0005829;GO:0005856;GO:0005515;GO:0042826;GO:0005634;GO:0019901;GO:0043254;GO:0032991;GO:0031625;GO:1990393;GO:0050750	protein binding;cytoplasm;membrane;cytoskeleton;cytosol;histone deacetylase binding;nucleus;regulation of transcription by RNA polymerase II;protein kinase binding;regulation of protein-containing complex assembly;protein-containing complex;ubiquitin protein ligase binding;3M complex;low-density lipoprotein particle receptor binding	3D-structure;ANK repeat;Cytoplasm;Cytoskeleton;Membrane;Reference proteome;Repeat		
COQ2	negative	OFD1	ENSG00000046651	COQ2	1	COQ2	1	0.00582790486924634				Orofaciodigital syndrome type 1;Orofaciodigital syndrome type 6;Primary ciliary dyskinesia;Retinitis pigmentosa;JOUBERT SYNDROME TYPE 10;ORAL-FACIAL-DIGITAL SYNDROME TYPE 1;Simpson-Golabi-Behmel syndrome type 2;JOUBERT SYNDROME 10;OROFACIODIGITAL SYNDROME I;RETINITIS PIGMENTOSA 23;Simpson-Golabi-Behmel syndrome type 2	GO:0005634;GO:0005737;GO:0016020;GO:0005856;GO:0042995;GO:0005515;GO:0005576;GO:0005813;GO:0005815;GO:0042802;GO:0005929;GO:0036064;GO:0060271;GO:0005829;GO:0030030;GO:0005814;GO:0034451;GO:0043014;GO:0000086;GO:0010389;GO:0097711;GO:0043015;GO:0060287	protein binding;nucleus;cytoplasm;membrane;cytoskeleton;cell projection;extracellular region;centrosome;microtubule organizing center;identical protein binding;cilium;ciliary basal body;cilium assembly;cytosol;cell projection organization;centriole;centriolar satellite;alpha-tubulin binding;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body-plasma membrane docking;gamma-tubulin binding;axoneme assembly;epithelial cilium movement involved in determination of left/right asymmetry	Alternative splicing;Cell projection;Ciliopathy;Cilium;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoskeleton;Disease mutation;Joubert syndrome;Nucleus;Phosphoprotein;Reference proteome;Retinitis pigmentosa	R-HSA-1852241;R-HSA-5617833;R-HSA-162582;R-HSA-1640170;R-HSA-453274;R-HSA-5358351;R-HSA-5610787;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-380320;R-HSA-68877;R-HSA-2565942;R-HSA-380259;R-HSA-380270;R-HSA-380284;R-HSA-380287;R-HSA-5620912;R-HSA-8854518	Organelle biogenesis and maintenance;Cilium Assembly;Signal Transduction;Cell Cycle;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;M Phase;G2/M Transition;Cell Cycle, Mitotic;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Anchoring of the basal body to the plasma membrane;AURKA Activation by TPX2
COQ2	negative	PIK3IP1	ENSG00000100100	COQ2	1	COQ2	1	0.00582790486924634					GO:0016020;GO:0016021;GO:0005886;GO:0005515;GO:0006508;GO:0014067;GO:0043553;GO:0004252;GO:0036313	membrane;integral component of membrane;plasma membrane;protein binding;proteolysis;negative regulation of phosphatidylinositol 3-kinase signaling;negative regulation of phosphatidylinositol 3-kinase activity;serine-type endopeptidase activity;phosphatidylinositol 3-kinase catalytic subunit binding	Alternative splicing;Cell membrane;Direct protein sequencing;Disulfide bond;Glycoprotein;Kringle;Membrane;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix		
COQ2	negative	KIAA0355	ENSG00000166398	COQ2	1	COQ2	1	0.00582790486924634							Phosphoprotein;Reference proteome		
COQ2	negative	PJA2	ENSG00000198961	COQ2	1	COQ2	1	0.00582790486924634	WBGene00021842				GO:0005737;GO:0016020;GO:0046872;GO:0016740;GO:0005783;GO:0005789;GO:0016567;GO:0005794;GO:0035329;GO:0004842;GO:0045111;GO:0005886;GO:0000139;GO:0030054;GO:0006954;GO:0045202;GO:0045211;GO:0045087;GO:0005515;GO:0010738;GO:0061630;GO:0014069;GO:0007616;GO:0046330;GO:0034236;GO:0034237;GO:0034137;GO:0043030;GO:1900745	ubiquitin-protein transferase activity;protein ubiquitination;hippo signaling;regulation of protein kinase A signaling;cytoplasm;membrane;metal ion binding;transferase activity;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;intermediate filament cytoskeleton;plasma membrane;cell junction;inflammatory response;Golgi membrane;synapse;innate immune response;protein binding;ubiquitin protein ligase activity;postsynaptic density;long-term memory;positive regulation of JNK cascade;protein kinase A catalytic subunit binding;protein kinase A regulatory subunit binding;positive regulation of toll-like receptor 2 signaling pathway;regulation of macrophage activation;positive regulation of p38MAPK cascade	Acetylation;Alternative splicing;Cell junction;Cell membrane;Cytoplasm;Direct protein sequencing;Endoplasmic reticulum;Golgi apparatus;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Synapse;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
COQ2	negative	AP5Z1	ENSG00000242802	COQ2	1	COQ2	1	0.00582790486924634				Autosomal recessive spastic paraplegia type 48;SPASTIC PARAPLEGIA 48 AUTOSOMAL RECESSIVE	GO:0044599;GO:0005634;GO:0005737;GO:0016607;GO:0015031;GO:0005654;GO:0006281;GO:0006974;GO:0005515;GO:0016197;GO:0000724;GO:0030119	AP-5 adaptor complex;nucleus;cytoplasm;nuclear speck;protein transport;nucleoplasm;DNA repair;cellular response to DNA damage stimulus;protein binding;endosomal transport;double-strand break repair via homologous recombination;AP-type membrane coat adaptor complex	Alternative splicing;Cytoplasm;DNA damage;DNA repair;Hereditary spastic paraplegia;Neurodegeneration;Nucleus;Polymorphism;Protein transport;Reference proteome;Transport		
COQ2	negative	EDN1	ENSG00000078401	COQ2	1	COQ2	1	0.0066420379087796				Auriculocondylar syndrome;Auriculocondylar syndrome;Auriculocondylar syndrome 3;Question mark ears isolated	GO:0005615;GO:0008284;GO:0061051;GO:0010595;GO:0051091;GO:0030335;GO:0045944;GO:0005737;GO:0010460;GO:0060298;GO:0010613;GO:0043507;GO:0007204;GO:0005576;GO:0005515;GO:0019229;GO:0007186;GO:0000122;GO:0030133;GO:0005125;GO:0043406;GO:0019722;GO:0045429;GO:0007166;GO:0007267;GO:0045840;GO:0005179;GO:0042310;GO:0048661;GO:0030195;GO:0014065;GO:0005102;GO:0031707;GO:0031708;GO:0001501;GO:0001516;GO:0001569;GO:0001666;GO:0001701;GO:0001821;GO:0003100;GO:0006885;GO:0007193;GO:0007205;GO:0007507;GO:0007585;GO:0007589;GO:0008217;GO:0009953;GO:0010193;GO:0010259;GO:0010629;GO:0010827;GO:0010870;GO:0014032;GO:0014823;GO:0014824;GO:0014826;GO:0019233;GO:0030072;GO:0030185;GO:0031583;GO:0032269;GO:0032308;GO:0032496;GO:0033574;GO:0034392;GO:0034696;GO:0035094;GO:0035556;GO:0035690;GO:0035810;GO:0035815;GO:0035994;GO:0042045;GO:0042313;GO:0042474;GO:0042482;GO:0042493;GO:0042554;GO:0043179;GO:0043200;GO:0044321;GO:0045321;GO:0045793;GO:0045987;GO:0046887;GO:0046888;GO:0048016;GO:0048514;GO:0051216;GO:0051482;GO:0051771;GO:0051899;GO:0051930;GO:0060137;GO:0060585;GO:0070101;GO:0071277;GO:0071346;GO:0071347;GO:0071356;GO:0071375;GO:0071385;GO:0071389;GO:0071398;GO:0071456;GO:0071548;GO:0071559;GO:0071560;GO:0090023;GO:1901224;GO:1902074;GO:1904707;GO:0033093;GO:0045178;GO:0048237	extracellular region;regulation of vasoconstriction;extracellular space;positive regulation of cell population proliferation;positive regulation of cell growth involved in cardiac muscle cell development;positive regulation of endothelial cell migration;positive regulation of DNA-binding transcription factor activity;positive regulation of cell migration;positive regulation of transcription by RNA polymerase II;cytoplasm;positive regulation of heart rate;positive regulation of sarcomere organization;positive regulation of cardiac muscle hypertrophy;cell;positive regulation of JUN kinase activity;positive regulation of cytosolic calcium ion concentration;protein binding;G protein-coupled receptor signaling pathway;negative regulation of transcription by RNA polymerase II;transport vesicle;cytokine activity;positive regulation of MAP kinase activity;calcium-mediated signaling;positive regulation of nitric oxide biosynthetic process;cell surface receptor signaling pathway;cell-cell signaling;positive regulation of mitotic nuclear division;endothelin receptor signaling pathway;hormone activity;vasoconstriction;positive regulation of smooth muscle cell proliferation;negative regulation of blood coagulation;phosphatidylinositol 3-kinase signaling;signaling receptor binding;endothelin A receptor binding;endothelin B receptor binding;skeletal system development;prostaglandin biosynthetic process;branching involved in blood vessel morphogenesis;response to hypoxia;in utero embryonic development;histamine secretion;regulation of systemic arterial blood pressure by endothelin;regulation of pH;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;protein kinase C-activating G protein-coupled receptor signaling pathway;heart development;respiratory gaseous exchange by respiratory system;body fluid secretion;regulation of blood pressure;dorsal/ventral pattern formation;response to ozone;multicellular organism aging;negative regulation of gene expression;regulation of glucose transmembrane transport;positive regulation of receptor biosynthetic process;neural crest cell development;response to activity;artery smooth muscle contraction;vein smooth muscle contraction;sensory perception of pain;peptide hormone secretion;nitric oxide transport;phospholipase D-activating G protein-coupled receptor signaling pathway;negative regulation of cellular protein metabolic process;positive regulation of prostaglandin secretion;response to lipopolysaccharide;response to testosterone;negative regulation of smooth muscle cell apoptotic process;response to prostaglandin F;response to nicotine;intracellular signal transduction;cellular response to drug;positive regulation of urine volume;positive regulation of renal sodium excretion;response to muscle stretch;epithelial fluid transport;protein kinase C deactivation;middle ear morphogenesis;positive regulation of odontogenesis;response to drug;superoxide anion generation;rhythmic excitation;response to amino acid;response to leptin;leukocyte activation;positive regulation of cell size;positive regulation of smooth muscle contraction;positive regulation of hormone secretion;negative regulation of hormone secretion;inositol phosphate-mediated signaling;blood vessel morphogenesis;cartilage development;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway;negative regulation of nitric-oxide synthase biosynthetic process;membrane depolarization;regulation of sensory perception of pain;maternal process involved in parturition;positive regulation of prostaglandin-endoperoxide synthase activity;positive regulation of chemokine-mediated signaling pathway;cellular response to calcium ion;cellular response to interferon-gamma;cellular response to interleukin-1;cellular response to tumor necrosis factor;cellular response to peptide hormone stimulus;cellular response to glucocorticoid stimulus;cellular response to mineralocorticoid stimulus;cellular response to fatty acid;cellular response to hypoxia;response to dexamethasone;response to transforming growth factor beta;cellular response to transforming growth factor beta stimulus;positive regulation of neutrophil chemotaxis;positive regulation of NIK/NF-kappaB signaling;response to salt;positive regulation of vascular smooth muscle cell proliferation;Weibel-Palade body;basal part of cell;rough endoplasmic reticulum lumen	3D-structure;Cleavage on pair of basic residues;Direct protein sequencing;Disease mutation;Disulfide bond;Polymorphism;Reference proteome;Secreted;Signal;Vasoactive;Vasoconstrictor	R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-416476;R-HSA-500792;R-HSA-373076;R-HSA-375276	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors
COQ2	negative	RPS6KA5	ENSG00000100784	COQ2	1	COQ2	1	0.0066420379087796	WBGene00008311	WBGene00012929(0);WBGene00044281(0)			GO:0045944;GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005654;GO:0000287;GO:0035556;GO:0005515;GO:0006954;GO:0002223;GO:0051092;GO:0006355;GO:0045892;GO:0007411;GO:0007173;GO:0070498;GO:0001818;GO:0016572;GO:0032793;GO:0033129;GO:0035066;GO:0043987;GO:0043988;GO:0043990	ATP binding;magnesium ion binding;protein phosphorylation;intracellular signal transduction;protein serine/threonine kinase activity;protein kinase activity;positive regulation of transcription by RNA polymerase II;nucleus;cytoplasm;metal ion binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;nucleoplasm;protein binding;inflammatory response;stimulatory C-type lectin receptor signaling pathway;regulation of transcription, DNA-templated;positive regulation of NF-kappaB transcription factor activity;negative regulation of transcription, DNA-templated;axon guidance;epidermal growth factor receptor signaling pathway;interleukin-1-mediated signaling pathway;negative regulation of cytokine production;histone phosphorylation;positive regulation of CREB transcription factor activity;positive regulation of histone phosphorylation;positive regulation of histone acetylation;histone H3-S10 phosphorylation;histone H3-S28 phosphorylation;histone H2A-S1 phosphorylation	3D-structure;ATP-binding;Alternative splicing;Cytoplasm;Inflammatory response;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;Stress response;Transferase;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-437239;R-HSA-162582;R-HSA-1280215;R-HSA-449147;R-HSA-5621481;R-HSA-375165;R-HSA-9006934;R-HSA-166016;R-HSA-166058;R-HSA-166166;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-937061;R-HSA-975138;R-HSA-975155;R-HSA-166520;R-HSA-187037;R-HSA-168142;R-HSA-168164;R-HSA-168176;R-HSA-448424;R-HSA-450294;R-HSA-975871;R-HSA-198725;R-HSA-198753;R-HSA-199920;R-HSA-450282;R-HSA-5621575	Innate Immune System;Immune System;Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1;Signal Transduction;Cytokine Signaling in Immune system;Signaling by Interleukins;C-type lectin receptors (CLRs);NCAM signaling for neurite out-growth;Signaling by Receptor Tyrosine Kinases;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Interleukin-17 signaling;MAP kinase activation;MyD88 cascade initiated on plasma membrane;Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;CREB phosphorylation;MAPK targets/ Nuclear events mediated by MAP kinases;CD209 (DC-SIGN) signaling
COQ2	negative	NME3	ENSG00000103024	COQ2	1	COQ2	1	0.0066420379087796	WBGene00009119				GO:0046872;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005515;GO:0006915;GO:0004550;GO:0006165;GO:0006183;GO:0006228;GO:0006241;GO:0009117;GO:0005829;GO:0006163;GO:0006220;GO:0015949	nucleoside diphosphate kinase activity;nucleoside diphosphate phosphorylation;GTP biosynthetic process;UTP biosynthetic process;CTP biosynthetic process;metal ion binding;nucleotide binding;ATP binding;kinase activity;transferase activity;phosphorylation;protein binding;apoptotic process;nucleotide metabolic process;cytosol;regulation of apoptotic process;purine nucleotide metabolic process;pyrimidine nucleotide metabolic process;nucleobase-containing small molecule interconversion	3D-structure;ATP-binding;Apoptosis;Kinase;Magnesium;Metal-binding;Nucleotide metabolism;Nucleotide-binding;Reference proteome;Transferase	R-HSA-1430728;R-HSA-15869;R-HSA-499943	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
COQ2	negative	CYTH1	ENSG00000108669	COQ2	1	COQ2	1	0.0066420379087796	WBGene00001743	WBGene00008685(0)			GO:0005737;GO:0016020;GO:0005829;GO:0005886;GO:0005515;GO:0030054;GO:0005086;GO:0032012;GO:0008289;GO:0005085;GO:0005923;GO:0031234;GO:0005912;GO:0000139;GO:0090162;GO:0016192;GO:0030155	ARF guanyl-nucleotide exchange factor activity;regulation of ARF protein signal transduction;cytoplasm;membrane;cytosol;plasma membrane;protein binding;cell junction;lipid binding;guanyl-nucleotide exchange factor activity;bicellular tight junction;extrinsic component of cytoplasmic side of plasma membrane;adherens junction;Golgi membrane;establishment of epithelial cell polarity;vesicle-mediated transport;regulation of cell adhesion	3D-structure;Acetylation;Alternative splicing;Cell junction;Cell membrane;Coiled coil;Cytoplasm;Guanine-nucleotide releasing factor;Lipid-binding;Membrane;Reference proteome;Tight junction;Ubl conjugation	R-HSA-5653656;R-HSA-199991;R-HSA-6811442;R-HSA-6811438	Vesicle-mediated transport;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Intra-Golgi traffic
COQ2	negative	PPP3CC	ENSG00000120910	COQ2	1	COQ2	1	0.0066420379087796	WBGene00006527	WBGene00006527(1)			GO:0016787;GO:0004721;GO:0006470;GO:0005739;GO:0005737;GO:0046872;GO:0005515;GO:0005516;GO:0005829;GO:1900740;GO:0033173;GO:0033192;GO:0097720;GO:0005955;GO:0007420;GO:1900242;GO:1900244;GO:0098793;GO:0098978;GO:0099523	hydrolase activity;phosphoprotein phosphatase activity;protein dephosphorylation;mitochondrion;cytoplasm;metal ion binding;protein binding;calmodulin binding;cytosol;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;calcineurin-NFAT signaling cascade;calmodulin-dependent protein phosphatase activity;calcineurin-mediated signaling;calcineurin complex;brain development;regulation of synaptic vesicle endocytosis;positive regulation of synaptic vesicle endocytosis;presynapse;glutamatergic synapse;presynaptic cytosol	Alternative splicing;Calmodulin-binding;Hydrolase;Iron;Metal-binding;Phosphoprotein;Polymorphism;Protein phosphatase;Reference proteome;Zinc	R-HSA-109581;R-HSA-162582;R-HSA-5357801;R-HSA-372790;R-HSA-388396;R-HSA-418594;R-HSA-111885;R-HSA-109606;R-HSA-114452;R-HSA-180024;R-HSA-111447	Apoptosis;Signal Transduction;Programmed Cell Death;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Opioid Signalling;Intrinsic Pathway for Apoptosis;Activation of BH3-only proteins;DARPP-32 events;Activation of BAD and translocation to mitochondria 
COQ2	negative	CIR1	ENSG00000138433	COQ2	1	COQ2	1	0.0066420379087796	WBGene00018892	WBGene00018892(1)			GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0016607;GO:0003714;GO:0005856;GO:0005515;GO:0005813;GO:0005815;GO:0019901;GO:0032991;GO:0045892;GO:0003700;GO:0044877;GO:0001701;GO:1903507	transcription corepressor activity;mRNA processing;RNA splicing;nucleus;cytoplasm;nuclear speck;cytoskeleton;protein binding;centrosome;microtubule organizing center;protein kinase binding;protein-containing complex;negative regulation of transcription, DNA-templated;DNA-binding transcription factor activity;protein-containing complex binding;negative regulation of transcription by RNA polymerase II;histone deacetylase binding;in utero embryonic development;negative regulation of nucleic acid-templated transcription	Alternative splicing;Cytoplasm;Cytoskeleton;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing		
COQ2	negative	REL	ENSG00000162924	COQ2	1	COQ2	1	0.0066420379087796			BCL2A1;BIRC3;CCL2;CDKN1A;CSRP1;IL1B;IL2RA;SELE;SOD2;TNFAIP3		GO:0005634;GO:0005737;GO:0006355;GO:0045893;GO:0003677;GO:0003700;GO:0005515;GO:0007249;GO:0000981;GO:0005829;GO:0006954;GO:0000977;GO:0045944;GO:0000122;GO:0000790;GO:0005654;GO:0001228;GO:0043123;GO:0003682;GO:0034097;GO:0000980;GO:0038061;GO:0010629;GO:0032688;GO:0043565;GO:1901215;GO:0005667	DNA binding;regulation of transcription, DNA-templated;nucleus;cytoplasm;DNA-binding transcription factor activity;positive regulation of transcription, DNA-templated;I-kappaB kinase/NF-kappaB signaling;protein binding;cytosol;innate immune response;DNA-binding transcription factor activity, RNA polymerase II-specific;nucleoplasm;inflammatory response;positive regulation of transcription by RNA polymerase II;negative regulation of transcription by RNA polymerase II;RNA polymerase II regulatory region sequence-specific DNA binding;nuclear chromatin;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;positive regulation of I-kappaB kinase/NF-kappaB signaling;chromatin binding;response to cytokine;NIK/NF-kappaB signaling;I-kappaB/NF-kappaB complex;negative regulation of gene expression;negative regulation of interferon-beta production;sequence-specific DNA binding;negative regulation of neuron death;transcription factor complex	Acetylation;Activator;Alternative splicing;DNA-binding;Nucleus;Phosphoprotein;Proto-oncogene;Reference proteome;Transcription;Transcription regulation	R-HSA-1280218;R-HSA-168256;R-HSA-983705;R-HSA-1168372;R-HSA-1169091	Adaptive Immune System;Immune System;Signaling by the B Cell Receptor (BCR);Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells
COQ2	negative	KLHL28	ENSG00000179454	COQ2	1	COQ2	1	0.0066420379087796					GO:0005515	protein binding	Alternative splicing;Kelch repeat;Polymorphism;Reference proteome;Repeat		
COQ2	negative	MYL5	ENSG00000215375	COQ2	1	COQ2	1	0.0066420379087796	WBGene00003369;WBGene00003370	WBGene00003370(0);WBGene00003369(0)			GO:0046872;GO:0005509;GO:0016459;GO:0005829;GO:0006936;GO:0008307;GO:0006937;GO:0005859	calcium ion binding;metal ion binding;myosin complex;cytosol;muscle contraction;structural constituent of muscle;regulation of muscle contraction;muscle myosin complex	Alternative splicing;Calcium;Metal-binding;Motor protein;Muscle protein;Myosin;Polymorphism;Reference proteome;Repeat	R-HSA-397014;R-HSA-445355	Muscle contraction;Smooth Muscle Contraction
COQ2	negative	APBA3	ENSG00000011132	COQ2	1	COQ2	1	0.0075551266789079	WBGene00002999	WBGene00002999(0)			GO:0005737;GO:0015031;GO:0005515;GO:0048471;GO:0050790;GO:0001540;GO:0005886;GO:0007268;GO:0045202;GO:0019899;GO:0004857;GO:0043086;GO:0043197;GO:0001701;GO:0010468	protein binding;enzyme inhibitor activity;regulation of catalytic activity;amyloid-beta binding;cytoplasm;protein transport;perinuclear region of cytoplasm;plasma membrane;chemical synaptic transmission;synapse;enzyme binding;negative regulation of catalytic activity;dendritic spine;in utero embryonic development;regulation of gene expression	3D-structure;Acetylation;Cytoplasm;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Repeat;Transport	R-HSA-112316;R-HSA-6794361;R-HSA-6794362	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
COQ2	negative	HECA	ENSG00000112406	COQ2	1	COQ2	1	0.0075551266789079	WBGene00010614;WBGene00015073	WBGene00015073(0);WBGene00010614(0)			GO:0016020;GO:0007275;GO:0003674;GO:0005634;GO:0005737;GO:0045930;GO:0030323	membrane;multicellular organism development;molecular_function;nucleus;cytoplasm;negative regulation of mitotic cell cycle;respiratory tube development	Developmental protein;Phosphoprotein;Reference proteome		
COQ2	negative	ATG14	ENSG00000126775	COQ2	1	COQ2	1	0.0075551266789079					GO:0005737;GO:0016020;GO:0005783;GO:0005789;GO:0005515;GO:0031410;GO:0006914;GO:0005776;GO:0034045;GO:0005829;GO:0000045;GO:0001934;GO:0000421;GO:0016236;GO:0005930;GO:0008333;GO:0001933;GO:0042149;GO:0000423;GO:0051020;GO:0097629;GO:0097632;GO:0016240;GO:0043552;GO:0009267;GO:0061635;GO:0098780;GO:0035032;GO:0001932;GO:0010608;GO:0090207;GO:0044233;GO:0045335	cytoplasm;membrane;endoplasmic reticulum;endoplasmic reticulum membrane;protein binding;cytoplasmic vesicle;autophagy;autophagosome;phagophore assembly site membrane;cytosol;autophagosome assembly;positive regulation of protein phosphorylation;autophagosome membrane;macroautophagy;axoneme;endosome to lysosome transport;negative regulation of protein phosphorylation;cellular response to glucose starvation;mitophagy;GTPase binding;extrinsic component of omegasome membrane;extrinsic component of phagophore assembly site membrane;autophagosome membrane docking;positive regulation of phosphatidylinositol 3-kinase activity;cellular response to starvation;regulation of protein complex stability;response to mitochondrial depolarisation;phosphatidylinositol 3-kinase complex, class III;regulation of protein phosphorylation;posttranscriptional regulation of gene expression;regulation of triglyceride metabolic process;mitochondria-associated endoplasmic reticulum membrane;phagocytic vesicle	3D-structure;Alternative splicing;Autophagy;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Endoplasmic reticulum;Membrane;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-9612973;R-HSA-8953897;R-HSA-1632852	Autophagy;Cellular responses to external stimuli;Macroautophagy
COQ2	negative	SCAPER	ENSG00000140386	COQ2	1	COQ2	1	0.0075551266789079	WBGene00012389	WBGene00012389(0)		Retinitis pigmentosa;Autosomal Recessive Mental Retardation;INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA	GO:0003676;GO:0005634;GO:0008270;GO:0046872;GO:0005829;GO:0005783;GO:0005515	zinc ion binding;nucleic acid binding;nucleus;metal ion binding;nucleoplasm;cytosol;endoplasmic reticulum;protein binding	Alternative splicing;Disease mutation;Endoplasmic reticulum;Mental retardation;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Retinitis pigmentosa;Zinc;Zinc-finger		
COQ2	negative	SERPINI1	ENSG00000163536	COQ2	1	COQ2	1	0.0075551266789079	WBGene00005643;WBGene00005644;WBGene00005647;WBGene00005648;WBGene00005642;WBGene00005649			Familial encephalopathy with neuroserpin inclusion bodies;ENCEPHALOPATHY FAMILIAL WITH NEUROSERPIN INCLUSION BODIES	GO:0005615;GO:0010976;GO:0010951;GO:0005576;GO:0031410;GO:0004867;GO:0030414;GO:0010466;GO:0043204;GO:0070062;GO:0007417;GO:0007422;GO:0043025;GO:0060205;GO:0030155;GO:0034774	extracellular space;positive regulation of neuron projection development;negative regulation of endopeptidase activity;extracellular region;cytoplasmic vesicle;serine-type endopeptidase inhibitor activity;peptidase inhibitor activity;negative regulation of peptidase activity;perikaryon;extracellular exosome;central nervous system development;peripheral nervous system development;neuronal cell body;cytoplasmic vesicle lumen;regulation of cell adhesion;secretory granule lumen	3D-structure;Cytoplasmic vesicle;Disease mutation;Glycoprotein;Neurodegeneration;Protease inhibitor;Reference proteome;Secreted;Serine protease inhibitor;Signal		
COQ2	negative	CCS	ENSG00000173992	COQ2	1	COQ2	1	0.0075551266789079	WBGene00004930;WBGene00007036				GO:0005634;GO:0005737;GO:0046872;GO:0055114;GO:0005515;GO:0030001;GO:0005507;GO:0006801;GO:0005829;GO:0045296;GO:0015035;GO:0016532;GO:0015680;GO:0019430;GO:0034599;GO:0051353;GO:0004784	metal ion binding;oxidation-reduction process;metal ion transport;superoxide dismutase activity;superoxide metabolic process;nucleus;cytoplasm;protein binding;copper ion binding;cytosol;cadherin binding;protein disulfide oxidoreductase activity;superoxide dismutase copper chaperone activity;protein maturation by copper ion transfer;removal of superoxide radicals;cellular response to oxidative stress;positive regulation of oxidoreductase activity	3D-structure;Chaperone;Copper;Cytoplasm;Disulfide bond;Isopeptide bond;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Zinc	R-HSA-2262752;R-HSA-8953897;R-HSA-3299685	Cellular responses to stress;Cellular responses to external stimuli;Detoxification of Reactive Oxygen Species
COQ2	negative	ADARB1	ENSG00000197381	COQ2	1	COQ2	1	0.0075551266789079	WBGene00000080	WBGene00022388(0)			GO:0003723;GO:0006396;GO:0006397;GO:0005634;GO:0046872;GO:0005829;GO:0005654;GO:0016787;GO:0005515;GO:0002376;GO:0045087;GO:0005730;GO:0051607;GO:0005737;GO:0004000;GO:0008285;GO:0051726;GO:0030336;GO:0003725;GO:0045070;GO:0044387;GO:0003729;GO:0003726;GO:0008251;GO:0006382;GO:0007274;GO:0021610;GO:0021618;GO:0021965;GO:0035264;GO:0050884;GO:0060384;GO:0060415;GO:0061744;GO:0097049	RNA binding;RNA processing;adenosine deaminase activity;mRNA processing;nucleus;metal ion binding;nucleoplasm;cytosol;hydrolase activity;protein binding;synapse;immune system process;innate immune response;nucleolus;defense response to virus;cytoplasm;negative regulation of cell population proliferation;regulation of cell cycle;negative regulation of cell migration;double-stranded RNA binding;positive regulation of viral genome replication;negative regulation of protein kinase activity by regulation of protein phosphorylation;mRNA binding;double-stranded RNA adenosine deaminase activity;tRNA-specific adenosine deaminase activity;adenosine to inosine editing;neuromuscular synaptic transmission;facial nerve morphogenesis;hypoglossal nerve morphogenesis;spinal cord ventral commissure morphogenesis;multicellular organism growth;neuromuscular process controlling posture;innervation;muscle tissue morphogenesis;motor behavior;motor neuron apoptotic process	3D-structure;Alternative promoter usage;Alternative splicing;Antiviral defense;Hydrolase;Immunity;Innate immunity;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Repeat;Zinc;mRNA processing	R-HSA-8953854;R-HSA-75072;R-HSA-75064;R-HSA-75102;R-HSA-77042	Metabolism of RNA;mRNA Editing;mRNA Editing: A to I Conversion;C6 deamination of adenosine;Formation of editosomes by ADAR proteins
COQ2	negative	N4BP2L2	ENSG00000244754	COQ2	1	COQ2	1	0.0075551266789079	WBGene00017812				GO:0005634;GO:0005515;GO:0000122;GO:0003714;GO:0070062;GO:0003674;GO:0019899;GO:0017053;GO:1902035;GO:1902037	nucleus;protein binding;negative regulation of transcription by RNA polymerase II;transcription corepressor activity;extracellular exosome;molecular_function;enzyme binding;transcriptional repressor complex;positive regulation of hematopoietic stem cell proliferation;negative regulation of hematopoietic stem cell differentiation	Alternative splicing;Coiled coil;Polymorphism;Reference proteome		
COQ2	negative	CALCOCO1	ENSG00000012822	COQ2	1	COQ2	1	0.00857700306677822					GO:0005634;GO:0005737;GO:0043231;GO:0005829;GO:0005515;GO:0016055;GO:0003713;GO:0045893;GO:0045944;GO:0008022;GO:0010628;GO:0044212;GO:0000980;GO:0003712;GO:0070016;GO:0008013;GO:0043565;GO:0007165;GO:0030374;GO:0030518;GO:0003682;GO:0000790	nucleus;cytoplasm;intracellular membrane-bounded organelle;metal ion binding;cytosol;protein binding;Wnt signaling pathway;transcription coactivator activity;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;protein C-terminus binding;positive regulation of gene expression;transcription regulatory region DNA binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;transcription coregulator activity;armadillo repeat domain binding;beta-catenin binding;sequence-specific DNA binding;signal transduction;nuclear receptor transcription coactivator activity;intracellular steroid hormone receptor signaling pathway;chromatin binding;nuclear chromatin	Activator;Alternative splicing;Coiled coil;Cytoplasm;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Wnt signaling pathway;Zinc;Zinc-finger		
COQ2	negative	OVGP1	ENSG00000085465	COQ2	1	COQ2	1	0.00857700306677822	WBGene00000503	WBGene00014162(0);WBGene00007471(0);WBGene00007465(0);WBGene00007469(0);WBGene00007470(0);WBGene00007467(0);WBGene00007473(0);WBGene00007472(0);WBGene00007466(0);WBGene00020141(0);WBGene00017233(0);WBGene00016665(0);WBGene00020407(0);WBGene00011162(0);WBGene00011164(0);WBGene00011170(0);WBGene00011163(0);WBGene00011846(0);WBGene00011167(0);WBGene00044807(0);WBGene00010799(0);WBGene00011166(0);WBGene00010945(0);WBGene00011159(0);WBGene00011157(0);WBGene00011158(0);WBGene00011161(0);WBGene00044546(0);WBGene00000503(0)			GO:0005975;GO:0007338;GO:0031410;GO:0008061;GO:0005737;GO:0005829;GO:0005576;GO:0030133;GO:0007339;GO:0007565;GO:0004568;GO:0006032;GO:2000360;GO:0035805;GO:0098595	carbohydrate metabolic process;chitin binding;cytoplasmic vesicle;cytoplasm;cytosol;single fertilization;extracellular region;transport vesicle;binding of sperm to zona pellucida;female pregnancy;chitin catabolic process;chitinase activity;negative regulation of binding of sperm to zona pellucida;egg coat;perivitelline space	Cytoplasmic vesicle;Disulfide bond;Fertilization;Glycoprotein;Polymorphism;Reference proteome;Signal	R-HSA-1474165;R-HSA-1187000;R-HSA-2534343	Reproduction;Fertilization;Interaction With Cumulus Cells And The Zona Pellucida
COQ2	negative	ANKRD10	ENSG00000088448	COQ2	1	COQ2	1	0.00857700306677822					GO:0005515	protein binding	ANK repeat;Alternative splicing;Polymorphism;Reference proteome;Repeat		
COQ2	negative	SLC22A17	ENSG00000092096	COQ2	1	COQ2	1	0.00857700306677822		WBGene00011456(0);WBGene00020701(0);WBGene00003842(0);WBGene00019408(0);WBGene00003843(0);WBGene00008110(0);WBGene00014127(0);WBGene00006220(0);WBGene00003837(0);WBGene00044455(0);WBGene00017751(0)			GO:0016020;GO:0016021;GO:0022857;GO:0055085;GO:0005215;GO:0006811;GO:0005886;GO:0005887;GO:0031301;GO:0005773;GO:0005774;GO:0004888;GO:0006879;GO:0055072;GO:0015891	integral component of membrane;transmembrane transporter activity;transmembrane transport;membrane;cell;ion transport;plasma membrane;integral component of plasma membrane;integral component of organelle membrane;vacuole;vacuolar membrane;transmembrane signaling receptor activity;cellular iron ion homeostasis;iron ion homeostasis;siderophore transport	Alternative splicing;Cell membrane;Glycoprotein;Ion transport;Iron;Iron transport;Membrane;Receptor;Reference proteome;Transmembrane;Transmembrane helix;Transport;Vacuole	R-HSA-382551;R-HSA-917937	Transport of small molecules;Iron uptake and transport
COQ2	negative	CRY2	ENSG00000121671	COQ2	1	COQ2	1	0.00857700306677822					GO:0005634;GO:0005737;GO:0016607;GO:0000166;GO:0005829;GO:0003677;GO:0005515;GO:0007623;GO:0048511;GO:0032922;GO:0050896;GO:0009881;GO:0018298;GO:0019902;GO:0005576;GO:0071949;GO:0000122;GO:0045892;GO:0000976;GO:2000323;GO:0042752;GO:0042754;GO:0003697;GO:0003684;GO:0043153;GO:0042593;GO:0032515;GO:0009416;GO:0009882;GO:0009785;GO:0014823;GO:2000118;GO:0016829;GO:0019900;GO:0019901;GO:0035257;GO:0006606;GO:0019915;GO:0032868;GO:2000850;GO:0005739	nucleus;cytoplasm;nuclear speck;nucleotide binding;cytosol;DNA binding;protein binding;circadian rhythm;rhythmic process;circadian regulation of gene expression;response to stimulus;photoreceptor activity;protein-chromophore linkage;phosphatase binding;extracellular region;single-stranded DNA binding;FAD binding;negative regulation of transcription by RNA polymerase II;negative regulation of transcription, DNA-templated;transcription regulatory region sequence-specific DNA binding;negative regulation of glucocorticoid receptor signaling pathway;regulation of circadian rhythm;negative regulation of circadian rhythm;damaged DNA binding;entrainment of circadian clock by photoperiod;glucose homeostasis;negative regulation of phosphoprotein phosphatase activity;response to light stimulus;blue light photoreceptor activity;blue light signaling pathway;response to activity;regulation of sodium-dependent phosphate transport;lyase activity;kinase binding;protein kinase binding;nuclear hormone receptor binding;protein import into nucleus;lipid storage;response to insulin;negative regulation of glucocorticoid secretion;mitochondrion	Alternative splicing;Biological rhythms;Chromophore;Cytoplasm;FAD;Flavoprotein;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Photoreceptor protein;Receptor;Reference proteome;Repressor;Sensory transduction;Transcription;Transcription regulation;Ubl conjugation	R-HSA-400253	Circadian Clock
COQ2	negative	MXD4	ENSG00000123933	COQ2	1	COQ2	1	0.00857700306677822	WBGene00003163	WBGene00003163(0)			GO:0005634;GO:0046983;GO:0003677;GO:0005515;GO:0000981;GO:0000790;GO:0003714;GO:0008285;GO:0000122	protein dimerization activity;nucleus;DNA binding;protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;transcription corepressor activity;negative regulation of cell population proliferation;negative regulation of transcription by RNA polymerase II	DNA-binding;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation	R-HSA-162582;R-HSA-9006934;R-HSA-1236394;R-HSA-1251985	Signal Transduction;Signaling by Receptor Tyrosine Kinases;Signaling by ERBB4;Nuclear signaling by ERBB4
COQ2	negative	KLC1	ENSG00000126214	COQ2	1	COQ2	1	0.00857700306677822	WBGene00002215;WBGene00002214	WBGene00002215(1);WBGene00002214(1)			GO:0005737;GO:0016020;GO:0003777;GO:0005871;GO:0005856;GO:0042995;GO:0005515;GO:0031410;GO:0005874;GO:0005829;GO:0030426;GO:0006890;GO:0016032;GO:0003774;GO:0007018;GO:0019886;GO:0035617	protein binding;microtubule motor activity;kinesin complex;cytoplasm;membrane;cytoskeleton;cell projection;cytoplasmic vesicle;microtubule;cytosol;growth cone;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;viral process;motor activity;microtubule-based movement;antigen processing and presentation of exogenous peptide antigen via MHC class II;stress granule disassembly	3D-structure;Alternative splicing;Cell projection;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Host-virus interaction;Microtubule;Motor protein;Phosphoprotein;Reference proteome;Repeat;TPR repeat	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-162582;R-HSA-194315;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-195258;R-HSA-2132295;R-HSA-983189;R-HSA-983231;R-HSA-5625970	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Signal Transduction;Signaling by Rho GTPases;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;RHO GTPase Effectors;MHC class II antigen presentation;Kinesins;Factors involved in megakaryocyte development and platelet production;RHO GTPases activate KTN1
COQ2	negative	SAT1	ENSG00000130066	COQ2	1	COQ2	1	0.00857700306677822	WBGene00008408	WBGene00008408(1)		Keratosis follicularis spinulosa decalvans	GO:0004145;GO:0005515;GO:0008080;GO:0005737;GO:0016740;GO:0016746;GO:0042802;GO:0005829;GO:0019809;GO:0006595;GO:0006598;GO:0032918;GO:0042127;GO:0001525;GO:0005622;GO:0006596;GO:0009447	protein binding;diamine N-acetyltransferase activity;N-acetyltransferase activity;cytoplasm;transferase activity;transferase activity, transferring acyl groups;cytosol;identical protein binding;spermidine binding;polyamine metabolic process;polyamine catabolic process;spermidine acetylation;regulation of cell population proliferation;angiogenesis;intracellular;polyamine biosynthetic process;putrescine catabolic process	3D-structure;Acyltransferase;Cytoplasm;Direct protein sequencing;Reference proteome;Transferase	R-HSA-1430728;R-HSA-71291;R-HSA-351202;R-HSA-351200	Metabolism;Metabolism of amino acids and derivatives;Metabolism of polyamines;Interconversion of polyamines
COQ2	negative	ZMYM5	ENSG00000132950	COQ2	1	COQ2	1	0.00857700306677822					GO:0005634;GO:0008270;GO:0046872;GO:0005515;GO:0000981;GO:0006357;GO:0022604	zinc ion binding;nucleus;metal ion binding;protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;regulation of transcription by RNA polymerase II;regulation of cell morphogenesis	3D-structure;Alternative splicing;Isopeptide bond;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ2	negative	GABARAPL1	ENSG00000139112	COQ2	1	COQ2	1	0.00857700306677822	WBGene00002980	WBGene00002981(0)			GO:0005737;GO:0006914;GO:0016020;GO:0005783;GO:0005794;GO:0005856;GO:0005515;GO:0031410;GO:0005874;GO:0030659;GO:0005776;GO:0005829;GO:0031625;GO:0008017;GO:0000045;GO:0000422;GO:0006995;GO:0016236;GO:0097352;GO:0000421;GO:0050811;GO:0005739;GO:0030957;GO:0048487;GO:0005622;GO:0032590;GO:0032839;GO:0044297	cytoplasm;autophagy;membrane;endoplasmic reticulum;Golgi apparatus;cytoskeleton;protein binding;cytoplasmic vesicle;microtubule;cytoplasmic vesicle membrane;cytosol;autophagosome;ubiquitin protein ligase binding;microtubule binding;autophagosome assembly;autophagy of mitochondrion;cellular response to nitrogen starvation;macroautophagy;autophagosome maturation;autophagosome membrane;GABA receptor binding;mitochondrion;Tat protein binding;beta-tubulin binding;intracellular;dendrite membrane;dendrite cytoplasm;cell body	3D-structure;Alternative splicing;Autophagy;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Endoplasmic reticulum;Golgi apparatus;Lipoprotein;Membrane;Microtubule;Reference proteome	R-HSA-9612973;R-HSA-8953897;R-HSA-1632852	Autophagy;Cellular responses to external stimuli;Macroautophagy
COQ2	negative	MAP1LC3B	ENSG00000140941	COQ2	1	COQ2	1	0.00857700306677822	WBGene00002981	WBGene00002981(0)			GO:0005737;GO:0016020;GO:0031090;GO:0005856;GO:0005515;GO:0031410;GO:0005874;GO:0006914;GO:0005776;GO:0005829;GO:0031625;GO:0000421;GO:0005930;GO:0008017;GO:0000045;GO:0000422;GO:0006995;GO:0016236;GO:0097352;GO:0012505;GO:0009267;GO:0005739;GO:0005622	cytoplasm;membrane;intracellular membrane-bounded organelle;organelle membrane;cytoskeleton;protein binding;cytoplasmic vesicle;microtubule;autophagy;cytosol;autophagosome;ubiquitin protein ligase binding;autophagosome membrane;axoneme;microtubule binding;autophagosome assembly;autophagy of mitochondrion;cellular response to nitrogen starvation;macroautophagy;autophagosome maturation;endomembrane system;cellular response to starvation;mitochondrion;intracellular	3D-structure;Autophagy;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Lipoprotein;Membrane;Microtubule;Phosphoprotein;Reference proteome;Ubl conjugation pathway	R-HSA-5653656;R-HSA-199991;R-HSA-9007101;R-HSA-9612973;R-HSA-8953897;R-HSA-1632852;R-HSA-5205647;R-HSA-5205685;R-HSA-8854214;R-HSA-8934903	Vesicle-mediated transport;Membrane Trafficking;Rab regulation of trafficking;Autophagy;Cellular responses to external stimuli;Macroautophagy;Mitophagy;Pink/Parkin Mediated Mitophagy;TBC/RABGAPs;Receptor Mediated Mitophagy
COQ2	negative	ADPRM	ENSG00000170222	COQ2	1	COQ2	1	0.00857700306677822					GO:0046872;GO:0016787;GO:0005829;GO:0034656;GO:0047631;GO:0047734;GO:0016020;GO:0016021	hydrolase activity;metal ion binding;cytosol;nucleobase-containing small molecule catabolic process;ADP-ribose diphosphatase activity;CDP-glycerol diphosphatase activity;membrane;integral component of membrane	Acetylation;Alternative splicing;Hydrolase;Metal-binding;Polymorphism;Reference proteome;Zinc	R-HSA-1430728;R-HSA-15869;R-HSA-74259;R-HSA-8956319;R-HSA-2393930	Metabolism;Metabolism of nucleotides;Purine catabolism;Nucleobase catabolism;Phosphate bond hydrolysis by NUDT proteins
COQ2	negative	JUN	ENSG00000177606	COQ2	1	COQ2	1	0.00857700306677822		WBGene00008945(0)	ABCB1;APOC3;ATF3;BECN1;BEX2;BRCA1;CCK;CCL2;CCND1;CD82;CREM;CSF1;CTSL;CXCL8;DDIT3;EGFR;ETS1;EZR;FAS;FOSL1;GJA1;HEY1;IFNG;IL12B;IL3;IL6;JUN;KRT16;LDHA;LGALS3;LOR;MAPK8;MAT2A;MEF2D;MMP1;MMP13;MMP2;MMP3;MMP7;MMP9;MSR1;NAMPT;NEFL;NEIL1;NOS2;NOX5;PLAT;PLAUR;PPARD;PTGS2;PTN;RARB;RHOB;SMAD7;SOX7;SPI1;SPRR1B;STMN1;TNC;TNF;TNFRSF1B;UGT2B15;VCAM1;VDR		GO:1904707;GO:0007179;GO:0045944;GO:0044212;GO:0045893;GO:0003723;GO:0005634;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0043547;GO:0005515;GO:0005096;GO:0003713;GO:0038095;GO:0042802;GO:0000981;GO:0000790;GO:0000978;GO:0000122;GO:0008134;GO:0005667;GO:0051726;GO:0007265;GO:0001228;GO:0032496;GO:0031625;GO:0019899;GO:0070412;GO:0045892;GO:0000976;GO:0000980;GO:0044389;GO:0001102;GO:1902895;GO:0046982;GO:0034614;GO:0071276;GO:0060395;GO:0042803;GO:0043065;GO:0032870;GO:2000144;GO:0009314;GO:0010033;GO:0034097;GO:0051090;GO:0035976;GO:0009612;GO:0042493;GO:0003682;GO:0003690;GO:0033613;GO:0035497;GO:0043565;GO:0071837;GO:0001525;GO:0001774;GO:0001836;GO:0001889;GO:0001938;GO:0003151;GO:0006351;GO:0006366;GO:0007568;GO:0007612;GO:0007623;GO:0008284;GO:0008285;GO:0009987;GO:0010634;GO:0014070;GO:0030224;GO:0031103;GO:0031953;GO:0035026;GO:0035994;GO:0042542;GO:0043066;GO:0043392;GO:0043524;GO:0043525;GO:0043922;GO:0043923;GO:0045597;GO:0045657;GO:0045740;GO:0048146;GO:0048661;GO:0051365;GO:0051591;GO:0051899;GO:0061029;GO:0070374;GO:0071277;GO:1990441;GO:0000228;GO:0005719;GO:0005829;GO:0017053	DNA binding;regulation of transcription, DNA-templated;DNA-binding transcription factor activity;positive regulation of vascular smooth muscle cell proliferation;transforming growth factor beta receptor signaling pathway;positive regulation of transcription by RNA polymerase II;transcription regulatory region DNA binding;positive regulation of transcription, DNA-templated;RNA binding;nucleus;nucleoplasm;positive regulation of GTPase activity;protein binding;GTPase activator activity;transcription coactivator activity;Fc-epsilon receptor signaling pathway;identical protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;RNA polymerase II cis-regulatory region sequence-specific DNA binding;negative regulation of transcription by RNA polymerase II;transcription factor binding;transcription factor complex;regulation of cell cycle;Ras protein signal transduction;DNA-binding transcription activator activity, RNA polymerase II-specific;response to lipopolysaccharide;ubiquitin protein ligase binding;regulation of cell population proliferation;enzyme binding;R-SMAD binding;negative regulation of transcription, DNA-templated;transcription regulatory region sequence-specific DNA binding;ubiquitin-like protein ligase binding;RNA polymerase II activating transcription factor binding;positive regulation of pri-miRNA transcription by RNA polymerase II;cellular response to reactive oxygen species;cellular response to cadmium ion;SMAD protein signal transduction;positive regulation of apoptotic process;cellular response to hormone stimulus;positive regulation of DNA-templated transcription, initiation;response to radiation;response to organic substance;response to cytokine;regulation of DNA-binding transcription factor activity;transcription factor AP-1 complex;response to mechanical stimulus;response to drug;chromatin binding;double-stranded DNA binding;activating transcription factor binding;cAMP response element binding;sequence-specific DNA binding;protein-containing complex binding;HMG box domain binding;angiogenesis;microglial cell activation;release of cytochrome c from mitochondria;liver development;positive regulation of endothelial cell proliferation;outflow tract morphogenesis;transcription, DNA-templated;transcription by RNA polymerase II;aging;learning;circadian rhythm;positive regulation of cell population proliferation;negative regulation of cell population proliferation;cellular process;positive regulation of epithelial cell migration;response to organic cyclic compound;monocyte differentiation;axon regeneration;negative regulation of protein autophosphorylation;leading edge cell differentiation;response to muscle stretch;response to hydrogen peroxide;negative regulation of apoptotic process;negative regulation of DNA binding;negative regulation of neuron apoptotic process;positive regulation of neuron apoptotic process;negative regulation by host of viral transcription;positive regulation by host of viral transcription;positive regulation of cell differentiation;positive regulation of monocyte differentiation;positive regulation of DNA replication;positive regulation of fibroblast proliferation;positive regulation of smooth muscle cell proliferation;cellular response to potassium ion starvation;response to cAMP;membrane depolarization;eyelid development in camera-type eye;positive regulation of ERK1 and ERK2 cascade;cellular response to calcium ion;negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress;nuclear chromosome;nuclear euchromatin;cytosol;transcriptional repressor complex	3D-structure;Acetylation;Activator;DNA-binding;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871796;R-HSA-1266738;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1643685;R-HSA-1257604;R-HSA-1280215;R-HSA-2262752;R-HSA-449147;R-HSA-5683057;R-HSA-5687128;R-HSA-6807070;R-HSA-8953897;R-HSA-9006925;R-HSA-6796648;R-HSA-157118;R-HSA-8939211;R-HSA-9006931;R-HSA-166016;R-HSA-166058;R-HSA-166166;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-937061;R-HSA-975138;R-HSA-975155;R-HSA-2559580;R-HSA-2559583;R-HSA-8943724;R-HSA-5617472;R-HSA-5619507;R-HSA-9018519;R-HSA-1912422;R-HSA-1912408;R-HSA-2559582;R-HSA-168142;R-HSA-168164;R-HSA-168176;R-HSA-448424;R-HSA-450294;R-HSA-975871;R-HSA-8862803;R-HSA-8863678;R-HSA-450282;R-HSA-450341	Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated MAPK activation;Developmental Biology;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Cellular responses to stress;Signaling by Interleukins;MAPK family signaling cascades;MAPK6/MAPK4 signaling;PTEN Regulation;Cellular responses to external stimuli;Intracellular signaling by second messengers;TP53 Regulates Transcription of DNA Repair Genes;Signaling by NOTCH;ESR-mediated signaling;Signaling by Nuclear Receptors;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;Oxidative Stress Induced Senescence;Cellular Senescence;Regulation of PTEN gene transcription;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Estrogen-dependent gene expression;Pre-NOTCH Expression and Processing;Pre-NOTCH Transcription and Translation;Senescence-Associated Secretory Phenotype (SASP);Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Interleukin-17 signaling;MAP kinase activation;MyD88 cascade initiated on plasma membrane;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;MAPK targets/ Nuclear events mediated by MAP kinases;Activation of the AP-1 family of transcription factors
COQ2	negative	C11orf71	ENSG00000180425	COQ2	1	COQ2	1	0.00857700306677822							Alternative splicing;Reference proteome		
COQ2	negative	ZNF277	ENSG00000198839	COQ2	1	COQ2	1	0.00857700306677822	WBGene00009772	WBGene00009772(1)			GO:0003676;GO:0005634;GO:0046872;GO:0003677;GO:0000978;GO:0070301;GO:2000772	nucleic acid binding;nucleus;metal ion binding;DNA binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;cellular response to hydrogen peroxide;regulation of cellular senescence	Acetylation;DNA-binding;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ2	negative	CCNL2	ENSG00000221978	COQ2	1	COQ2	1	0.00857700306677822	WBGene00000876;WBGene00000508	WBGene00000507(0);WBGene00000508(0);WBGene00021714(0)			GO:0005634;GO:0016607;GO:0043231;GO:0005654;GO:0005515;GO:0000079;GO:0006357;GO:0016538	nucleus;nuclear speck;intracellular membrane-bounded organelle;nucleoplasm;protein binding;regulation of cyclin-dependent protein serine/threonine kinase activity;regulation of transcription by RNA polymerase II;cyclin-dependent protein serine/threonine kinase regulator activity	Acetylation;Alternative splicing;Cyclin;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation		
COQ2	negative	MZF1	ENSG00000099326	COQ2	1	COQ2	1	0.00971817601439273	WBGene00021931		PADI1;BLMH		GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0003677;GO:0003700;GO:0042803;GO:0005515;GO:0000981;GO:0000978;GO:0001227;GO:0000122;GO:0001228;GO:0045944;GO:0044212	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleic acid binding;nucleus;metal ion binding;nucleoplasm;DNA binding;protein homodimerization activity;protein binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;DNA-binding transcription activator activity, RNA polymerase II-specific;positive regulation of transcription by RNA polymerase II;transcription regulatory region DNA binding	3D-structure;Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ2	negative	BRD1	ENSG00000100425	COQ2	1	COQ2	1	0.00971817601439273	WBGene00003034	WBGene00021810(0);WBGene00003034(0)			GO:0005634;GO:0016607;GO:0046872;GO:0006325;GO:0042393;GO:0043966;GO:0070776;GO:0005515;GO:0035902;GO:0051602;GO:0030425;GO:0043204	protein binding;nucleus;nuclear speck;metal ion binding;chromatin organization;histone binding;histone H3 acetylation;histone H3-K14 acetylation;histone H3-K14 acetyltransferase complex;positive regulation of erythrocyte differentiation;MOZ/MORF histone acetyltransferase complex;response to immobilization stress;response to electrical stimulus;dendrite;perikaryon	3D-structure;Acetylation;Alternative splicing;Bromodomain;Chromatin regulator;Chromosome;Erythrocyte maturation;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-5633007;R-HSA-3247509;R-HSA-4839726;R-HSA-3214847;R-HSA-6804758	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of TP53 Activity;Chromatin modifying enzymes;Chromatin organization;HATs acetylate histones;Regulation of TP53 Activity through Acetylation
COQ2	negative	NFAT5	ENSG00000102908	COQ2	1	COQ2	1	0.00971817601439273				Inflammatory bowel disease-recurrent sinopulmonary infections syndrome	GO:1901224;GO:0071345;GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0006366;GO:0005515;GO:0000978;GO:0044798;GO:0045944;GO:0000981;GO:0000790;GO:0008134;GO:0005667;GO:0001228;GO:0003682;GO:0007165;GO:0007588;GO:0001816;GO:0033173;GO:1904996;GO:0006970;GO:0010628;GO:0070884;GO:0016020;GO:0016021	positive regulation of NIK/NF-kappaB signaling;cellular response to cytokine stimulus;nucleus;cytoplasm;nucleoplasm;cytosol;regulation of transcription, DNA-templated;DNA binding;DNA-binding transcription factor activity;transcription by RNA polymerase II;protein binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;nuclear transcription factor complex;positive regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;transcription factor binding;transcription factor complex;DNA-binding transcription activator activity, RNA polymerase II-specific;chromatin binding;signal transduction;excretion;cytokine production;calcineurin-NFAT signaling cascade;positive regulation of leukocyte adhesion to vascular endothelial cell;response to osmotic stress;positive regulation of gene expression;regulation of calcineurin-NFAT signaling cascade;membrane;integral component of membrane	3D-structure;Acetylation;Activator;Alternative splicing;Cytoplasm;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation		
COQ2	negative	CDKN1B	ENSG00000111276	COQ2	1	COQ2	1	0.00971817601439273	WBGene00000517			Multiple endocrine neoplasia type 1;Multiple endocrine neoplasia type 4;MULTIPLE ENDOCRINE NEOPLASIA TYPE IV	GO:1904706;GO:0008285;GO:0005634;GO:0005737;GO:0043231;GO:0016301;GO:0016310;GO:0005515;GO:0007049;GO:0007050;GO:0004860;GO:0004861;GO:0005768;GO:0042127;GO:0006977;GO:0005654;GO:0005829;GO:0045736;GO:0045786;GO:0045892;GO:0000082;GO:0007507;GO:0019903;GO:0045930;GO:0051087;GO:0030308;GO:0010942;GO:0045732;GO:0000079;GO:0030332;GO:0045787;GO:0019901;GO:0044877;GO:0071850;GO:0033673;GO:0042326;GO:1904030;GO:1905179;GO:0005072;GO:0030544;GO:0001666;GO:0001890;GO:0006813;GO:0007096;GO:0007219;GO:0007605;GO:0008219;GO:0008284;GO:0009749;GO:0014070;GO:0031116;GO:0032355;GO:0042493;GO:0043066;GO:0043200;GO:0043434;GO:0045737;GO:0046686;GO:0048102;GO:0048839;GO:0050680;GO:0051271;GO:0060770;GO:0071236;GO:0071285;GO:0071407;GO:1902746;GO:0031464;GO:0032991	nucleus;cytoplasm;cyclin-dependent protein serine/threonine kinase inhibitor activity;cell cycle arrest;regulation of cell population proliferation;negative regulation of vascular smooth muscle cell proliferation;negative regulation of cell population proliferation;intracellular membrane-bounded organelle;kinase activity;phosphorylation;nucleoplasm;endosome;protein binding;cell cycle;protein kinase inhibitor activity;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;cytosol;negative regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of cell cycle;negative regulation of transcription, DNA-templated;G1/S transition of mitotic cell cycle;heart development;protein phosphatase binding;negative regulation of mitotic cell cycle;chaperone binding;negative regulation of cell growth;positive regulation of cell death;positive regulation of protein catabolic process;regulation of cyclin-dependent protein serine/threonine kinase activity;cyclin binding;positive regulation of cell cycle;protein kinase binding;protein-containing complex binding;mitotic cell cycle arrest;negative regulation of kinase activity;negative regulation of phosphorylation;negative regulation of cyclin-dependent protein kinase activity;negative regulation of cardiac muscle tissue regeneration;transforming growth factor beta receptor, cytoplasmic mediator activity;Hsp70 protein binding;response to hypoxia;placenta development;potassium ion transport;regulation of exit from mitosis;Notch signaling pathway;sensory perception of sound;cell death;positive regulation of cell population proliferation;response to glucose;response to organic cyclic compound;positive regulation of microtubule polymerization;response to estradiol;response to drug;negative regulation of apoptotic process;response to amino acid;response to peptide hormone;positive regulation of cyclin-dependent protein serine/threonine kinase activity;response to cadmium ion;autophagic cell death;inner ear development;negative regulation of epithelial cell proliferation;negative regulation of cellular component movement;negative regulation of epithelial cell proliferation involved in prostate gland development;cellular response to antibiotic;cellular response to lithium ion;cellular response to organic cyclic compound;regulation of lens fiber cell differentiation;Cul4A-RING E3 ubiquitin ligase complex;protein-containing complex	3D-structure;Cell cycle;Cytoplasm;Direct protein sequencing;Endosome;Nucleus;Phosphoprotein;Polymorphism;Protein kinase inhibitor;Reference proteome;Tumor suppressor;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-6804116;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-1643685;R-HSA-1257604;R-HSA-2262752;R-HSA-5663202;R-HSA-69242;R-HSA-69278;R-HSA-69563;R-HSA-69580;R-HSA-69615;R-HSA-69620;R-HSA-8953897;R-HSA-9006925;R-HSA-195258;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-2219528;R-HSA-5674400;R-HSA-9614085;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-2559583;R-HSA-69231;R-HSA-69236;R-HSA-2559582;R-HSA-8848021;R-HSA-9006927;R-HSA-5625900;R-HSA-9617828;R-HSA-9634638;R-HSA-198323;R-HSA-2559586;R-HSA-8849470	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Disease;PIP3 activates AKT signaling;Cellular responses to stress;Diseases of signal transduction;S Phase;Cell Cycle, Mitotic;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cellular responses to external stimuli;Intracellular signaling by second messengers;RHO GTPase Effectors;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;PI3K/AKT Signaling in Cancer;Constitutive Signaling by AKT1 E17K in Cancer;FOXO-mediated transcription;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Cellular Senescence;Cyclin D associated events in G1;G1 Phase;Senescence-Associated Secretory Phenotype (SASP);Signaling by PTK6;Signaling by Non-Receptor Tyrosine Kinases;RHO GTPases activate CIT;FOXO-mediated transcription of cell cycle genes;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;AKT phosphorylates targets in the cytosol;DNA Damage/Telomere Stress Induced Senescence;PTK6 Regulates Cell Cycle
COQ2	negative	ARRDC3	ENSG00000113369	COQ2	1	COQ2	1	0.00971817601439273	WBGene00011732;WBGene00012467;WBGene00018060;WBGene00020612;WBGene00009852;WBGene00011052;WBGene00011054;WBGene00012464;WBGene00013043;WBGene00015441;WBGene00018061;WBGene00009579;WBGene00011053;WBGene00011055;WBGene00014161;WBGene00015440	WBGene00011054(0);WBGene00018061(0);WBGene00011052(0);WBGene00020612(0);WBGene00018060(0);WBGene00011053(0);WBGene00013043(0);WBGene00008843(0);WBGene00014161(0);WBGene00009852(0);WBGene00009853(0);WBGene00012464(0)			GO:0005737;GO:0016020;GO:0005886;GO:0005515;GO:0005764;GO:0005768;GO:0005769;GO:0120163;GO:0051443;GO:0031699;GO:0001659;GO:0031651;GO:0043588;GO:0060613;GO:0071878;GO:0090327	cytoplasm;membrane;endosome;plasma membrane;protein binding;lysosome;early endosome;negative regulation of cold-induced thermogenesis;positive regulation of ubiquitin-protein transferase activity;beta-3 adrenergic receptor binding;temperature homeostasis;negative regulation of heat generation;skin development;fat pad development;negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway;negative regulation of locomotion involved in locomotory behavior	3D-structure;Cell membrane;Cytoplasm;Endosome;Lysosome;Membrane;Reference proteome;Repeat		
COQ2	negative	COL7A1	ENSG00000114270	COQ2	1	COQ2	1	0.00971817601439273	WBGene00003482;WBGene00003497;WBGene00001263;WBGene00002280			Acral dystrophic epidermolysis bullosa;Centripetalis recessive dystrophic epidermolysis bullosa;Dominant dystrophic epidermolysis bullosa nails only;Dystrophic epidermolysis bullosa pruriginosa;Epidermolysis bullosa simplex superficialis;Generalized dominant dystrophic epidermolysis bullosa;Pretibial dystrophic epidermolysis bullosa;Recessive dystrophic epidermolysis bullosa inversa;Recessive dystrophic epidermolysis bullosa generalized intermediate;Severe generalized recessive dystrophic epidermolysis bullosa;TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN;EPIDERMOLYSIS BULLOSA DYSTROPHICA AUTOSOMAL DOMINANT;EPIDERMOLYSIS BULLOSA DYSTROPHICA AUTOSOMAL RECESSIVE;EPIDERMOLYSIS BULLOSA DYSTROPHICA PRETIBIAL;EPIDERMOLYSIS BULLOSA PRURIGINOSA;EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS;NAIL DISORDER NONSYNDROMIC CONGENITAL 8;TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	GO:0007155;GO:0005615;GO:0004867;GO:0010951;GO:0005515;GO:0005576;GO:0005581;GO:0000139;GO:0031012;GO:0030414;GO:0010466;GO:0005604;GO:0030020;GO:0062023;GO:0005788;GO:0003429;GO:0006888;GO:0030198;GO:0048208;GO:0033116;GO:0008544;GO:0030134;GO:0035987;GO:0005590	protein binding;serine-type endopeptidase inhibitor activity;cell adhesion;extracellular space;negative regulation of endopeptidase activity;extracellular region;collagen trimer;Golgi membrane;extracellular matrix;peptidase inhibitor activity;negative regulation of peptidase activity;basement membrane;extracellular matrix structural constituent conferring tensile strength;collagen-containing extracellular matrix;endoplasmic reticulum lumen;growth plate cartilage chondrocyte morphogenesis;endoplasmic reticulum to Golgi vesicle-mediated transport;extracellular matrix organization;COPII vesicle coating;endoplasmic reticulum-Golgi intermediate compartment membrane;epidermis development;COPII-coated ER to Golgi transport vesicle;endodermal cell differentiation;collagen type VII trimer	Alternative splicing;Basement membrane;Cell adhesion;Collagen;Direct protein sequencing;Disease mutation;Disulfide bond;Epidermolysis bullosa;Extracellular matrix;Glycoprotein;Hydroxylation;Polymorphism;Protease inhibitor;Reference proteome;Repeat;Secreted;Serine protease inhibitor;Signal	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-446203;R-HSA-1474228;R-HSA-1474244;R-HSA-199977;R-HSA-948021;R-HSA-1442490;R-HSA-1474290;R-HSA-1650814;R-HSA-2022090;R-HSA-216083;R-HSA-8948216;R-HSA-204005;R-HSA-5694530;R-HSA-3000157;R-HSA-2214320	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;Asparagine N-linked glycosylation;Degradation of the extracellular matrix;Extracellular matrix organization;ER to Golgi Anterograde Transport;Transport to the Golgi and subsequent modification;Collagen degradation;Collagen formation;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Collagen chain trimerization;COPII-mediated vesicle transport;Cargo concentration in the ER;Laminin interactions;Anchoring fibril formation
COQ2	negative	ASH1L	ENSG00000116539	COQ2	1	COQ2	1	0.00971817601439273	WBGene00003040	WBGene00019584(0);WBGene00018023(0);WBGene00008527(0);WBGene00019690(0);WBGene00020919(0);WBGene00016603(0);WBGene00021282(0);WBGene00022431(0);WBGene00008062(0);WBGene00008206(0);WBGene00020006(0)		Intellectual disability;MENTAL RETARDATION AUTOSOMAL DOMINANT 52	GO:0005634;GO:0005794;GO:0046872;GO:0016740;GO:0005654;GO:0008168;GO:0032259;GO:0003677;GO:0006325;GO:0005694;GO:0030054;GO:0003682;GO:0018024;GO:0005923;GO:0000981;GO:0007267;GO:0006366;GO:0006323;GO:0046974;GO:0051567;GO:0046975;GO:0097676;GO:0005515;GO:0042800;GO:0001501;GO:0002674;GO:0007338;GO:0009791;GO:0010468;GO:0030317;GO:0032635;GO:0043124;GO:0043409;GO:0045944;GO:0046697;GO:0048733;GO:0050728;GO:0051568;GO:0061038;GO:1903699;GO:1903709	DNA binding;nucleus;protein binding;chromatin binding;histone-lysine N-methyltransferase activity;Golgi apparatus;metal ion binding;transferase activity;nucleoplasm;methyltransferase activity;methylation;chromatin organization;chromosome;cell junction;bicellular tight junction;DNA-binding transcription factor activity, RNA polymerase II-specific;cell-cell signaling;transcription by RNA polymerase II;DNA packaging;histone methyltransferase activity (H3-K9 specific);histone H3-K9 methylation;histone methyltransferase activity (H3-K36 specific);histone H3-K36 dimethylation;histone methyltransferase activity (H3-K4 specific);skeletal system development;negative regulation of acute inflammatory response;single fertilization;post-embryonic development;regulation of gene expression;flagellated sperm motility;interleukin-6 production;negative regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of MAPK cascade;positive regulation of transcription by RNA polymerase II;decidualization;sebaceous gland development;negative regulation of inflammatory response;histone H3-K4 methylation;uterus morphogenesis;tarsal gland development;uterine gland development	3D-structure;Acetylation;Activator;Alternative splicing;Bromodomain;Cell junction;Chromatin regulator;Chromosome;Disease mutation;Isopeptide bond;Mental retardation;Metal-binding;Methylation;Methyltransferase;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;S-adenosyl-L-methionine;Tight junction;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc;Zinc-finger	R-HSA-3247509;R-HSA-4839726;R-HSA-3214841	Chromatin modifying enzymes;Chromatin organization;PKMTs methylate histone lysines
COQ2	negative	CSAD	ENSG00000139631	COQ2	1	COQ2	1	0.00971817601439273	WBGene00006762				GO:0005737;GO:0003824;GO:0016829;GO:0016831;GO:0030170;GO:0019752;GO:0042412;GO:0004068;GO:0004782;GO:0019449;GO:0019452	catalytic activity;pyridoxal phosphate binding;carboxylic acid metabolic process;carboxy-lyase activity;cytoplasm;lyase activity;taurine biosynthetic process;aspartate 1-decarboxylase activity;sulfinoalanine decarboxylase activity;L-cysteine catabolic process to hypotaurine;L-cysteine catabolic process to taurine	3D-structure;Alternative splicing;Decarboxylase;Lyase;Pyridoxal phosphate;Reference proteome	R-HSA-1430728;R-HSA-71291;R-HSA-1614558;R-HSA-1614635	Metabolism;Metabolism of amino acids and derivatives;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism
COQ2	negative	BCAS3	ENSG00000141376	COQ2	1	COQ2	1	0.00971817601439273	WBGene00018953	WBGene00018953(0)			GO:0005730;GO:0005634;GO:0005737;GO:0005856;GO:0005515;GO:0043547;GO:0045944;GO:2000114;GO:0031252;GO:0003682;GO:0090630;GO:0001525;GO:0008134;GO:0042393;GO:0051491;GO:0010595;GO:0035148;GO:0051895;GO:0010698;GO:0048487;GO:0007030;GO:0090316;GO:0005881;GO:0071391;GO:0035257;GO:0042594;GO:0031023;GO:0035327;GO:0043085;GO:0035035;GO:2000251;GO:0045111;GO:0034260;GO:0071944	protein binding;nucleus;cytoplasm;cytoskeleton;positive regulation of GTPase activity;positive regulation of transcription by RNA polymerase II;regulation of establishment of cell polarity;cell leading edge;chromatin binding;activation of GTPase activity;angiogenesis;transcription factor binding;histone binding;positive regulation of filopodium assembly;positive regulation of endothelial cell migration;tube formation;negative regulation of focal adhesion assembly;acetyltransferase activator activity;beta-tubulin binding;Golgi organization;positive regulation of intracellular protein transport;cytoplasmic microtubule;cellular response to estrogen stimulus;nuclear hormone receptor binding;response to starvation;microtubule organizing center organization;transcriptionally active chromatin;positive regulation of catalytic activity;histone acetyltransferase binding;positive regulation of actin cytoskeleton reorganization;intermediate filament cytoskeleton;negative regulation of GTPase activity;cell periphery	Acetylation;Alternative splicing;Angiogenesis;Chromosomal rearrangement;Cytoplasm;Cytoskeleton;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;Transcription;Transcription regulation;Ubl conjugation		
COQ2	negative	PDCD4	ENSG00000150593	COQ2	1	COQ2	1	0.00971817601439273					GO:2000353;GO:1904706;GO:0050729;GO:1900016;GO:1905064;GO:1905461;GO:0005634;GO:0030509;GO:0060940;GO:0071222;GO:0003723;GO:0005737;GO:0005829;GO:0005515;GO:0045892;GO:0006915;GO:0035722;GO:1901224;GO:0045786;GO:0007569;GO:1904761;GO:0043508;GO:0034393;GO:0043066;GO:0051246	negative regulation of transcription, DNA-templated;positive regulation of endothelial cell apoptotic process;negative regulation of vascular smooth muscle cell proliferation;positive regulation of inflammatory response;negative regulation of cytokine production involved in inflammatory response;negative regulation of vascular smooth muscle cell differentiation;positive regulation of vascular associated smooth muscle cell apoptotic process;nucleus;BMP signaling pathway;epithelial to mesenchymal transition involved in cardiac fibroblast development;cellular response to lipopolysaccharide;RNA binding;cytoplasm;cytosol;protein binding;apoptotic process;interleukin-12-mediated signaling pathway;positive regulation of NIK/NF-kappaB signaling;negative regulation of cell cycle;cell aging;negative regulation of JUN kinase activity;negative regulation of myofibroblast differentiation;positive regulation of smooth muscle cell apoptotic process;negative regulation of apoptotic process;regulation of protein metabolic process	3D-structure;Acetylation;Alternative splicing;Apoptosis;Cytoplasm;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Repeat;Tumor suppressor;Ubl conjugation	R-HSA-168256;R-HSA-1280215;R-HSA-449147;R-HSA-447115;R-HSA-8950505;R-HSA-9020591	Immune System;Cytokine Signaling in Immune system;Signaling by Interleukins;Interleukin-12 family signaling;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
COQ2	negative	TIPARP	ENSG00000163659	COQ2	1	COQ2	1	0.00971817601439273					GO:0005634;GO:0046872;GO:0016740;GO:0016757;GO:0003950;GO:0045732;GO:1990404;GO:0070213;GO:0071407;GO:0010629;GO:0006471;GO:0035326;GO:0140289;GO:0001570;GO:0001822;GO:0006807;GO:0008209;GO:0008210;GO:0008585;GO:0009791;GO:0030097;GO:0048008;GO:0048705;GO:0048745;GO:0060021;GO:0060325;GO:1904612	metal ion binding;NAD+ ADP-ribosyltransferase activity;nucleus;transferase activity;transferase activity, transferring glycosyl groups;positive regulation of protein catabolic process;protein ADP-ribosylase activity;protein auto-ADP-ribosylation;cellular response to organic cyclic compound;negative regulation of gene expression;protein ADP-ribosylation;cis-regulatory region binding;protein mono-ADP-ribosylation;vasculogenesis;kidney development;nitrogen compound metabolic process;androgen metabolic process;estrogen metabolic process;female gonad development;post-embryonic development;hemopoiesis;platelet-derived growth factor receptor signaling pathway;skeletal system morphogenesis;smooth muscle tissue development;roof of mouth development;face morphogenesis;response to 2,3,7,8-tetrachlorodibenzodioxine	ADP-ribosylation;Glycosyltransferase;Metal-binding;NAD;Nucleus;Polymorphism;Reference proteome;Transferase;Zinc;Zinc-finger		
COQ2	negative	ZC3H12A	ENSG00000163874	COQ2	1	COQ2	1	0.00971817601439273	WBGene00016260	WBGene00022003(0);WBGene00021998(0);WBGene00013107(0);WBGene00021287(0);WBGene00016260(0)			GO:0010628;GO:0010629;GO:0005737;GO:0045600;GO:0032088;GO:0045019;GO:0071222;GO:0003723;GO:0005634;GO:0016020;GO:0046872;GO:0005654;GO:0005783;GO:0016787;GO:0003677;GO:0005856;GO:0005515;GO:0006974;GO:0006915;GO:0004519;GO:0016579;GO:0007275;GO:0004518;GO:0006954;GO:0036464;GO:0090503;GO:0030154;GO:0043022;GO:0002376;GO:0051607;GO:0007399;GO:0003729;GO:0004843;GO:0000932;GO:0004521;GO:0045944;GO:0098586;GO:0061158;GO:0003682;GO:0032991;GO:0071347;GO:0071356;GO:0042307;GO:0001525;GO:0090502;GO:0034599;GO:0061014;GO:0032715;GO:0032720;GO:0001933;GO:0051259;GO:0050852;GO:0003730;GO:0030867;GO:0035613;GO:0004540;GO:0045766;GO:0042406;GO:0010595;GO:0043124;GO:0002230;GO:1903936;GO:0010884;GO:1900016;GO:0042149;GO:1900745;GO:0010942;GO:0005791;GO:1901223;GO:0035925;GO:0010468;GO:2000379;GO:0090501;GO:0035198;GO:0043031;GO:0010656;GO:0050713;GO:0055118;GO:1990869;GO:0004532;GO:1900119;GO:1900165;GO:1903003;GO:1904468;GO:0000294;GO:0002757;GO:0010508;GO:0044828;GO:1902714;GO:1903799;GO:1904637;GO:2000320;GO:2000627	positive regulation of gene expression;negative regulation of gene expression;negative regulation of NF-kappaB transcription factor activity;cytoplasm;positive regulation of fat cell differentiation;negative regulation of nitric oxide biosynthetic process;cellular response to lipopolysaccharide;RNA binding;nucleus;membrane;metal ion binding;nucleoplasm;endoplasmic reticulum;hydrolase activity;DNA binding;cytoskeleton;protein binding;cellular response to DNA damage stimulus;apoptotic process;protein deubiquitination;multicellular organism development;nuclease activity;endonuclease activity;inflammatory response;cytoplasmic ribonucleoprotein granule;RNA phosphodiester bond hydrolysis, exonucleolytic;mRNA binding;cell differentiation;immune system process;defense response to virus;nervous system development;thiol-dependent ubiquitin-specific protease activity;P-body;endoribonuclease activity;positive regulation of transcription by RNA polymerase II;cellular response to virus;3'-UTR-mediated mRNA destabilization;chromatin binding;protein-containing complex;cellular response to interleukin-1;cellular response to tumor necrosis factor;viral process;positive regulation of protein import into nucleus;angiogenesis;ribosome binding;RNA phosphodiester bond hydrolysis, endonucleolytic;cellular response to oxidative stress;positive regulation of mRNA catabolic process;negative regulation of interleukin-6 production;negative regulation of tumor necrosis factor production;negative regulation of protein phosphorylation;T cell receptor signaling pathway;mRNA 3'-UTR binding;protein complex oligomerization;rough endoplasmic reticulum membrane;RNA stem-loop binding;negative regulation of NIK/NF-kappaB signaling;ribonuclease activity;positive regulation of angiogenesis;extrinsic component of endoplasmic reticulum membrane;positive regulation of endothelial cell migration;negative regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of defense response to virus by host;cellular response to sodium arsenite;positive regulation of lipid storage;negative regulation of cytokine production involved in inflammatory response;cellular response to glucose starvation;positive regulation of p38MAPK cascade;positive regulation of cell death;rough endoplasmic reticulum;mRNA 3'-UTR AU-rich region binding;positive regulation of reactive oxygen species metabolic process;regulation of gene expression;RNA phosphodiester bond hydrolysis;miRNA binding;negative regulation of macrophage activation;negative regulation of muscle cell apoptotic process;negative regulation of interleukin-1 beta secretion;negative regulation of cardiac muscle contraction;cellular response to chemokine;exoribonuclease activity;positive regulation of execution phase of apoptosis;negative regulation of interleukin-6 secretion;positive regulation of protein deubiquitination;negative regulation of tumor necrosis factor secretion;nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay;immune response-activating signal transduction;positive regulation of autophagy;negative regulation by host of viral genome replication;negative regulation of interferon-gamma secretion;negative regulation of production of miRNAs involved in gene silencing by miRNA;cellular response to ionomycin;negative regulation of T-helper 17 cell differentiation;positive regulation of miRNA catabolic process	3D-structure;Angiogenesis;Antiviral defense;Apoptosis;Cytoplasm;DNA damage;DNA-binding;Developmental protein;Differentiation;Endonuclease;Endoplasmic reticulum;Host-virus interaction;Hydrolase;Immunity;Inflammatory response;Magnesium;Membrane;Metal-binding;Neurogenesis;Nuclease;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Repressor;Stress response;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ2	negative	FAM102A	ENSG00000167106	COQ2	1	COQ2	1	0.00971817601439273	WBGene00006368	WBGene00006368(0)			GO:0005515	protein binding	Alternative splicing;Reference proteome		
COQ2	negative	CHD2	ENSG00000173575	COQ2	1	COQ2	1	0.00971817601439273	WBGene00010369			Lennox-Gastaut syndrome;Myoclonic-astastic epilepsy;Epileptic encephalopathy;Epileptic encephalopathy childhood-onset	GO:0003723;GO:0005634;GO:0043231;GO:0000166;GO:0005524;GO:0005730;GO:0005654;GO:0016787;GO:0003677;GO:0006325;GO:0005515;GO:0032508;GO:0003678;GO:0004386;GO:0007517;GO:0042393;GO:0006357;GO:0000978	ATP binding;RNA binding;nucleus;intracellular membrane-bounded organelle;nucleotide binding;nucleoplasm;nucleolus;hydrolase activity;DNA binding;chromatin organization;protein binding;DNA duplex unwinding;DNA helicase activity;helicase activity;muscle organ development;histone binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;regulation of transcription by RNA polymerase II;cellular response to DNA damage stimulus;hematopoietic stem cell differentiation	ATP-binding;Alternative splicing;Chromatin regulator;DNA-binding;Disease mutation;Epilepsy;Helicase;Hydrolase;Myogenesis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation		
COQ2	negative	DUSP8	ENSG00000184545	COQ2	1	COQ2	1	0.00971817601439273	WBGene00006923				GO:0005634;GO:0005737;GO:0016787;GO:0004721;GO:0006470;GO:0004725;GO:0016311;GO:0035335;GO:0016791;GO:0008138;GO:0017017;GO:0000188	phosphatase activity;protein tyrosine phosphatase activity;protein dephosphorylation;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;MAP kinase tyrosine/serine/threonine phosphatase activity;nucleus;cytoplasm;hydrolase activity;phosphoprotein phosphatase activity;peptidyl-tyrosine dephosphorylation;inactivation of MAPK activity	3D-structure;Cytoplasm;Hydrolase;Nucleus;Protein phosphatase;Reference proteome	R-HSA-168256;R-HSA-162582;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-112409;R-HSA-5675221	Immune System;Signal Transduction;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;RAF-independent MAPK1/3 activation;Negative regulation of MAPK pathway
COQ2	negative	PPARA	ENSG00000186951	COQ2	1	COQ2	1	0.00971817601439273	WBGene00003601;WBGene00003629;WBGene00003675;WBGene00003709;WBGene00004786	WBGene00044353(0);WBGene00013512(0);WBGene00011565(0);WBGene00011566(0);WBGene00008901(0);WBGene00011568(0);WBGene00022639(0);WBGene00022640(0);WBGene00022637(0);WBGene00008208(0);WBGene00012050(0);WBGene00010017(0);WBGene00006471(0);WBGene00014068(0);WBGene00010186(0);WBGene00012056(0);WBGene00003641(0);WBGene00008884(0);WBGene00010601(0);WBGene00010602(0);WBGene00010600(0);WBGene00003642(0);WBGene00010603(0);WBGene00018404(0);WBGene00016927(0);WBGene00016926(0);WBGene00010180(0);WBGene00018541(0);WBGene00003614(0);WBGene00018545(0);WBGene00018544(0);WBGene00003608(0);WBGene00003702(0);WBGene00011396(0);WBGene00007367(0);WBGene00003653(0);WBGene00003640(0);WBGene00016367(0);WBGene00016366(0);WBGene00016365(0);WBGene00016368(0);WBGene00020750(0);WBGene00018542(0);WBGene00003638(0);WBGene00015897(0);WBGene00003648(0);WBGene00020852(0);WBGene00003715(0);WBGene00020850(0);WBGene00020849(0);WBGene00003705(0);WBGene00020851(0);WBGene00020015(0);WBGene00017961(0);WBGene00003685(0);WBGene00003696(0);WBGene00003708(0);WBGene00003728(0);WBGene00022805(0);WBGene00003669(0);WBGene00021610(0);WBGene00003632(0);WBGene00003698(0);WBGene00008830(0);WBGene00021611(0);WBGene00018265(0);WBGene00018266(0);WBGene00003646(0);WBGene00003725(0);WBGene00044699(0);WBGene00003620(0);WBGene00021617(0);WBGene00003651(0);WBGene00003618(0);WBGene00015497(0);WBGene00016517(0);WBGene00008619(0);WBGene00008630(0);WBGene00003723(0);WBGene00018415(0);WBGene00018622(0);WBGene00012446(0);WBGene00003655(0);WBGene00013584(0);WBGene00015901(0);WBGene00015900(0);WBGene00015902(0);WBGene00018539(0);WBGene00003680(0);WBGene00010215(0);WBGene00003722(0);WBGene00006790(0);WBGene00021522(0);WBGene00020062(0);WBGene00003693(0);WBGene00003617(0);WBGene00003716(0);WBGene00003718(0);WBGene00003724(0);WBGene00003686(0);WBGene00003712(0);WBGene00003677(0);WBGene00003694(0);WBGene00011520(0);WBGene00003692(0);WBGene00011750(0);WBGene00020385(0);WBGene00014189(0);WBGene00003663(0);WBGene00003671(0);WBGene00003672(0);WBGene00010410(0);WBGene00008778(0);WBGene00003662(0);WBGene00003667(0);WBGene00008474(0);WBGene00008289(0);WBGene00008056(0);WBGene00011651(0);WBGene00009608(0);WBGene00008158(0);WBGene00016233(0);WBGene00022756(0);WBGene00015758(0);WBGene00001062(0);WBGene00022726(0);WBGene00012596(0);WBGene00003714(0);WBGene00016772(0);WBGene00003658(0);WBGene00003704(0);WBGene00012703(0);WBGene00018412(0);WBGene00019742(0);WBGene00019741(0);WBGene00019743(0);WBGene00003688(0);WBGene00003713(0);WBGene00003689(0);WBGene00003645(0);WBGene00003720(0);WBGene00020153(0);WBGene00020152(0);WBGene00021163(0);WBGene00003649(0);WBGene00003721(0);WBGene00019115(0);WBGene00020555(0);WBGene00003634(0);WBGene00019116(0);WBGene00003707(0);WBGene00017503(0);WBGene00017512(0);WBGene00003700(0);WBGene00016364(0);WBGene00003684(0);WBGene00016091(0);WBGene00003717(0);WBGene00008309(0);WBGene00012449(0);WBGene00013067(0);WBGene00003644(0);WBGene00020460(0);WBGene00003615(0);WBGene00003699(0);WBGene00003676(0);WBGene00003601(0);WBGene00003611(0);WBGene00011002(0);WBGene00003622(0);WBGene00010604(0);WBGene00003643(0);WBGene00004786(0);WBGene00003624(0);WBGene00003682(0);WBGene00003660(0);WBGene00014193(0);WBGene00045515(0);WBGene00011150(0);WBGene00013940(0);WBGene00022097(0);WBGene00018189(0);WBGene00013483(0)	ANGPTL4;APOB;CETP;CYP1A1;LPL;NFKBIA;PDK4;PTGS2;SERPINE1;UGT1A9		GO:0005634;GO:0006355;GO:0003677;GO:0004879;GO:0030522;GO:0008270;GO:0003700;GO:0043565;GO:0050728;GO:0045944;GO:0046872;GO:0005654;GO:0005515;GO:0003707;GO:0043401;GO:0048511;GO:0032922;GO:0045893;GO:0008289;GO:0000981;GO:0030154;GO:0000977;GO:0000122;GO:0000790;GO:0008134;GO:0000978;GO:0001227;GO:0090575;GO:0038023;GO:0001228;GO:0009755;GO:0045892;GO:0000976;GO:0001223;GO:0019902;GO:0019904;GO:0044877;GO:0051525;GO:0097371;GO:0001666;GO:0006631;GO:0007507;GO:0008544;GO:0010468;GO:0032091;GO:0032099;GO:0032868;GO:0035095;GO:0042060;GO:0042157;GO:0042752;GO:0045722;GO:0045776;GO:0046321;GO:0061052;GO:0070166;GO:1901215;GO:0007275;GO:0006367;GO:0008144;GO:0006629;GO:1902894;GO:0001103;GO:0005504;GO:0019216;GO:0030374;GO:0010745;GO:0010887;GO:0015908;GO:1903038;GO:0033993;GO:0010871;GO:0032000;GO:0010891;GO:0045820;GO:0072369;GO:0031624;GO:0072363;GO:0072366	DNA binding;regulation of transcription, DNA-templated;nucleus;nuclear receptor activity;intracellular receptor signaling pathway;zinc ion binding;DNA-binding transcription factor activity;sequence-specific DNA binding;steroid hormone receptor activity;negative regulation of inflammatory response;positive regulation of transcription by RNA polymerase II;metal ion binding;nucleoplasm;protein binding;steroid hormone mediated signaling pathway;rhythmic process;lipid binding;circadian regulation of gene expression;positive regulation of transcription, DNA-templated;DNA-binding transcription factor activity, RNA polymerase II-specific;cell differentiation;multicellular organism development;negative regulation of transcription by RNA polymerase II;RNA polymerase II regulatory region sequence-specific DNA binding;nuclear chromatin;transcription factor binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;RNA polymerase II transcription factor complex;signaling receptor activity;DNA-binding transcription activator activity, RNA polymerase II-specific;hormone-mediated signaling pathway;negative regulation of transcription, DNA-templated;transcription regulatory region sequence-specific DNA binding;transcription coactivator binding;phosphatase binding;protein domain specific binding;protein-containing complex binding;NFAT protein binding;MDM2/MDM4 family protein binding;response to hypoxia;fatty acid metabolic process;heart development;epidermis development;cellular response to starvation;regulation of gene expression;negative regulation of protein binding;negative regulation of appetite;response to insulin;behavioral response to nicotine;wound healing;lipoprotein metabolic process;regulation of circadian rhythm;positive regulation of gluconeogenesis;negative regulation of blood pressure;positive regulation of fatty acid oxidation;negative regulation of cell growth involved in cardiac muscle cell development;enamel mineralization;negative regulation of neuron death;transcription initiation from RNA polymerase II promoter;drug binding;lipid metabolic process;RNA polymerase II repressing transcription factor binding;fatty acid binding;regulation of lipid metabolic process;negative regulation of glycolytic process;nuclear receptor transcription coactivator activity;ligand-activated transcription factor activity;response to lipid;negative regulation of macrophage derived foam cell differentiation;negative regulation of cholesterol storage;fatty acid transport;negative regulation of leukocyte cell-cell adhesion;response to nutrient levels;negative regulation of receptor biosynthetic process;positive regulation of fatty acid beta-oxidation;negative regulation of sequestering of triglyceride;positive regulation of fatty acid metabolic process;cellular response to lipid;regulation of fatty acid metabolic process;ubiquitin conjugating enzyme binding;regulation of cellular ketone metabolic process	3D-structure;Activator;Alternative splicing;Biological rhythms;DNA-binding;Lipid-binding;Metal-binding;Nucleus;Polymorphism;Receptor;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-1266738;R-HSA-1852241;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-381340;R-HSA-400206;R-HSA-2990846;R-HSA-3108232;R-HSA-8957322;R-HSA-1368108;R-HSA-400253;R-HSA-1592230;R-HSA-2151201;R-HSA-1655829;R-HSA-2426168;R-HSA-1368082;R-HSA-383280;R-HSA-4090294	Developmental Biology;Organelle biogenesis and maintenance;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;Metabolism of lipids;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of steroids;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Circadian Clock;Mitochondrial biogenesis;Transcriptional activation of mitochondrial biogenesis;Regulation of cholesterol biosynthesis by SREBP (SREBF);Activation of gene expression by SREBF (SREBP);RORA activates gene expression;Nuclear Receptor transcription pathway;SUMOylation of intracellular receptors
COQ2	negative	TSC22D2	ENSG00000196428	COQ2	1	COQ2	1	0.00971817601439273	WBGene00011824;WBGene00016269	WBGene00011824(0);WBGene00012994(0)			GO:0006355;GO:0003700;GO:0006357;GO:0000981;GO:0006970	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;response to osmotic stress	Alternative splicing;Polymorphism;Reference proteome		
COQ2	negative	ENTPD4	ENSG00000197217	COQ2	1	COQ2	1	0.00971817601439273	WBGene00003254;WBGene00016380	WBGene00003254(1);WBGene00016380(1)			GO:0016787;GO:0016020;GO:0016021;GO:0005794;GO:0000139;GO:0031410;GO:0000421;GO:0030173;GO:0017110;GO:0045134;GO:0034656;GO:0006256;GO:0097637	hydrolase activity;membrane;integral component of membrane;nucleotide binding;ATP binding;Golgi apparatus;cytoplasmic vesicle;Golgi membrane;autophagosome membrane;integral component of Golgi membrane;nucleoside-diphosphatase activity;uridine-diphosphatase activity;nucleobase-containing small molecule catabolic process;UDP catabolic process;integral component of autophagosome membrane	Alternative splicing;Calcium;Cytoplasmic vesicle;Disulfide bond;Glycoprotein;Golgi apparatus;Hydrolase;Magnesium;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-15869;R-HSA-8956319;R-HSA-8850843	Metabolism;Metabolism of nucleotides;Nucleobase catabolism;Phosphate bond hydrolysis by NTPDase proteins
COQ2	negative	LBH	ENSG00000213626	COQ2	1	COQ2	1	0.00971817601439273					GO:0005634;GO:0005737;GO:0006355;GO:0007275;GO:0045893;GO:0005515;GO:0032991;GO:0045892;GO:0043408;GO:0010468;GO:0030879;GO:0033147;GO:0060644;GO:1904674;GO:1904677;GO:2000103;GO:2000737	regulation of transcription, DNA-templated;nucleus;cytoplasm;multicellular organism development;positive regulation of transcription, DNA-templated;protein binding;protein-containing complex;negative regulation of transcription, DNA-templated;regulation of MAPK cascade;regulation of gene expression;mammary gland development;negative regulation of intracellular estrogen receptor signaling pathway;mammary gland epithelial cell differentiation;positive regulation of somatic stem cell population maintenance;positive regulation of somatic stem cell division;positive regulation of mammary stem cell proliferation;negative regulation of stem cell differentiation	Cytoplasm;Developmental protein;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation		
COQ2	negative	TNFRSF25	ENSG00000215788	COQ2	1	COQ2	1	0.00971817601439273					GO:0016020;GO:0016021;GO:0007165;GO:0005515;GO:0005829;GO:0005886;GO:0005576;GO:0006915;GO:0033209;GO:0038023;GO:0042981;GO:0005887;GO:0007166;GO:0097190;GO:0005031	protein binding;signal transduction;membrane;integral component of membrane;cytosol;plasma membrane;extracellular region;apoptotic process;tumor necrosis factor-mediated signaling pathway;signaling receptor activity;regulation of apoptotic process;integral component of plasma membrane;cell surface receptor signaling pathway;apoptotic signaling pathway;tumor necrosis factor-activated receptor activity	3D-structure;Alternative splicing;Apoptosis;Cell membrane;Disulfide bond;Glycoprotein;Membrane;Polymorphism;Receptor;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix	R-HSA-168256;R-HSA-1280215;R-HSA-5668541;R-HSA-5669034	Immune System;Cytokine Signaling in Immune system;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
